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CASPASE ISOFORMS IN INFLAMMASOME FORMATION
Zsofia Digby 
Summary
Inflammasomes are macromolecular signalling platforms composed of a receptor (for example 
NLRP3 or NLRC4), an adaptor (ASC) and effectors (caspases) that are thought to play critical 
roles in the host defence against microbial infections. Activation of inflammasomes leads to the 
processing of the pro-inflammatory cytokines pro-IL-1β and pro- IL-18 to their active form and 
cleavage of gasdermin D to induce pyroptosis. Caspase-1 is the main inflammatory caspase 
responsible for cytokine maturation and induction of cell death, while human caspase-4, -5 and the 
mouse orthologue caspase-11 play an essential role in cytosolic bacterial LPS recognition. The 
putative importance of inflammasomes suggest that their constituents should be conserved across 
different animal species, but there are major differences, particularly in the caspase repertoire, in 
both invertebrates and vertebrates. The dog (Canis lupus familiaris), for example, has a 
pseudogene for NLRC4 and has a unique caspase-1/4/11 hybrid gene (CASP1-4/5/11) comprising 
the caspase-1 caspase recruitment domain (CARD) and the catalytic domain of caspase-4/5/11. 
Dogs produce bioactive IL-1β despite the apparent lack of the catalytically active domain of 
caspase-1, but how this occurs and whether inflammasome activation of CASP1-4/5/11 is required 
remains to be resolved. 
In this study I characterised inflammasome function in dog macrophages (DH82 cell line) and 
mouse macrophages where a caspase 1/4/11 fusion protein that is functional equivalent to CASP1-
4/5/11 (DogMo) had been generated by CRISPR/Cas9 gene editing. I used imaging (ASC and 
active caspase speck formation), cell death analysis and IL-β production as readouts before and 
after editing of key genes in inflammasome formation using CRISPR-Cas9 gene editing 
approaches. 
The NLRP3 inflammasome is functional in dog macrophages, but the rate of inflammasome 
formation is lower compared to wild-type murine macrophages. This suggests that dog 
macrophages may be adapted to be tolerant to NLRP3 inflammasome activation only undergoing 
lytic cell death and IL-1β maturation when exposed to high concentrations of NLRP3 
inflammasome activating ligands. DogMo cells retained full NLRP3 functionality. 
viii 
Cytosolic LPS-induced non-canonical inflammasome activation induced IL-1β maturation and 
secretion without concomitant cell death induction in dog macrophages. No ASC speck formation 
or activated caspase speck was seen suggesting there are alternative pathways for cytosolic LPS 
recognition and the consequential IL-1β maturation. DogMo cells did not induce non-canonical 
inflammasome formation. 
The NLRC4 inflammasome should not function in the dog and indeed DH82 cells infected with 
wild-type S. Typhimurium showed no ASC speck formation or active caspase recruitment and 
delayed cell death (compared to their wild-type mouse counterpart), but cleaved IL-1β was present 
in the supernatant. The processed IL-1β was smaller than the p17 fragment normally associated 
with cleavage by caspase-1. DogMo cells, which express NLRC4, did not process IL-1β as 
expected due to the lack of the catalytic domain of caspase-1 but still induced cell death albeit at 
a reduced level to wild-type mouse macrophages. 
S. Typhimurium infection of CRISPR/Cas9 gene edited DH82 cells to remove CASP1-4/5/11
showed that cell death was independent of this caspase. Collectively, these data indicate that in
dog cells processing of pro-IL-1β and cell death occurs by inflammasome-independent pathways.
CRISPR/Cas9 gene editing of DH82 cells to remove the necroptotic cell death initiator RIP kinase
1 and apoptotic cell death initiator caspase-8 genes identified an essential role for RIPK1 in pro-
IL-1β priming, and potentially, for caspase-8 in IL-1β maturation.
The characterisation of caspase functionality in dog and DogMo cells show marked differences 
despite their expression of a similar protein. The deficit in inflammasome functionality in the dog 
could point to an evolutionary adaptation to tolerate microorganisms associated with their lifestyle 
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1.1 Innate Immunity 
Pathogenic microorganisms including bacteria, fungi, viruses and protozoans are capable of 
causing infection which can be detrimental to the host. To counteract this microbial threat, host 
species have evolved immune systems that function in the prevention and clearance of infection. 
In vertebrates, the immune system is comprised of both the innate and adaptive arms which provide 
non-specific and specific immunity to pathogens, respectively. In comparison, invertebrates and 
jawless fish are solely reliant on their innate immune system to combat infection. The innate 
arm provides rapid but non-clonal responses which are conserved in nature. Innate 
immunity effectively serves as a first line of defence and responds to pathogens and changes 
in cellular homeostasis to initiate responses in order to resolve infection and repair tissue 
damage. Moreover, innate immune responses (e.g. antigen presentation, cytokine release) are 
also required for the development of the adaptive immune response (e.g. B and T cell 
activation). The existence of an innate immune memory termed “trained immunity”, has been 
proposed through transcriptional and epigenetic reprogramming of innate immune cells [1], [2] 
1.2 Pattern Recognition Receptors 
Innate immune responses are principally mediated via a group of germ-line encoded proteins called 
pattern recognition receptors (PRRs) which are able to detect both evolutionarily conserved 
structures associated with microorganisms termed pathogen associated molecular patterns 
(PAMPs) and host-derived endogenous ligands. PRRs can be found across the animal kingdom 
ranging from primitive organisms to higher vertebrates [3]. The concept of PRRs in innate 
immunity was first introduced by Charles Janeway [4]. This was proceeded by the discovery of 
the first innate signalling receptor (Toll) in Drosophila Melanogaster which was shown to be 
activated by the endogenous cytokine Spätzle, that is generated in response to microbial pathogens 
[3]. There is a large variation in the PRR repertoire found in different vertebrate species which 
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may have arisen as the consequence of differences in evolutionary pressures imparted during the 
development of the innate immune system.  
 
PRRs can be conveniently divided into five distinct classes (Figure 1.2.1) based on their function, 
ligand specificity and cellular localisation [4], [5]. PRRs are expressed in a variety of immune cell 
sub-sets including macrophages, dendritic cells, monocytes, neutrophils and also non-immune cell 
types e.g. epithelial cells and fibroblasts [6]. Activated PRRs can induce signalling cascades 
resulting in pro-inflammatory responses which aim to eliminate invading pathogens and restore 
cellular homeostasis [7]. These cellular events include the production of a plethora of different 
cytokines and chemokines, as well as the induction of various forms of cell death [8]. Cytokine 
induced cell signalling can initiate particular responses following receptor binding on target cells 
in an autocrine, paracrine or endocrine fashion. The inflammatory roles afforded to cytokines 
include enhancing agent specific immune activation, memory development and the recruitment of 




Figure 1.2.1 Five distinct classes of PRRs. PRRs comprise the Toll-like receptors (TLRs), C-
type lectin receptors (CLRs), RIG-like receptors (RLRs), NOD-like receptors (NLRs), absent in 




 1.2.1 Toll-like Receptors 
 
Toll-like receptors (TLRs) represent a family of transmembrane glycoproteins which sense 
invading pathogens through recognition of PAMPS. They also play a role in the detection of 
endogenous (host-derived) damage associated molecular patterns (DAMPs). To date, humans 
contain ten (TLR1-10), dogs contain nine functional TLRs (TLR1, 3-10) whereas mice express a 
complement of twelve (TLR1-9, 11-13) [9], [10]. Little is known  however, about the effect of 
differences in TLRs on canine specific pathogen recognition and their associated downstream 
signalling pathways [11]. For example, dogs possess TLR2, -11 and -12 as pseudogenes, where 
the former is positioned upstream in tandem with its functional counterpart [9], while the canine 
TLR4 receptor is predicted to lack a transmembrane region [12].  
 
TLR structure and function are highly conserved across the animal kingdom. They are expressed 
in both, immune (monocytes, dendritic cells, macrophages) and non-immune cells (fibroblasts, 
endothelial cells and epithelial cells). Human TLR1, -2, -4, -5, -6, -10 and -11 are expressed in the 
plasma membrane, while TLR3, -7, -8 and -9 are expressed in endosomal membranes. TLRs 
comprise a tripartite structure: an N-terminal leucine-rich repeat domain involved in ligand-
sensing, a transmembrane spanning region and a cytoplasmic Toll/IL-1R (TIR) domain [13]. TIR 
domain homologues are found in plants which confer resistance against pathogens in plants [10]. 
Ligand binding results in the dimerization/stabilisation of pre-formed dimers of TLRs, leading to 
TIR domain interactions and the recruitment of compatible adaptor proteins; myeloid 
differentiation primary response 88 (MyD88), TIR-domain-containing adapter-inducing 
interferon-β (TRIF), MyD88 adaptor-like (Mal) or TRIF-related adaptor molecule (TRAM) [14], 
[15]. Activated TLRs promote transcription of pro-inflammatory receptors and cytokines via 
downstream signalling pathways mediated by their adaptor proteins. TLR1-2, 5-11 preferentially 
signal through MyD88/Mal adaptors activating nuclear factor kappa-light-chain-enhancer of 
activated B cells (NF-κβ) and interferon regulatory factor 3 (IRF3) transcriptions factors resulting 
in inflammatory gene transcription [16], [17]. TLR4 can signal via all adaptor proteins 
(MyD88/Mal/TRIF/TRAM) whilst TLR3 signals through adaptor TRIF activating the NF-κβ 
transcription factor and mitogen-activated protein kinases (MAPK) [16], [17]. Toll-like receptors 
exhibit high ligand specificity (Table 2.1.1). For example, TLR1 recognises triacyl lipoproteins 
4 
 
[18], TLR2 recognises peptidoglycans and signals in heterodimers with either TLR1 or TLR6 [19], 
while TLR4 recognises bacterial LPS [20]. Collectively, TLRs are crucial for host defence against 
a broad spectrum of pathogenic agents, while their inappropriate activation can lead to chronic 
inflammatory and auto-inflammatory disease in humans [21]. Thus far, efforts to link TLRs and 




Table 1.2.1.1 List of functional Toll-like receptors (TLRs) found in humans and mice and 
their cognate ligands.  
 
 1.2.2 Nod-like Receptors 
 
The identification of plant R-genes responsible for species-specific resistance against plant 
pathogens  [24], [25] and their subsequent sequence homology studies in humans led to the 
discovery of the first NLR protein [26]. As a group, the NLRs are members of the ATPases 
associated with diverse cellular activities (AAA+) or signal transduction ATPases with numerous 
Toll-like receptor (TLR) Ligand Species 
TLR1 Triacylated lipoproteins human, mouse 
TLR2 Triacylated lipoproteins human, mouse 
TLR3 dsRNA human, mouse 
TLR4 LPS human, mouse 
TLR5 Bacterial flagellin human, mouse 
TLR6 Diacetylated lipoproteins human, mouse 
TLR7 Viral ssRNA human, mouse 
TLR8 Viral ssRNA human, mouse 
TLR9 
Non-methylated CpG DNA 
motifs 
 human, mouse 
TLR10 Unknown human 
TLR11 Bacterial flagellin mouse 
TLR12 Unknown mouse 
TLR13 Unknown mouse 
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domains (STAND) family [27]. NLRs provide an essential function in the recognition of 
intracellular pathogens and their consequent cellular disturbances [28]–[30]. NLRs are cytosolic 
proteins [31] which can be conveniently divided into four subfamilies based on the structure of 
their variable N-terminal region (Figure 1.2.2.1) [32]. Genes encoding NLR proteins appeared 
early in evolution as shown by the presence of NLR precursors in basal metazoans, such as sea 
urchins however, they are absent in nematodes and insects [33], [34]. NLR proteins typically 
comprise of three distinct domains: The N-terminal effector domain consists of either PYRIN 
(PYD), caspase activation and recruitment (CARD) or baculovirus inhibitor repeats (BIR). Their 
central nucleotide-binding domains (NBD), which can contain either NACHT (domain present in 
neuronal apoptosis inhibitor protein [NAIP], CIITA (major histocompatibility complex class II 
(MHC-II) transactivator), HET-E (plant het gene product involved in vegetative incompatibility), 
TP-1 (telomerase-associated protein 1) or NACHT-associated domain (NAD) [35]. NBD have 
been associated with functions including the regulation of signal transduction, but are also known 
to form homo- and heterotypic protein interactions [36]. These interactions mediate ATP-
dependent proximity-induced self-oligomerisation which is essential for their activation and 
initiation of downstream signalling events [27]. The C-terminal domain consisting of leucine-rich 
repeats (LRRs) can play a role in ligand binding [6], [36].  
 
To date, there are over 22 NLRs found in humans and 34 described in mice [6]. Although they are 
highly conserved among eukaryotic species, comparative genome studies have revealed several 
species-specific differences in NLR repertoires. For example, nucleotide-binding oligomerization 
domain, leucine rich repeat and pyrin domain containing protein 11 (NLRP11) appears to be 
primate specific [37], murine NAIPs have undergone expansion [38], NLRP4 is primate and rodent 
specific, while NLRP8 and -13 have been lost in rodents [37]. Zebrafish NLRs have undergone a 
large expansion and contain over 400 members within the family with some members being unique 
to teleost fish [39], [40]. Dogs lack NAIP genes and their NLRC4 gene exists as a pseudogene [41]. 
There exists little evidence to explain how these species-specific differences have shaped the NLR-








Figure 1.2.2.1 NLR family members and their domain organisation. Structurally NLRs 
comprise a variable amino-terminal death-fold domain (DD), caspase activation and recruitment 
domain (CARD), pyrin domain (PYD), baculovirus inhibitor repeats (BIRs), central nucleotide-
binding domain (NBD) and a carboxyl-terminal leucine-rich repeat domains (LRRs). 
 
An important consequence of NLR-mediated cytosolic recognition of PAMPs and DAMPs is the 
assembly of a cytosolic macromolecular protein complex called the inflammasome.  
 
 1.2.3 Inflammasomes 
 
Inflammasomes act as a platform for inflammatory caspase activation leading to the processing of 
inflammatory cytokines pro-interleukin-1β (pro-IL-1β) and pro-IL-18 into their active forms 
through direct cleavage [42]. An additional consequence of inflammasome assembly is the 
induction of pyroptotic cell death and the release of the processed cytokines via the cleavage and 
activation of executioner protein Gasdermin D (GSDMD) which forms pores in membranes [43], 
[44]. 
 
The term inflammasome was first introduced in a study from 2002 which described the interaction 
of NLR’s with the apoptosis-associated speck-like protein (ASC) via their PYD-PYD domains, 
which in turn facilitates recruitment of caspase-1 to ASC via a CARD-CARD interaction [42]. 
Upon sensing PAMPs and DAMPs, certain PRRs including NLRP3 [45], NAIP/nod-like receptor 
family caspase-activating and recruitment domain containing 4 (NLRC4) [46], hematopoietic 
expression interferon-inducible nature nuclear localization (HIN-200); absent in melanoma-2 
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(AIM-2) [47], PYRIN [48] and gamma-interferon-inducible protein 16 (IFI16) [49] oligomerize 
to form inflammasomes. Other NLRs, including human NLRP2 [50], NLRP7 [51] and mouse 
NLRP6 [52], NLRP9b [53] and NLRP12 [54] have also been proposed to form inflammasomes, 
although this has yet to be fully confirmed experimentally. 
 
ASC, contains both a PYD and CARD domain and is essential for PYD containing receptors that 
do not comprise a CARD domain (e.g. NLRP3) to recruit caspase-1, while CARD containing 
receptors e.g. NLRC4 can recruit and activate pro-caspase-1 via homotypic interaction [55]. ASC 
activation and recruitment to the receptors induces oligomerisation of the ASC monomers [56] and 
has been shown to facilitate downstream signalling in response to PYD and also CARD containing 
receptor activation [57]. Condensed ASC effectively serves as a bridge between NLRs and the 
effector caspase proteins [57], [58]. There are species-specific differences with regards 
inflammasome composition which form part of the subject of this thesis.  
 
Inflammasomes have been classified as either canonical or non-canonical. Assembly of a canonical 
inflammasome (Figure 1.2.3.1) results in caspase-1 activation [59], whereas non-canonical 
inflammasome formation (Figure 1.2.3.2) is mediated by caspase-11 in mice [60] and caspase-4, -
5 in humans [61].  
 
Depending on the type of insult, more than one NLR can be activated within a single cell forming 
an inflammasome which can contain the multiple NLRs and caspases [62]. After the assembly of 
the receptor complex, recruited ASC oligomerizes via the PYD domains forming a filamentous 
scaffold [58], [63]. Analysis of electron micrographs of purified NAIP5-NLRC4 inflammasomes 
from HEK293E cells showed that inflammasomes adopt an open wheel like structure displaying 
11-12 spokes on their surface [64], [65]. ASC CARD domains remain exposed on the surface [63], 
which can then interact with pro-caspase-1 via CARD-CARD interactions. The ASC oligomeric 
complex [66] cluster can be visualised as a discrete cytoplasmic ASC speck [67], [68] with a 
diameter of approximately 1 micron. These protein-protein interactions result in the assembly of a 
platform where pro-caspase-1 can be recruited, leading to proximity induced dimerization and 




GSDMD is a recently described human caspase-1/-4/-5 and mouse caspase-1/-11 protein substrate 
[43], [44]. GSDMD protein is highly conserved in mammals and is comprised of approximately 
480 amino acids [69]. Following inflammatory caspase activation, GSDMD is cleaved into N- and 
C-terminal fragments. The N-terminal domain of approximately 30 kDa [43] binds with high 
affinity to phosphatidylserines and cardiolipins [70] of the plasma membrane causing pore 
formation which facilitates pro-inflammatory cytokine release and pyroptotic cell death [71]–[73]. 
Cleavage of the GSDMD linker region by human caspase-4 and -5 was also shown in mouse 
BMDMs [44]. Pores formed in the cell membrane by GSDMD-N fragment have a ring like 
structure [74] with an approx. 10-14nm inner diameter and comprises 16 symmetric protomers 
[75].  
 
Inflammasome activation and formation is a tightly regulated process, however, gain of function 
or loss of function mutations in inflammasome genes can lead to inappropriate inflammasome 
activation. Dysregulated inflammatory responses can then lead to the development of auto-
inflammatory or autoimmune diseases. Some of the many auto-inflammatory diseases include 
gain-of-function mutations in the NLRP3 gene causing cryopyrin-associated periodic syndrome 






Figure 1.2.3.1 A subset of PRRs can form canonical inflammasomes. PRR activation upon 
ligand recognition promotes the recruitment of the adaptor protein ASC. Polymerised ASC acts as 
a scaffold facilitating the recruitment of pro-inflammatory caspase-1 to the inflammasome. 
Activated caspase-1 cleaves inflammatory cytokines pro-IL-1β and pro-IL-18 into their active 





Figure 1.2.3.2 Schematic of non-canonical inflammasome formation mediated by human 
caspase-4, -5 and its murine homologue caspase-11. Gram-negative bacterial LPS is directly 
recognised by human caspase-4, -5 and murine caspase-11. This results in their oligomerisation, 
subsequent activation and non-canonical inflammasome formation. Caspase-4/5/11 cleaves 
GSDMD which in turn drives pyroptotic cell death. GSDMD cleavage subsequently activates non-






NLRP3, also known as cryopyrin or NALP3, was first shown to be activated in response to ATP 
and bacterial toxins (nigericin and maitotoxin) and that it also assembles into an inflammasome 
following its activation [78]. The NLRP3 inflammasome is the most well studied and different 
activation mechanisms have been proposed to explain the molecular events that underly its 
assembly. It has been proposed that NLRP3 acts as a general sensor for perturbations in cell 
homeostasis [79], [80]. These include increase in intracellular calcium [81] and reduction in levels 
of intracellular potassium [82]. Moreover, increase of extracellular potassium and the inhibition of 
potassium efflux [83] has been shown to inhibit NLRP3 inflammasome formation. Activating 
signals also include extracellular ATP [82], uric acid crystals [84], bacterial pore forming toxins 
[82], [85], Gram-positive (e.g. Staphylococcus aureus) [86] and Gram-negative bacteria (e.g. S. 
Typhimurium) [62], [87], viruses [88], fungal [89] and protozoan infections [90]. These activators 
can induce mitochondrial membrane disruption [82], lysosomal rupture [91], cathepsin B release 
[92], mitochondrial-associated dysfunction [93], cardiolipin translocation of the mitochondria [94] 
and oxidised mitochondrial DNA release [95]. Despite the expression of NLRP3 in many other 
species, its’ precise function and importance in controlling pathogenesis remains not fully 
understood. Recent research investigating the role of NLRP3 in other species suggests similar roles 
to that observed in humans and mice. For example, NLRP3 was shown in vitro to play an important 
role in swine PBMCs response to classical swine fever virus [96] and in vivo in Cherry Valley 
Duck immune responses to challenge with avian pathogenic E. coli [97].  
 
The sequence of events leading to the activation of the canonical NLRP3 inflammasome (Figure 
1.2.4.1) consists  of two distinct stages [98]. The first step involves ligand  priming of the TLR, 
when TLRs via the MyD88 pathway [99], nucleotide-binding oligomerisation domain containing 
protein 2 (NOD2) or TNFR1/2 activation [100] induces NF-κB transcription factor [98] and 
MAPK activation [101], resulting in the upregulation of NLRP3 and pro-IL-1β expression. 
Schroder et al. suggested that the priming step also induces post-translational modifications in 
NLRP3 receptors, as a short-period of pre-incubation with LPS did not alter NLRP3 expression 
levels, but did augment inflammasome activation [102]. The second, activation step is initiated 
upon NLR ligand binding in an ATP-dependent manner, which is followed by NLRP3-
oligomerisation and ASC recruitment. Several molecules have been shown to regulate the 
transcriptional and translational induction and modification of the NLRP3 receptor. 
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BRCA1/BRCA2-Containing Complex Subunit 3 (BRCC3) mediated deubiquitylation of NLRP3 
has been suggested to be preconditional to NLRP3 inflammasome activation [103]. Among others, 
FAS-associated death domain protein (FADD) and caspase-8 have been shown to regulate priming 
and induction of NLRP3 expression [104], whilst MyD88, IL-1 receptor-associated kinase 1 and 
4 (IRAK1/4) and TRIF regulate transcriptional and post-transcriptional NLRP3 induction and 
activation [105], [106]. The role of never in mitosis A (NIMA)-related kinase family member 
NEK7 as an NLRP3 inflammasome regulator has been reported in three independent studies 
[107]–[109]. The NEK7 catalytic domain has been shown to directly bind the LRR domain of 
NLRP3 to control NLRP3 oligomerization, and subsequent ASC-speck formation and caspase-1 
activation  [107], [108]. Additional post-translational modifications by spleen tyrosine kinase 
(SYK) [110], protein-tyrosine kinase 2 (PYK2) [111] and bruton tyrosine kinase (BTK) [112] were 
shown to positively regulate NLRP3 inflammasome formation. In contrast, phosphorylation by 
protein kinase A (PKA) [113], nitrosylation [114] and autophagy [115] appear to negatively 
regulate the NLRP3 inflammasome. Although, NLRP3 was first discovered as the underlying 
driver in the pathogenesis of familial cold auto-inflammatory and Muckle-Wells syndromes [76], 
its role in excessive inflammation has been linked to numerous other inflammatory diseases 








Figure 1.2.4.1 The NLRP3 inflammasome. NLRP3 inflammasome formation involves a two-
step activation system. Signal 1 induces protein expression of pro-inflammatory cytokines and 
inflammasome components. Ligand sensing acts as signal 2 resulting in NLRP3 oligomerisation, 
ASC and inflammatory pro-caspase-1 recruitment. Active caspase-1 drives cytokine maturation 
and GSDMD cleavage. The active N-terminal fragment of GSDMD induces pore formation in the 




NLRC4 was originally named IL-1-converting enzyme (ICE)-protease-activating factor due to its 
role in caspase-1 activation [121], [122]. It contains a C-terminal LRR, a central NACHT and an 
N-terminal CARD domain, which can bind directly to pro-caspase-1 via homotypic CARD 
interactions [121]. NLRC4 has been shown to be crucial in immune responses against intracellular 
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pathogens such as S. Typhimurium [123], Shigella flexneri, Pseudomonas aureginosa and 
Legionella pneumophila [124]. Unlike NLRP3, NLRC4 is constitutively expressed in 
macrophages and dendritic cells and therefore does not require transcriptional priming [121], 
[125]. In a resting cell, NLRC4 exists in an auto-inhibited state via LRRs and NBD cis interactions 
[126]. Upon ligand detection, protein kinase C delta (PKCδ) or leucine-rich repeat kinase 2 
(LRRK2) [127] mediated phosphorylation of NLRC4 on S533 [128], [129] driving self-
oligomerisation, adapter ASC recruitment and inflammasome formation [130]. The NLRC4 family 
contains the NAIPs which act as sensor molecules upstream of NLRC4 [131], and their direct 
interaction with bacterial ligands provide specific ligand recognition of PAMPs translocated to the 
host cytosol by the bacterial type III secretion systems (T3SS) [55], [132]. Upon ligand binding, 
NAIP and NLRC4 hetero-oligomerize and form the NAIP/NLRC4 inflammasome [64]. Further 
studies have revealed that flagellin, T3SS rod and needle proteins are also capable of NLRC4-
mediated caspase-1 activation. Specifically, murine NAIP1 recognises T3SS needle proteins e.g. 
Prgl and SSaG [133], NAIP2 recognises T3SS rod proteins e.g. PrgJ, while NAIP5/6 recognises 
flagellin [46]. Human NAIP [38] recognises the needle component of the T3SS, similarly to 
murine NAIP1 [46]. Bacterial ligand binding occurs via NAIPs’ HD1-WHD-HD2 domain regions 
[131], which results in the exposure of the catalytic surface of the receptor. These conformational 
changes allow NLRC4 receptor binding which then undergoes structural changes at the WHD 
domain region [134]. This facilitates the recruitment and self-oligomerization of additional 
NLRC4 receptors, and ultimately the formation of  NAIP/NLRC4 inflammasomes (Figure 1.2.5.1) 
[46].  
 
The mouse genome contains multiple NAIP genes, while humans encode only a single gene 
equivalent. Alternative splicing of human NAIP however has been suggested in primary human 
macrophages [135]. NAIP/NLRC4 receptors are highly conserved across mammalian species. 
There is, however, evidence for species-specific differences e.g. zebrafish lack NAIP/NLRC4 
orthologues but inflammasome-like complexes have been shown to assemble in zebrafish 
neutrophils in response to S. Typhimurium flagellin [136]. NAIP orthologues are present in frogs 
[137], while dogs and pigs lack functional NAIP/NLRC4 genes [41], [138]. Specifically, dogs lack 
NAIPs and their NLRC4 gene has been rendered inactive due to multiple deleterious mutations 
[41]. The very same mutations can also be found in wolves. Interestingly this not the case for 
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felidae, another member of the carnivora order, where the respective NLRC4 gene does not contain 
premature stop codons [41]. The functional consequences of these differences in species-specific 
pathogen recognition and subsequent clearance have yet to be fully elucidated.  
 
Within the NAIP/NLRC4 inflammasome a single NAIP receptor can be found in association with 
multiple NLRC4 receptors [134] and arranged in a wheel-like structure [139]. NLRC4  can recruit 
pro-caspase-1 directly via CARD-CARD interactions [121], or indirectly via ASC adapter protein 
[140] to form the canonical NLRC4 inflammasome. NLRC4 inflammasome mediated pyroptosis 
and GSDMD cleavage happen independently from ASC [123], but IL-1β and IL-18 maturation is 
greatly enhanced when ASC is recruited to the complex [140], [141]. The NLRC4 inflammasome 
can cooperate with NLRP3 to augment the inflammatory responses resulting in the recruitment of 
both, caspase-1 and caspase-8 to the assembled complex. Within the inflammasome active 
caspase-1 drives IL-1β and IL-18 maturation, while recruited caspase-8 modulates their processing 












Figure 1.2.5.1 The NLRC4 inflammasome. Flagellin and type III SS components are directly 
recognised by NAIP sensor proteins. Ligand bound NAIPs engage with multiple NLRC4 receptors 
resulting in their activation and oligomerisation. NLRC4 subsequently recruits ASC and pro-
caspase-1 resulting in NLRC4 inflammasome assembly. Activated caspase-1 drives pro-
inflammatory cytokines IL-1β and IL-18 maturation and induces pyroptotic cell death via 
GSDMD-NT. 
 
 1.2.6 Caspases 
 
Caspases are evolutionary conserved cysteine-aspartic acid proteases [142] that play an essential 
role in programmed cell death (apoptosis and pyroptosis) and cytokine maturation [143]. Caspase-
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1, originally named IL-1β-converting enzyme was the first of the caspases to be identified and was 
shown to exist in an inactive zymogen form within the cytosol [144], [145]. The N-terminal 
domain can either contain a CARD (caspase-1, -2, -4, -5, -9, -11, -12) or DED pro-domain 
(caspase-8, 10) which enable homotypic protein-protein interactions. The C-terminal domain 
consists of a smaller and larger subunit (p10 and p20, respectively) which together contain residues 
essential for catalytic activity with the small and large subunits linked together with an inter-
subunit linker region [146]. Close proximity of multiple pro-caspases induces their auto-
proteolytic cleavage (pro-domain linker and inter-subunit linker) [147] leading to  the generation 
and heterodimerization of p10 and p20 subunits and their subsequent activation. Caspases can be 
divided into two major groups based on their function. To date there are five known mammalian 
pro-inflammatory (caspase-1, 4, 5, 11, 12) and seven pro-apoptotic (caspase-2, 3, 6, 7, 8, 9, 10) 
caspases [148]. Pro-apoptotic caspases can be further categorised into initiator (caspase-2, -8, -9 
and -10) and effector (caspase-3, -6, and -7) caspases based on their function [149]. In contrast, 
caspase-14 has been suggested to have a role in proliferation and differentiation, it appears to have 
no apoptotic or inflammatory function [150]. Activated inflammatory caspases cleave after 
aspartic residues in the precursor forms of IL-1β and IL-18 converting them into their biologically 
active forms [142]. Activated caspase 1/11/4/5 also execute pyroptotic cell death by cleaving 
GSDMD [43], [44], [151].  
 
Caspases contain a somewhat variable substrate recognition motif which enables functional 
complexity and also redundancy in their substrates and therefore functions [142]. Mammalian 
inflammatory genes are present in a so-called inflammatory gene cluster. Early on during 
mammalian evolution the amplification of the caspase-1 gene resulted in the appearance of 
additional inflammatory caspases. Gene amplification and selective gene loss can give rise to 
caspases redundant in their function and also caspases gaining different or even entirely new 
functions in different species. In humans, there are 14 proteins containing a C14 peptidase domain. 
With the exception of caspase-12, which has been reported  to inhibit inflammation in mice [152] 
the proteolytic activity of all other caspases has been shown [153]. Interestingly, the human 
equivalent of inflammatory caspases-1 and -4 are fused together forming a hybrid gene in dogs 
and cats [154]. Human caspase-12 gene produces a truncated protein after the CARD domain [153] 
generating a catalytically inactive enzyme. Genes encoding inflammatory caspase-12 in dogs and 
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cats contain multiple splice variants resulting in the expression of either one or two CARD 
domains. In contrast to human caspase-12, canine caspase-12 was shown to be capable of 
autocatalytic processing in an E. coli overexpression system [41].  
 
 1.2.6.1 Caspase-1 
 
The elucidation of the Nematode cell death protein 3’s (CED3) essential role in cell death [155], 
[156] led to the discovery and characterisation of its mammalian homologue ICE, later termed 
caspase-1 [144]. Caspase-1 activation requires ASC polymerisation [157] and subsequent 
inflammasome formation [123]. Mature caspase-1 cleaves the pro-inflammatory cytokines IL-1β 
and IL-18 at aspartic acid resides Asp116-117 and Asp35-Asn36, respectively [144]. Caspase-1 is 
the main inflammatory caspase recruited to the canonical NLRP3 and NLRC4 inflammasomes in 
inducing cell death and cytokine maturation. It also has a crucial role in cytokine processing 
downstream of the non-canonical caspase-11 inflammasome induced NLRP3 inflammasome 
[158], [159]. The function of human and mouse inflammatory caspases have been extensively 
researched, while there is little known about their function in other species. The canine caspase-1 
family locus contains only two C14 peptidase domain containing genes, namely caspase-12 and 
the hybrid caspase-1-4/5/11. Dogs, as well as cats have lost the 3’terminal of caspase-1 and the 
5’terminal of caspase-4 genes [154]. The first three exons of the hybrid gene resemble the first 
three exons of human and murine caspase-1, while exons 4 to 10 shows high similarity to exons 2 
to 8 of the human caspase-4 and murine caspase-11, respectively [154]. These proteins show the 
typical domain organization of caspases, that is, an N-terminal pro-domain, a C-terminal 
catalytically active caspase domain and cleavage sites [154]. Alternative splicing can produce two 
isoforms by facultative inclusion of the exon 4, which results in the presence of two tandem CARD 
domains [154]. There is, however, little information about the functional consequences of the 
caspase-1/4/11 gene fusion.  
 
 1.2.6.2 Caspase-11, -4 and -5 
 
Caspase-11 was discovered based on its high sequence similarity (46%) to caspase-1 [160]. Early 
in vivo experiments carried out using caspase-1-/- and caspase-11-/- mice suggested redundant roles 
of these caspases in resistance to lethal sepsis [161], [162]. Later on, caspase-1-/-  mice proved to 
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be also deficient for caspase-11 due to a passenger mutation present in 129-embryonic stem cells 
used to generate caspase-1 knock-out mice [60]. Subsequent experiments showed that caspase-1-
/- mice were susceptible to LPS induced lethal sepsis, while caspase-11-/- mice proved to be 
resistant [60]. These results suggested the existence of two different pathways mediated by these 
caspases. Activated caspase-11 alone, within cells, cannot cleave pro-IL-1β and pro-IL-18 [163]. 
Further experiments showed that the induction of pyroptotic cell death does not require the 
presence of either NLRP3, adapter protein ASC [60] or caspase-1. In contrast to the induction of 
cell death, inflammatory cytokines pro-IL-1β and IL-18 maturation relies on the activation of 
caspase-1 via the NLRP3 inflammasome [60].  
 
Caspase-11 was shown to form a so-called non-canonical inflammasome (Figure 1.2.6.2.1) in 
response to e.g. E. coli [60], Shigella Flexneri [164] and S. Typhimurium [165] leading to  
pyroptotic cell death and pro-IL-1β maturation. The non-canonical caspase-11 inflammasome can 
restrict the replication and promote the clearance of cytosolic bacteria (e.g. enteropathogenic E. 
coli) in vivo [166], [167].  Ligand recognition is mediated via a TLR4 and NLR-independent 
manner where the CARD domain of murine capase-11 and human caspase-4, -5 is thought to 
directly bind and form a complex with the lipid A moiety of intracellular LPS [61], [163], [168].  
 
Similar to canonical inflammasome formation, activation of the non-canonical caspase-11 
inflammasome involves a two-step procedure. In resting cells caspase-11 is not constitutively 
expressed and therefore, the first step is the transcriptional priming of caspase-11 via the activation 
of NF-κβ and signal transducer and activator of transcription (STAT) transcriptional factors by 
TLR agonists and IFNs [169]. The TLR2 agonist Pam3CSK4 activates caspase-11 expression via 
MyD88, the TLR3 agonist polyI:C via TRIF/IRF3 and TLR4 agonist extracellular LPS via 
MyD88/TRIF pathways [164], [168], [170]. The second step involves intracellular LPS 
recognition and subsequent caspase-11 dimerization and activation [171]. Activated caspase-11 
induces pyroptotic cell death by directly cleaving pyroptosis executioner GSDMD protein [43], 
[44].  
 
Caspase-11 can only recognise bacterial LPS, however, once it has gained access into the cytosol.  
Different mechanisms have been proposed to explain how LPS enters the cytosol e.g. via outer-
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membrane vesicles (OMV) secreted by Gram-negative bacteria [172] which have been shown to 
facilitate pathogen-host interactions and bacterial survival. OMVs contain a variety of molecules, 
including LPS, phospholipids, peptidoglycan and nucleic acids (DNA and RNA) [173] and are 
important in the delivery of extracellular LPS into the cytosol of BMDMs [174]. Released OMVs 
are taken up by host cell via clarithin-mediated endocytosis where LPS can be released from early 
endosomes and present for detection in the cytosol [174]. Guanylate-binding proteins (GBPs) 
[175], [176] and immunity-related GTPase family member (IRG) have also been implicated in 
enhancing the release of LPS from OMVs and Gram-negative bacteria [177]–[179]. IRGs are 
important in the recognition and association of self-derived vesicles, while GBPs (e.g. GBP2) bind 
and rupture vesicles lacking IRGs (e.g. bacterium-derived vesicles) [180]. Mice deficient for GBPs 
showed increased survival and reduced levels of IL-1β and IL-18 in the serum, compared to their 
wild-type siblings following injection with E. coli-derived purified OMVs [181]. While in vitro 
experiments carried out on BMDMs deficient for GBPs showed reduced caspase-11 activation and 
pyroptosis in response to Legionella pneumophila infection [177]. Pathogen-containing vesicles 
(PCVs) generated by the host cell membrane have also been implicated in LPS introduction to the 
cytosol [178].  
 
Primates carry two orthologues of the murine caspase-11, namely caspase-4 and caspase-5. Human 
caspase-4 is constitutively expressed in myeloid and epithelial cells [61], [167], while caspase-5 
requires transcriptional priming [182]. The murine caspase-11 orthologue human caspase-4 and -
5 have also been shown to activate the non-canonical inflammasome in human monocytes [61], 
[183]. A recent study, however, suggested differential roles for human caspase-4 and caspase-5.  
Caspase-5 activity was essential for Pseudomonas aureginosa OMV induced inflammasome 
formation, while caspase-4 induced inflammasome activation occurred in response to 
Pseudomonas aureginosa LPS that was not associated with OMVs in human THP-1 monocytes 
[184]. LPS-induced inflammasome formation can be activated in a single step in human primary 
monocytes. Two distinct mechanisms have been proposed for this so far although both pathways 
rely on TLR4. One proposed TLR4-mediated LPS internalisation and subsequent caspase-5 
activation [183]. The other pathway relies on TLR4/TRIF-mediated complex II formation 
containing RIPK1/caspase-8/FADD upstream of this alternative NLRP3 activation [185]. These 
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results support the presence of species-specific differences in pathogenic extracellular and 




Figure 1.2.6.2.1 The non-canonical inflammasome. Cytosolic LPS is recognised and directly 
binds to the CARD domain of caspase-11. This interaction induces the oligomerisation, proximity 
induced auto-proteolysis and activation of pro-caspase-11. Activated caspase-11 drives pyroptosis 
by cleaving executioner GSDMD protein and pro-inflammatory cytokine maturation by caspase-
1 via the downstream activation of the NLRP3 inflammasome.  
 




The role of caspase-8 in driving extrinsic apoptosis and regulating necroptosis [186]–[188] in 
response to death receptor activation or mitochondrial damage [189] is well documented (Figure 
1.2.6.3.1). Caspase-8 consists of a pro-domain containing two tandem DED domains and a CARD 
domain consisting of a small and a large catalytic subunit. Caspase-8 deletion is embryonic lethal 
in mice [188]. Accompanying loss of receptor-interacting serine/threonine-protein kinase 3 
(RIPK3) however rescues the lethality phenotype [187], [190]. These results suggested a role for 
caspase-8 in inhibiting necroptotic cell death and provided evidence on crosstalk between distinct 
cell death pathways. When pro-apoptotic signals (TNFα) bind to their death receptors (TNFR) in 
the plasma membrane, it induces death receptor trimerization. The resulting conformational 
change of the cytoplasmic portion exposes the death-domain (DD) [191], [192] of the receptor 
which enables the recruitment of the FADD [193], tumour necrosis factor receptor type 1-
associated death domain protein (TRADD) and RIPK1 via homotypic DD-DD interactions [194], 
[195]. The resulting protein assembly is referred to as Complex I.  
 
Depending on the type of posttranslational modification, RIPK1 can either initiate cell survival or 
induce apoptotic (complex IIa) or necroptotic (complex IIb) cell death pathways. Linear 
ubiquitination of RIPK1 drives transforming growth factor beta-activated kinase 1 (TAK1)/ Iκβ 
kinase (IKK) dependent transcriptional activation of NF-κβ transcription factor [196], [197]. 
Activation of NF-κβ drives cytokine and pro-survival protein transcription [198]. Post-
translational modifications (e.g. phosphorylation) of RIPK1 are important to limit RIPK1/caspase-
8/FADD association [199], therefore promoting cell survival.  
 
Upon cell death induction, complex I dissociates from the death receptor which enables 
RIPK1/FADD complex to recruit pro-caspase-8 via homotypic death-effector domain (DED) 
interactions assembling complex IIa, therefore inducing apoptosis [200], [201]. Proximity induced 
auto-proteolysis and dimerization results in the activation of pro-caspase-8 [202], [203]. 
Catalytically active caspase-8 (p18 subunit) can directly cleave and activate effector caspases (e.g. 
caspase-3) [204] or indirectly via BH3 interacting-domain death agonist (Bid) which stimulates 




In apoptotic-deficient cells, TNFR activation induces complex IIb formation, thereby initiating 
necroptotic cell death [206] which requires the kinase activity of RIPK1, RIPK3 and mixed lineage 
kinase domain like pseudokinase (MLKL) [207]–[210]. Recent studies have showed that the 
NLRP3 inflammasome in murine BMDMs, murine and human dendritic cells lacking either 
GSDMD or proteolytically active caspase-1 were able to recruit and activate pro-caspase-8 within 
the ASC complex [211]–[213]. Furthermore, activated caspase-8 induced a so called secondary 
pyroptosis and delayed IL-1β release [213]. Caspase-8 can induce apoptotic cell death in murine 
macrophage and dendritic cells lacking functional caspase-1 or GSDMD [214], [215]. Recent 
research suggests that besides driving apoptosis and regulating necroptosis, caspase-8 can 
substitute for caspase-1 and drive lytic cell death and cytokine maturation. Caspase-8 has been 
shown to process IL-1β in HEK293T cells [216], mouse BMDCs [217] and BMDMs [218]. It has 
also been shown to be recruited to the NLRC4 inflammasome in S. Typhimurium infected wild-
type murine BMDMs in an ASC-dependent manner [140]. Where caspase-8 has been suggested 
to interact with ASC via DED-PYD interactions resulting in caspase-8 filament formation and 
subsequent ASC activation [219]. S. Typhimurium induced cell death and pro-IL-18 processing 
was shown to be caspase-8 independent, while it was shown to regulate IL-1β processing and 
expression [140]. Other studies also highlighted the essential role of caspase-8 in the priming of 
inflammatory cytokine expression [104], [220] and some suggested caspase-8 mediated pro-IL-1β 
processing [216], [221], [222]. Purified caspase-8 is able to cleave recombinant mouse GSDMD 
in vitro and also drive rapid cell death that is morphologically similar to pyroptosis [216], [223]–
[225]. The efficiency of caspase-8 in cleaving GSDMD, however, was considerably lower than 
that observed for caspase-1 [223]. 
 
These results suggest that in the absence of functional inflammatory caspases, caspase-8 can 
function as a substitute inflammatory caspase in addition to its’ defined roles in regulating 
necroptosis and driving apoptosis. Depending on the type of insult, caspase-8 can drive an 
inflammatory type of cell death in the form of secondary pyroptosis and inflammatory cytokine 
maturation.    
 
These experiments suggest that components of the inflammasome complex can have highly 
redundant roles. While each recruited effector protein has a preferential function, in their absence 
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other members can substitute for these functions in order to drive effective innate immune 




Figure 1.2.6.3.1 Caspase-8 role in initiating apoptosis and inhibiting necroptosis. Cells 
undergo apoptotic cell death when death ligands bind (e.g. TNF) to death receptors (e.g. TNFR) 
or cells sense cellular stress (e.g. mitochondrial dysfunction). This results in the recruitment of 
adaptor proteins (TRADD, FADD) and activation of initiator caspase-8. Active caspase-8 can then 
directly activate executioner caspases-3, -6 and -7 or indirectly via caspase-9. Cleaved Bid protein 
relocates to the mitochondrial membrane and causes cytochrome c release via membrane 
permeabilization and subsequent activation of pro-caspase-9. Activated caspase-9 can then directly 




 1.2.7 Gasdermins 
 
Gasdermin (GSDM) proteins are expressed in a variety of cell types (e.g. macrophages, 
neutrophils, dendritic cells) and tissues (skin, gastrointestinal track) [226]. Members of the GSDM 
family include human GSDMA (murine GSDMA1-3), GSDMB (absent in mice), GSDMC 
(murine GSDMC1-4), GSDMD, GSDME and Pejvakin (PJVK) [227], [228]. With the exception 
of PJVK, all of the identified members of the GSDM family contain an N-terminal fragment and 
exhibit pore-forming activity [75], [229]. Gasdermins have a conserved two domain arrangement, 
where the C-terminal autoinhibitory domain binds to the catalytic N-terminal domain which are 
bridged together via a linker loop [75], [230]. Gasdermins require proteolytic cleavage within the 
linker region for the activation and release of the ~30 kDa N-terminal domain [70], [75], [231]. 
GSDMD was identified as a caspase-1, -11 substrate by two independent studies; a whole genome 
CRISPR screen of macrophages and a mouse ENU mutagenesis based forward genetic screen [43], 
[44]. GSDME (also known as DFNA5) was also shown to be cleaved by apoptotic caspase-3, 
resulting in an N-terminal fragment with pore forming attributes similar to its GSDMD counterpart 
[232]. Activated human inflammatory caspase-1, -4 and -5 can cleave GSDMD at 275-Asp 
position and murine caspase-1 and -11 at 276-Asp [43], [44], [71]. The N-terminal fragment 
preferentially binds to the cardiolipin (CL), phosphatidylserine, and phosphoinositol residues in 
the cell membrane [70], [74], [231] and mitochondrial membrane [233] thereby forming pores of 
varying sizes between 10-20 nm in diameter [70], [72], [234]. This suggests that passive release 
of IL-1β and IL-18 and DAMPs (cytochrome c, cathepsin B) can occur prior to cell lysis upon 
pore formation [235], [236]. An additional role for GSDMD is a purported bactericidal activity by 
direct binding to target lipids (namely cardiolipin) in the bacterial cell wall [70]. Mouse BMDMs 
stimulated with bacterial peptidoglycan, mouse BMDCs in response to oxidized phospholipid 
oxPAPc and mouse neutrophils following acute S. typhimurium challenge secrete IL-1β without 
concurrent pyroptosis [236]–[238].  Cells lacking GSDMD released reduced levels of IL-1β [236], 
[238]. These observations suggest that cell death and cytokine release may be decoupled where 
cell fate may be determined by a threshold of GSDMD pores formed within a membrane.  
 
Gasdermin orthologue proteins can be found in other species for example in zebrafish [239] which 
contains two gasdermin pore-forming domains (gsdmea and gsdmeb). In vivo challenge of 
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zebrafish embryos with mycobacterial DNA suggest gsdmeb gene to be an orthologue of 
mammalian GSDMD [239]. GSDMD has been annotated in several other species including dogs, 
horses and pigs. Little is known, however, about whether their functions in the context of pathogen 
clearance are homologous to their human and mouse counterparts.  
 
1.3 Innate Immunity induced cell death mechanisms 
 
Following infection, PAMPs can be recognised by a multitude of PRRs. Their activation result in 
the induction of different signalling pathways that can lead to the production of chemokines, 
cytokines and the induction of programmed cell death [8]. Programmed cell death is important in 
both, physiological (organ development, tissue homeostasis) and pathological processes [240]. It 
plays a crucial role in removing unwanted, damaged and potentially harmful cells. It also disrupts 
pathogens’ replicative niche while alerting neighbouring cells leading to pathogenic clearance [8]. 
Programmed cell death (Figure 1.3.1) can occur through caspase-dependent (for example, 















Figure 1.3.1 Programmed cell death pathways. Schematic diagrams showing the major steps 
involved in the apoptotic, pyroptotic and necroptotic cell death pathways. (A) Cells undergo 
apoptotic cell death when death ligands bind to death receptors or cells sense cellular stress (e.g. 
mitochondrial dysfunction). This results in the recruitment of adaptor proteins and activation of 
initiator caspases-2 and -8. Cleaved caspases can then directly activate executioner caspases 3- and 
-7. (B) Cells undergo pyroptotic cell death when intracellular NLRs along with adaptor protein 
ASC form inflammasomes. Within the inflammasome pro-caspase-1 is recruited and cleaved into 
its active form. Active caspase-1 then drives pyroptotic cell death by cleaving GSDMD. (C) Cells 
undergo necroptotic cell death when death ligand binds to death receptors under caspase-deficient 
conditions. This trigger the formation of necrosome containing FADD, RIPK1 and RIPK3 proteins 
which drives the phosphorylation and activation of executioner protein MLKL.  
 
Apoptosis was first described by Kerr et al. [241] and is a caspase-dependent cell death mechanism 
[242]. Apoptotic cell death can be triggered by intrinsic and extrinsic signals, either when pro-
survival factors are depleted, cellular stress sensors are activated or by death-inducing ligands 
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binding to their receptors [243]. While apoptosis plays an essential role in embryonic development 
[244], it is also important in pathogenesis [245]. Cells undergoing apoptosis exhibit a characteristic 
set of morphological features (Figure 1.3.2). Apoptotic cells undergo shrinkage [246], [247], their 
plasma membranes bleb and cells are packaged into membrane-enveloped fragments known as 
apoptotic bodies [243]. Chromatin within apoptotic cells condenses and terminal deoxynucleotidyl 
transferase dUTP nick end labelling (TUNEL) staining reveals high levels of DNA damage [248]. 
Apoptotic cells do not release their cellular contents into the milieu and their apoptotic bodies are 
readily cleared by phagocytic cells [249], [250]. Apoptosis was, therefore, thought to be 
immunologically silent triggering little or no inflammation [251] although whether this process is 
truly immunologically silent is currently the topic of some debate.  
 
Besides apoptosis, programmed necrosis includes additional forms of regulated cell death 
processes, e.g. necroptosis and pyroptosis. Programmed necrosis is a lytic, pro-inflammatory form 
of cell death. It is characterised by swelling and subsequent membrane and organelle rupturing 
[252]. The loss of membrane integrity results in the release of cellular contents thereby triggering 
inflammatory responses [253]. Pyroptosis was initially identified as a caspase-dependent form of 
apoptosis [242], [254]. Pyroptosis is typically induced by inflammatory caspases which cause the 
affected cells to display membrane vesicles, followed by cell swelling [255]. This results in pore 
formation in their plasma membranes through which inflammatory cytokines (e.g. IL-1β, IL-18) 
and cytoplasmic contents (e.g. LDH) are released into the extracellular milieu [246]. Like 
apoptosis, cells undergoing pyroptosis display DNA damage [256], the extent of which is less than 
what occurs during apoptosis (Figure 1.3.2). Phagocytes including macrophages [254], dendritic 
cells [257] and monocytes [183] can undergo pyroptotic cell death. The cell rupture results in the 
release of intracellular pathogens, while the secreted cytokines and chemokines recruit other type 
of immune cells (neutrophils) to facilitate pathogenic clearance [8]. Necroptosis was first reported 
as a Fas ligand (FasL), tumour necrosis factor (TNF) or TNF-related apoptosis inducing ligand 
when primary murine macrophage cells are stimulated with pan-caspase inhibitor Z-VAD-FMK 
[258], [259]. Cells undergo necroptotic cell death in response to rapid, severe insults (oxidative 
stress) [260] and in response to pathogenic infections (murine cytomegalovirus) [261]. Necroptosis 
associated morphology resembles that of its pyroptotic counterpart. Cells undergoing necroptosis 
(Figure 1.3.2) swell and rupture, resulting in the release of DAMPS (e.g. HMGB1 (High mobility 
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group box 1) which is normally chromatin associated)) triggering inflammatory responses [253].  
RIPK1 has been shown to play a fundamental role in regulating cellular responses and determining 
cell fate [262], [263]. RIPK1 has a tripartite domain organisation. It consists of an N-terminal 
kinase domain (KD), a central intermediate domain (ID) including a receptor interacting protein 
(RIP) homotypic interaction motif (HIM) and a C-terminal DD [186], [264], [265]. Activated 
RIPK1 kinase domain has been shown to function in promoting cell death via necroptotic or 
apoptotic cell death pathways [190], [266]. Interaction with FADD and caspase-8 can induce 
RIPK1-dependent apoptosis [267], while binding and phosphorylation of RIPK3 mediates 
necroptotic cell death pathway [268]. The kinase [200], [269] and intermediate domains have been 
shown to be essential in mediating cell death responses [270], while the death domain is important 
in mediating RIPK1 dimerization and subsequent activation [265]. The DD is also crucial in 
mediating TNFR activation-induced cytokine expression via the NF-κβ transcription factor [270], 




Figure 1.3.2 Cell markers and morphological features characteristic of apoptotic, 
necroptotic and pyroptotic forms of cell death. Image adapted from Labbe & Saleh, 2011. 
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Programmed cell death mechanisms and autophagy work synergistically to contribute to 
the effective innate immune responses against invading pathogens. It is not inconceivable that 
multiple cell death mechanisms can be activated simultaneously in order to increase the 
magnitude of the innate immune responses.  Perhaps the presence of multiple death pathways can 
also compensate for one another if one or more of these pathways prove to be defective.  
1.4 S. Typhimurium 
Salmonella is a Gram-negative, motile, pathogenic bacterium. Epidemiological studies have 
revealed that the majority of Salmonella-related foodborne disease related deaths are caused by 
non-typhoidal Salmonella enterica infections with more than 200 million worldwide cases of 
disease reported each year [273]. The genus Salmonella comprises two distinct species, Salmonella 
enterica and Salmonella bongori. The former can be subdivided into a further six subspecies and 
another, 50+ serogroups and 2400 serovars based on their O somatic and H flagellar antigens, 
respectively. Salmonella enterica serovars can cause enteric fever (typhoidal) or diarrhoea (non-
typhoidal). Depending on the immune status of the host, the latter can cause gastroenteritis in 
immunocompetent and bacteraemia in immunocompromised individuals [274]. Salmonella 
Pathogenicity Islands (SPIs) encode virulence factors which are important in their pathogenicity 
[275]. There are twelve SPIs: 1-6, 9, 11-14 and 16, but virulence factors are mainly associated 
with T3SS 1 and 2. Expression of SPIs is tightly regulated and can rapidly respond to 
environmental changes [276], [277].  SPI1 and SPI2 form molecular syringes which enable the 
injection of effector proteins into the host cytosol following entry into the cell. SPI-1 produces the 
bacterial proteins (Salmonella invasion protein (Sip) B, C and D)) which are essential in host cell 
adhesion and invasion [278]. The T3SS is responsible for the expression of secretory system 
components, effector proteins, chaperones and transcriptional regulators. Salmonella effector 
proteins trigger host cytoskeletal rearrangement [279] followed by micropinocytic uptake [280] in 
epithelial cells. Salmonella initially resides in the host phagosomal compartments creating 
‘Salmonella-containing vacuole’ (SCV) and induces SPI-2 T3SS-2 expression [281]. Salmonella 
has evolved numerous different strategies to avoid host cell defence mechanisms. These include 
prevention of SCV fusion with lysosomes, attenuation of superoxide production via the distraction 
31 
 
of the nicotinamide adenine dinucleotide phosphate-oxidase (NADPH) assembly [282] and 
neutralisation of host antimicrobial peptides [283].  
 
1.4.1 S. Typhimurium and Innate Immunity 
 
Salmonella infection in mice and humans occurs via consumption of contaminated food so the 
resident innate immune system of the gastrointestinal tract is especially important in these 
infections. There are two distinct steps involved in Salmonella pathogenesis, namely adhesion to 
the intestinal epithelial cells (IECs) and the subsequent invasion and colonisation of the intestinal 
lumen [284]. Salmonellae are recognised by an array of intra- and extracellular receptors. These 
receptors can initiate distinct signalling pathways in order to limit Salmonellae replication, drive 
their clearance and to alert neighbouring immune cells. TLRs resident in the plasma- and 
endosomal membranes are the first pattern-recognition receptors to detect Salmonellae. Mice 
lacking TLR4 infected with S. Typhimurium show reduced survival rate and higher bacterial 
burden compared to their wild-type counterpart [285]. This underlines the particular importance 
for TLR4 in early cytokine production and controlling bacterial burden of S. Typhimurium in vivo 
[286]. While S. Typhimurium flagellin recognition by TLR5 in gut enterocytes induces 
inflammatory cytokine IL-8 expression via NF-κβ signalling [287], it is not required for controlling 
systemic S. Typhimurium infection in mice [288]. Intracellularly, NLRC4 has been shown to be 
important to regulate S. Typhimurium early in infection. Using in vivo mouse models, IEC-specific 
activation of NLRC4 inflammasome induced caspase-1, caspase-8 and GSDMD-dependent 
pyroptotic cell death and intrinsic IEC expulsion from the epithelial layer provide protection 
against intestinal S. Typhimurium invasion [289]. NLRC4 inflammasome activation following 
Salmonella infection results in inflammatory cytokine maturation and release via pyroptosis. 
While S. Typhimurium can also activate the formation of the NLRP3 inflammasome which was 
shown to play redundant roles to NLRC4 in a mouse model of lethal, but not in sub-lethal, S. 
Typhimurium infection [62], [141]. Mice lacking both NLRP3 and NLRC4 receptors showed 
higher bacterial burden in their mesenteric lymph nodes, spleen and liver compared to wild-type 
mice in lethal infection models [141]. Inflammasome activation results in the activation of 
inflammatory caspase-1 which has been shown to be a crucial mediator of the host immune 
response against S. Typhimurium, providing resistance during the intestinal and systemic phase of 
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infection [290]. In vivo experiments carried out using caspase-1-/- mice showed increased bacterial 
burden systemically and afflicted mice succumbed to lethal infection earlier compared to their 
wild-type siblings [291]. Mice lacking either IL-1β or IL-18 exhibited enhanced susceptibility to 
S. Typhimurium infection [290]. Inflammasome assembly showed the simultaneous recruitment 
of caspase-1, caspase-8 and NLRP3 downstream of the NLRC4 receptor to the ASC-speck in S. 
Typhimurium infected macrophages [62], [292]. Caspase-1 induced pyroptotic cell death disrupts 
the replicative niche of S. Typhimurium while also initiating its clearance by neutrophils [293], 
[294]. Upon SCV lysis the released cytosolic LPS is recognised by murine caspase-11 and its 
human homologue caspase-4 [60], [295]. Mice in vivo models have suggested that caspase-11 may 
be important in restricting intracellular S. Typhimurium replication in the intestinal epithelium 
[167].   
 
1.4.2 S. Typhimurium infection in different species 
 
A wide range of different animal species are susceptible to salmonellosis depending upon the type 
of Salmonella. These species include  reptiles (e.g. turtle), amphibians (frogs), poultry (e.g. 
chicken), rodents (e.g. mice), farm animals (e.g. cows, sheep and pigs), dogs, cats and horses 
[296]–[298]. Similar to humans, the primary route is mainly via the consumption of contaminated 
food or water. Although Salmonella enterica subspecies enterica contains over 2400 serovars, 
salmonellosis in humans and domestic animals is caused by a relatively small number of serovars. 
For example Salmonella enterica serotype Enteritidis and Salmonella enterica serotype 
Typhimurium can infect a wide range of different species, however, host-specific serovars have 
also been identified. For example, fowl typhoid and pullorum diseases are caused by Salmonella 
enterica serovar Gallinarum and Pullorum, respectively [299]. Salmonellosis in cattle is mainly 
associated with serovar Dublin [300], [301], while in pigs disease is predominantly caused by 
Salmonella enterica servovar Cholerasuis [302]. S. Typhimurium infections of calves mimics the 
pathology of gastroenteritis characterised in humans [303]. Interestingly, pigs can acquire infection 
via the intranasal route, causing pneumonia in the majority of cases [304]. Salmonella enterica 
serovar Abortus ovis is an ovine-restricted serovar. Although the infection spreads mainly via the 
oral-faecal route, conjunctival and vaginal routes have also been proposed [305]. The existence of 
different infection routes identified in different species makes Salmonella an interesting pathogen. 
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Little is known, however, about whether the mechanism of infection and the signalling pathways 
induced following Salmonella recognition are homologous in different host species.   
 
Subclinical infections and active carriage of Salmonella serovars have been reported in domestic 
animals with clinical salmonellosis mainly occurring in young or immunocompromised 
individuals [306]. In subclinical infections, bacteria are largely constrained to the gastrointestinal 
tract of the infected animal with faecal excretion of bacteria sometimes reported for months or 
even for years [307]. Salmonella pathogenesis and virulence varies between different host species. 
Interestingly, Salmonella species can cause enteritis and diarrhoea in cats and dogs. However a 
large number of asymptomatic Salmonella infections have been reported in both species [308], 
[309]. For example, examination of faeces taken from healthy dogs showed that 23% of the 
samples were indicative of a subclinical Salmonella infection with S. Typhimurium being one of 
the most commonly isolated serovars [310], [311]. Salmonella pathogenesis has predominantly 
been studied in human and rodent systems. There are, however, major species-specific differences 
in pattern recognition receptors and in inflammasome components. Understanding the 
consequences of these differences is paramount to better understand pathogen recognition and how 
the bacteria are controlled by the host. The work in this thesis will investigate the consequence of 





Inflammasomes are macromolecular signalling complexes that play a fundamental role in host 
defence against microbial infections. However, inflammasomes have also been implicated in 
numerous inflammatory disorders described in humans, and therefore represent a viable target for 
therapeutic intervention. There exists major differences in the pattern recognition receptor and 
caspase repertoires found in different animal species. One of the model species used in the area of 
anti-inflammatory research is the dog (Canis Lupus Familiaris). Surprisingly, inflammasome 




In this thesis I aim to investigate the functional consequences that arise as a result of the major 
differences in the inflammasome associated repertoire that exists in the dog. The main objectives 
are as follows: 
 
a) To perform Multiple Sequence Comparison by Log-Expectation analysis of amino acid 
sequences of the main inflammasome components present in the dog, mouse and human 
genome and identify their catalytic sites. 
b) To confirm by immunoblotting the expression of the main inflammasome components in 
the immortalised dog macrophage cell line, DH82.  
c) To characterise inflammasome responses in the dog using a combination of imaging (ASC 
and active caspase speck formation), cell death analysis and IL-β detection in the DH82 
cell line in response to well described sterile inflammatory ligands and infectious whole 
bacteria using Salmonella enterica serovar Typhimurium (S. Typhimurium).  
d) To confirm inflammatory responses of DH82 macrophages to sterile ligands and S. 
Typhimurium infection in canine primary mononuclear cells (MNCs) isolated from whole 
blood.   
e) To optimise electroporation conditions and parameters for CRISPR-Cas9 gene editing  in 
the DH82 cell line. 
f) To identify one, key components of cell death response induced by sterile inflammatory 
ligands and following S. Typhimurium infection in  DH82 cells by editing key genes  
associated with pyroptotic, necroptotic and apoptotic pathways using the optimised 
CRISPR-Cas9 methodology arising from (e) and two, assess the functional consequences 
of targeted gene disruption. 
g) To characterise primary murine bone marrow derived macrophages (BMDMs) harbouring 
a functional equivalent to the CASP-1/4/5/11 gene found in the dog. 
h) To generate a phylogenetic tree for the comparative analysis of putative and confirmed 







Materials and Methods 
 
2.1 Cell culture 
 
Murine immortalised bone-marrow derived macrophages (iBMDMs), a kind gift from Professor 
Kate Fitzgerald (University of Massachusetts Medical School, USA) and the canine malignant 
histiocytic macrophage-like cell line, DH82 (ATCC CRL-10389) were maintained in DMEM-
complete medium (DMEM+) (Dulbecco’s Modified Eagle Medium (DMEM) (Sigma-Aldrich, 
D6546), 10% Foetal Calf Serum (FCS) (Thermo Fisher Scientific, 16000044), 5 mM L-glutamine 
(Sigma-Aldrich, G3126), 100 µg/ml streptomycin and 100 units/ml of penicillin (Sigma-Aldrich, 
P4333) at 37°C, 5% CO2. Primary mouse BMDMs were isolated by Dr Panagiotis Tourlomousis 
(Department of Veterinary Medicine, University of Cambridge, UK) from wild type C57BL/6 
mice obtained from Charles River, UK. Dog-Mouse (DogMo) chimeric primary BMDMs were a 
gift from Vishva Dixit (Genentech, USA). Primary BMDMs were maintained in primary complete 
medium (10% FCS, 20 mM L-glutamine, 100 µg/ml streptomycin and 100 units/ml penicillin, 
20% L929 conditioned medium). L292 conditioning medium was prepared by culturing the L929 
mouse fibroblast cell line for up to two weeks in RPMI medium supplemented with 10% FCS and 
2mM L-glutamine. Saturated L929 supernatant was harvested and then clarified using a 0.22 µm 
filter (Millipore). For bacterial infection studies, cell cultures and bacteria were prepared in 
antibiotic-free medium (DMEM-). 
 
2.2 Mononuclear cell isolation from canine blood 
 
Peripheral blood mononuclear cells (PBMCs) were derived from residual blood samples taken 
from dogs admitted to the Queen’s Veterinary School Hospital (Department of Veterinary 
Medicine, University of Cambridge) for venous blood sampling and testing (Table 2.2.1). 
Histopaque-1077 density gradient medium (Sigma-Aldrich, H8889) was carefully introduced via 
the central hole to the insert of a SepMateTM mononuclear cell (MNC) isolation tube (Stem Cell 
Technologies, 85415). Blood samples acquired from different dogs (see Table 2.2.1) were pooled 
and the samples were immediately diluted in an equivalent volume of wash buffer (Dulbecco’s 
phosphate buffered saline (DPBS) (Sigma-Aldrich, D8537) plus 2% FCS, 0.22 µm filtered). The 
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diluted blood was then used to overlay the density gradient medium in the SepMateTM tube. 
Samples were centrifuged at 1200 x g for 10 minutes at room temperature with the centrifuge break 
on. The top layer above the insert containing MNCs was decanted off with a single, quick inversion 
and subsequently washed two times with wash buffer.  The cells were pelleted in between washes 
by centrifugation at 300 x g for 8 minutes. Following the final wash, the pelleted cells were 
resuspended in primary cell culture DMEM medium, using 10 ml medium / 3 ml of undiluted 
blood sample. The cells were seeded in 10 cm2 Petri-dishes and differentiated as described in 2.3 
Preparation of primary bone marrow derived macrophages.  
Identifier Veterinarian Breed Age Reason for blood test 
1379 2901 Mott Whippet 9 years Chemo monitoring 
1379 3501 Catton Retriever 12 years Monitoring of treatment for anal sac adenocarcinoma 
1379 4801 Shelton Cocker Spaniel Unknown Monitoring of immune-mediated haemolytic anaemia 
1379 5301 Peckham Staffordshire Bull Terrier 11 years Chemo monitoring 
1379 5401 Russel Labradoodle 12 years Screening 
1379 6201 Matthews Greyhound 6 years Chemo monitoring 
1386 0901 Teparitcharov Pug 5 years Protein-losing enteropathy  
1386 1301 Akhter Cacapoo 4 years Immune Mediated Thrombocytopenia re-check 
1386 3601 Rice Staffordshire Bull Terrier 8 years Screening 
1393 5602 Gadsby Staffordshire Bull Terrier Unknown Acute hepatitis 
1393 8601 Ayliffe Bullmastiff 7 years Vomiting and diarrhoea 
1393 9901 Floto Labradoodle 3 years Hypoadrenocorticism 
1394 1801 Rose Springer Spaniel 8 years Chemo monitoring 
1394 3201 Wilkin X-Breed 9 years Post liver biopsy monitoring 
Table 2.2.1 List of patients whose blood was used in experiments (including information of 
the breed, their age and reason for phlebotomy). 
2.3 Preparation of primary bone marrow derived macrophages 
Mice were euthanised by cervical dislocation and sterilised by immersion in 70% ethanol. Fur and 
skin were removed, and the legs were separated from the body at the hip joint. The legs were 
placed into fresh cold DMEM medium and maintained on ice until further processing. In a sterile 
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tissue culture hood, the legs were placed into Petri-dishes containing 10 ml of cold DMEM medium 
and all soft tissue was removed. The tibia and femur bones were separated by cutting the knee 
ligaments using a scalpel. The ends of each bone were subsequently removed to generate an 
opening for retrieval of the bone marrow. In order to harvest the bone marrow, each bone was 
repeatedly flushed out with DMEM medium using a 25-gauge needle and 20 ml syringe. Cells 
were transferred to a 50 ml falcon tube and centrifuged at 1000 rpm for 5 minutes. Pelleted cells 
were then plated out into sterile petri-dishes for differentiation into macrophages. Alternatively, 
cells were re-suspended in freezing medium (90% FCS and 10% DMSO (Sigma Aldrich, D8418-
100ML)) and stored at -80°C for 24 hours, then transferred to -150°C for long term storage. During 
the process of reviving frozen primary bone marrow macrophages, cells were placed in a 37°C 
water bath until they were completely thawed. Cells were re-suspended in 8ml of fresh primary 
cell culture DMEM medium and centrifuged at 1000 rpm for 5 minutes. Pelleted cells from each 
vial were re-suspended in 30 ml of fresh primary cell culture DMEM medium and transferred into 
Petri-dishes, 10 ml/dish. Cells were cultured for 3 days at 37°C in 5% CO2. On day 3, an additional 
10 ml of primary cell culture DMEM medium was added to the cells prior to incubation for a 
further 3 days at 37°C in 5% CO2 atmospheric conditions. On day 7 cell culture medium was 
removed from each dish and was replaced with 10 ml fresh primary cell culture DMEM medium. 
Cells were gently scraped off and were transferred into a 50 ml conical tube. The same process 
was repeated for each dish and cells from the same genotype were pooled. Cells were pelleted at 
1000 rpm for 5 minutes. Cells used for gentamicin protection assays were re-suspended in 10 ml 
of fresh primary DMEM- medium, whereas macrophages used for nigericin and cytosolic LPS 
ligand stimulations were re-suspended in 10 ml of primary DMEM+ medium. Cells were 
enumerated using the trypan blue exclusion method and were plated on flat bottom 96-well cell 
culture plates at the desired cell concentration.  
  
2.4 Culturing of S. Typhimurium and growth curves 
 
Frozen glycerol stocks  of  wild-type  Salmonella Typhimurium (S. Typhimurium) strain SL1344 
and SL1344 mutant strains ∆FliC/FliB, ∆PrgJ, ∆FliC/FliB/PrgJ (generated by Dr John Wright, 
Department of Veterinary Medicine, University of Cambridge) were thawed and streaked onto 
each of two LB agar plates (Sigma-Aldrich, L2897-1KG) and incubated for 24 hours at 37°C. 
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Three single colony forming units (CFUs) were emulsified in 5 ml fresh LB agar broth (Sigma-
Aldrich, L3022-1KG) and incubated for 17.5 hours at 37°C in a shaking incubator at 200 rpm. 
After incubation, 500 µl of inoculum was transferred into 5 ml fresh LB agar broth and incubated 
for an additional 2 hours at 37°C in a shaking incubator at 200 rpm. Bacteria were then pelleted at 
3,500 x g for 10 minutes at room temperature and re-suspended in 1 ml of DMEM-. The optical 
density (OD) was measured at 600 nm and the inoculum was diluted in 15 ml fresh LB agar broth 
to obtain OD 0.01. This value represented the 0-hour time-point. A dilution series of the inoculum 
was prepared and plated in triplicate onto LB agar plates. Plates were incubated at 37°C overnight 
and CFU were enumerated the following morning. The inoculum was subsequently returned to the 
shaking incubator at 37°C, 200 rpm. Thereafter, ODs were measured, and serial dilutions of the 
inoculum were prepared hourly for a total duration of eight hours. 
 
2.5 Infection of BMDMs with S. Typhimurium  
 
Murine immortalised wild-type, Nlrc4-/-, caspase-1-/-caspase-11-/- iBMDMs and primary wild-type 
and DogMo BMDMs, DH82 and blood-derived primary macrophage cells were seeded in 96-well 
flat-bottomed plates at a concentration of either 1x106 or 5x105 cells/ml in DMEM- and incubated 
overnight at 37°C in 5% CO2. Cells were infected with either stationary phase S. Typhimurium 
wild-type strain SL1344 and mutant strains ∆FliC/FliB, ∆PrgJ or ∆FliC/FliB/PrgJ (as described 
in Section 2.4 culturing of Salmonella Typhimurium and growth curves) for 1 hour with 
multiplicity of infection (MOI) 1, 10 or 50. The culture supernatant was subsequently removed 
and stored at -80°C for further analysis (1-hour time-point). In experiments using the mutant 
bacterial strains, the inocula were centrifuged onto the adherent macrophages at 500 x g for 10 
minutes. To ensure the correct number of bacteria were used for infection, ten-fold serial dilutions 
of each MOI of SL1344, ∆FliC/FliB, ∆PrgJ, ∆FliC/FliB/PrgJ were prepared in sterile DPBS. 
Thereafter, 50 µl from the appropriate dilution was spread out on to each of two LB agar plates 
and incubated overnight at 37°C. MOIs were then calculated the following day based on the 
number of CFU counted. For 2-hour time-point infections, cell culture medium containing bacteria 
was replaced with DMEM- cell culture medium supplemented with gentamicin (Thermo Fisher, 
15750060) at 50 µg/ml final concentration. Cells were further incubated for one hour at 37°C in 
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5% CO2 (during which time the high concentration of gentamicin kills remaining extracellular 
bacteria). The supernatant was then removed and stored at -80°C until required (2-hour time-
point). For the 6- and 24-hour time-points, 50 µg/ml gentamicin was replaced with fresh DMEM- 
cell culture medium containing gentamicin at a final concentration of 10µg/ml. Percentage of cell 
lysis induced as consequence of bacterial infection was measured at each time-point using the 
CytoTox 96® Non-Radioactive Cytotoxicity Assay (Promega, G1780) according to the 
manufacturer’s instructions. This assay measures the extracellular release of the stable, cytosolic 
enzyme lactate dehydrogenase (LDH) present in cells in a coupled enzymatic reaction where the 
amount of converted end product linearly correlates with the amount of LDH released into the 
supernatant. In this assay, 50 µl of substrate reagent was added to 50 µl of cell culture supernatant 
in 96-well flat-bottom plates (Corning, CLS3599) and incubated for up to 30 minutes in the dark. 
To stop the reaction, 25 µl of stop solution was added to each well and the absorbance was read at 
490 nm wavelength using either the PHERAstar (BMG, Labtech) or CLARIOstar Microplate 
Reader (BMG, Labtech). Wavelength correction was set to subtract 570 nm readings from 490 nm 
wavelength readings, which allows for the correction of optical imperfection in plates. 
 
Experiments involving primary canine mononuclear cells (MNCs) could only be performed once 
due to the limited number of samples sourced from the Queen’s Veterinary School Hospital. 
Therefore, results obtained from these experiments should be interpreted with a degree of caution. 
Furthermore, residual blood samples were taken from patients who had undergone chemotherapy 
or suffer from autoimmune disease (Table 2.2.1). One can assume that these factors may introduce 
heterogeneity in the observed cellular responses to ligand stimulation. Furthermore, the blood 
samples were collected from multiple different breeds and therefore genetic influence cannot be 
eliminated. Therefore, my results can only be taken as an indication of what the responses of 
primary canine MNCs are like post infection with S. Typhimurium. 
 
2.6 Inflammasome activators and inhibitors 
 
Murine, canine iBMDMs and primary cells were seeded at either 5x105 or 6x106 cells/ml in a 96-
well flat-bottomed plate (200 µl/well) overnight at 37°C, 5% CO2. Adherent cells were primed 
with either ultrapure E.coli lipopolysaccharide (LPS) (InvivoGen, tlrl-3pelps) at a final 
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concentration of 200 ng/ml for 3 hours or Pam3CSK4 (Pam3) (InvivoGen, tlrl-pms) at a final 
concentration of 10 µg/ml for 4 hours at 37°C, 5% CO2. Cells were then stimulated with either 
nigericin (Sigma-Aldrich, N7143-5MG) ranging from 10 µM to 200 µM final concentration for 1 
hour. For non-canonical inflammasome activation, cells were incubated with ultrapure LPS at 1 
µg/ml or 5 µg/ml final concentration in the presence of FuGENE HD transfection reagent 
(Promega, E2311) for 16 hours at 37°C, 5% CO2. LPS and transfection reagent were pre-incubated 
for 15 minutes at room temperature prior to addition to the cells. For inhibitor experiments, cells 
were pre-incubated with either pan-caspase Z-VAD-FMK (R&D Systems, FMK001) at a final 
concentration of 10 µM or caspase-8 Z-IETD-FMK (R&D Systems, FMK007) at a final 
concentration of 10 µM (Table 2.6.1). Culture medium was supplemented with inhibitors during 







concentration Receptor/ Target Supplier 
cLPS 5 mg/ml 1µg/ml and 5 µg/ml Caspase-11 InvivoGen 
LPS 5 mg/ml 200 ng/ml TLR4 InvivoGen 
Nigericin 10 mM 10-, 20-, 50-, 100-, 150-, 200 µM NLPR3 Sigma-Aldrich 
Pam3 1 mg/ml 10 µg/ml TLR1/2 InvivoGen 
Z-IETD-FMK 20 mM 10 µM Caspase-8 R&D Systems 
Z-VAD-FMK 20 mM 10 µM Pan-caspase R&D Systems 
 
Table 2.6.1 List of activators and inhibitors used in cell stimulation experiments. Information 
includes stock concentration, working concentrations, receptor/target proteins and supplier. 
 
Experiments involving primary canine mononuclear cells (MNCs) could only be performed once 
due to the limited number of samples sourced from the Queen’s Veterinary School Hospital. 
Therefore, results obtained from these experiments should be interpreted with a degree of caution. 
Furthermore, residual blood samples were taken from patients who had undergone chemotherapy 
or suffer from autoimmune disease (Table 2.2.1). One can assume that these factors may introduce 
heterogeneity in the observed cellular responses to ligand stimulation. Furthermore, the blood 
samples were collected from multiple different breeds and therefore genetic influence cannot be 
eliminated. Therefore, my results can only be taken as an indication of what the responses of 
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primary canine MNCs are like in response to sterile inflammatory ligands and post infection with 
S. Typhimurium. 
 
2.7 Sample preparation for immunofluorescent staining and imaging 
 
Murine and canine iBMDMs and primary macrophages were seeded at a density of 2x105 
cells/well on an 8-well chamber slide (ThermoFisher, 154534) and incubated overnight at 37oC, 
5% CO2. Following ligand stimulation, cells were incubated with either FAM FLICA caspase-1 
(Bio-Rad, ICT097), caspase-8 (Bio-Rad, ICT099) or poly-caspase (Bio-Rad, ICT0091) diluted 
1:300 in culture medium for 30 minutes at 37°C. Post stimulation, cells were washed three times 
with DPBS and subsequently fixed in 4% paraformaldehyde (PFA)/DPBS (Thermo Fisher 
Scientific, 28908) for 15 minutes at room temperature in the dark. Fixed cells were washed twice 
with DPBS and then incubated in blocking buffer (DPBS containing 0.01% saponin (Sigma-
Aldrich, 47036-50G-F) and 10% normal goat serum (NGS) (Dako, X0907) for 1 hour at 37°C. 
After blocking, cells were incubated with anti-ASC (AL177) pAb (Adipogen, AG-25B-0006-
C100) diluted 1:500 in blocking reagent for 50 minutes at 37°C. Each well was washed three times 
with pre-warmed DPBS prior to incubation with goat-anti-rabbit-IgG-AlexaFluor488 (Invitrogen, 
A11034) or -AlexaFluor568 (Invitrogen, A11036) for 40 minutes at 37°C. All secondary antibodies 
were diluted 1:1000 in DBPS prior to use. Following primary and secondary antibody staining, 
cells were stained with nuclear Hoechst 33342 (Invitrogen, H3570) labelling solution for 10 
minutes at room temperature at a final concentration of 5 μg/ml (Table 2.7.1). Cells were then 
mounted in VECTASHIELD Antifade Mounting Medium (H-1000, Vector) and kept at 4°C in the 
dark until required for imaging. Immuno-labelled cells were imaged using an Inverted 










Table 2.7.1 List of reagents used for immunofluorescence staining of cells. Information 
includes host animal, catalogue number, supplier, stock concentration, dilutions used and 
conjugate.  
 
2.8 Cytokine measurement using ELISA 
 
Mouse IL-1β and canine IL-1β released into cell culture supernatant was measured using Mouse 
IL-1β ELISA Set BD OptEIATM (BD Biosciences, 559603) and Canine IL-1β/IL-1F2 DuoSet 
(R&D Systems, DY3747) respectively, as described in the manufacturer’s instructions. Capture 
antibody (40 µl/well) was added to each triplicate well of a 96-well half area high protein binding 
microplate (Grenier Bio-One, 675061). For mouse IL-1β, capture antibody was diluted 1:250 in 
coating buffer (7.13g NaHCO3 + 1.59g Na2CO3 in 1 litre of MilliQ water, pH adjusted to 9.5 with 
10N NaOH). Canine IL-1β capture antibody was diluted 1:180 in reagent diluent comprising 1% 
BSA (Bovine Serum Albumin, Fisher Scientific, BP9702-100) in DPBS, pH 7.2-7.4, 0.22 μm 
filtered). Plates were sealed and incubated overnight at 4°C (mouse IL-1β) or room temperature 
(canine IL-1β). Thereafter, the wells were aspirated and washed three times with ELISA wash 
buffer (DPBS + 0.05% Tween-20 (Promega, H5151)). Following the final wash, each plate was 
inverted and blotted on paper towels in order to remove any residual wash buffer. Plates were 
blocked in species-specific reagent diluent (180 µl/well) for two hours at room temperature. Mouse 
Reagent Host Catalogue number Manufacturer 
Stock 
concentration Dilution Conjugate 
Anti-ASC pAb (clone 




Sciences 1mg/ml 1:500 HRP 
FAM FLICATM caspase-




8 kit N/A ICT099 Bio-Rad N/A 1:300 
Alexa Fluor 
488nm 
FAM FLICATM poly 
caspase kit N/A ICT091 Bio-Rad N/A 1:300 
Alexa Fluor 
488nm 
Goat anti-rabbit IgG goat A11034 Invitrogen 2 mg/ml 1:500 Alexa Fluor 488nm 
Goat anti-rabbit IgG goat A11036 Invitrogen 2 mg/ml 1:500 Alexa Fluor 568nm 
Hoechst 33342 anti-





reagent diluent consisted of 10% FCS in DPBS 0.22µm filtered, while canine consisted of DPBS 
alone. After blocking, the washing step was repeated, during which time the appropriate dilutions 
of samples and standards were prepared in the same type of culture medium as the supernatant. 
Forty microliters of standard or sample was added/well and incubated for an additional two hours 
at room temperature. The washing step was repeated (mouse IL-1β five times, canine IL-1β three 
times) and detection antibody (40 µl/well) diluted in reagent diluent (mouse IL-1β 1:500, canine 
IL-1β 1:180) was added to each well. Mouse IL-1β plates were incubated for one hour, whilst 
canine IL-1β plates were incubated for a period of two hours, both at room temperature. The 
washing step was repeated (mouse IL-1β five times, canine IL-1β three times) and Streptavidin-
HRP (40 µl/well) diluted in reagent diluent (mouse IL-1β 1:250, canine IL-1β 1:200) was added 
to each well and incubated at room temperature. Mouse IL-1β plates were subsequently incubated 
for 30 minutes, whereas canine IL-1β plates were incubated for 20 minutes in the dark at room 
temperature. The washing step was repeated (mouse IL-1β seven times, canine IL-1β three times) 
and BD TMB Substrate Reagent (Fisher Scientific, BD555214) (40 µl/well) was added. Mouse 
and canine IL-1β plates were incubated in the dark at room temperature for 30 minutes and 20 
minutes, respectively. Stop solution (20 µl/well) was added to each plate and the absorbance was 
read at 450 nm wavelength using either a PHERAstar or CLARIOstar Microplate Reader (BMG, 
Labtech). Wavelength correction was set to subtract 570nm readings from 450 nm wavelength 
readings which allows for correction of optical imperfection in the ELISA plates. 
 
2.9 Total protein extraction of cell lysates 
 
Supernatants were aspirated from macrophages cultured in 6-well flat bottom plates (Corning, 
CLS3516) and replaced with 1 ml of fresh DMEM medium. Cells were gently scraped and then 
pelleted by centrifugation at 1000 rpm for 5 minutes. Thereafter, the medium was removed and 
the cell pellet was disrupted in 40 µl of ice-cold RIPA solution (150 mM NaCl, 10 mM Tris-HCl, 
5 mM EDTA, 1% Triton-X100, 10 mM NaF, 1 mM NaVO4, 20 mM PMSF) supplemented with 
Protease Inhibitor Cocktail (Sigma-Aldrich, P8340-5ML) (1:100 dilution) and incubated for 30 
minutes on ice. Lysed cells were centrifuged at 14,000 rpm for 15 minutes at 4ºC. Supernatants 
containing protein were transferred into a new 1.5 ml Eppendorf tube and the protein concentration 
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was determined using the PierceTM BCA Protein Assay Kit (Thermo Fisher, 23227), following the 
manufacturer’s instructions. Briefly, 5 µl of each cell lysate was diluted 1:10 in RIPA solution and 
serial dilutions were prepared for each sample (1:20, 1:40, 1:80). In addition, serial dilutions of 
standard protein (Bovine Serum Albumin (BSA)) were prepared at final concentrations of 2000 
µg/µl, 1000 µg/µl, 500 µg/µl, 250 µg/µl, 125 µg/µl, 62.5 µg/µl and 31.25 µg/µl. 5 µl of each 
sample and standard was transferred in triplicate to a 96-well flat bottom plate and 95 µl of working 
solution (A:49 parts – B:1 part) was added to each well. The assay was incubated for up to 30 
minutes at room temperature and the absorbance was measured on a PHERAstar Microplate 
Reader (BMG, Labtech). Actual protein concentrations were calculated using the measurements 
based on standard curve generated in Microsoft Excel. Standardised amounts of each cell lysate 
were then prepared for immunoblotting by incubating the appropriate volume of sample with 
Pierce™ Lane Marker (5x) Reducing Sample Buffer (Thermo Fisher, 39000) on a hot block for 
10 minutes at 100°C. Following denaturation, the lysates were placed on ice and then briefly 
centrifuged to pool the sample prior to storage at -80°C until required. Alternatively, cell lysates 
were prepared by replacing supernatants from cells cultured in 96-well flat-bottomed plates with 
30µl of ice-cold 0.5% Triton-X100/DPBS per well. Plates were then stored at -20°C to facilitate 
passive lysis of the cells. When required, plates containing lysed cells were thawed and triplicate 
wells were pooled. Thereafter, 64 µl of each pooled sample was transferred into a new 1.5 ml 
Eppendorf tube and mixed with 16 µl of Pierce™ Lane Marker (5x) Reducing Sample Buffer prior 
to heating at 100°C for 10 minutes. After denaturation lysates were cooled briefly on ice followed 
by centrifugation and analysis by western blot. 
 
2.10 Total protein extraction from cell culture supernatants 
 
Cell culture supernatants were transferred into a 15 ml falcon tube and centrifuged at 1000 rpm for 
5 minutes in order to remove dead cells. Clarified supernatants were transferred to a fresh 15 ml 
falcon tube and 1 x volume of ice-cold methanol and 0.25 x volume of chloroform were added to 
each sample and vortexed briefly for 20 seconds. Samples were then centrifuged at 16,000 x g for 
12 minutes at 4°C. After centrifugation, upper and lower phases were aspirated to leave only the 
intermediate phase containing the precipitated protein. The protein layer was carefully aspirated 
and centrifuged for 10 minutes at 4°C. Protein pellets were washed twice in 500 µl of ice-cold 
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methanol. In between washes the resuspended pellets were centrifuged at 16,000 x g for 5 minutes 
at 4°C. After the final wash, all of the methanol was carefully removed, and the pellets were 
allowed to dry. Pellets were re-suspended in 40 µl of Laemmli 2 x concentrate sample buffer 
(Sigma Aldrich, S3401-10VL) and heated at 100°C for 10 minutes and stored at -80°C until 
required. Alternatively, protein from supernatants derived from cells cultured in 96-well plates 
were prepared by transferring 100 µl of supernatant from each replicate into fresh 1.5 ml 
Eppendorf tubes. 400 µl of ice-cold methanol was then added to each sample and briefly vortexed 
before a further 100 µl of chloroform was added to the tube. After brief vortexing, 300 µl of ddH20 
was added to each sample and then centrifuged at 14,000 x g for 2 minutes. The top, aqueous layer 
was pipetted off and protein residing in the interphase layer was collected and transferred to a fresh 
1.5 ml Eppendorf tube. 400 µl of ice-cold methanol was then added and the samples were vortexed 
briefly prior to centrifugation at 14,000 x g for 3 minutes. Methanol was then carefully aspirated, 
and the pellet was allowed to air-dry at room temperature. Samples were re-suspended in 40 µl of 
Laemmli 2× Concentrate Sample Buffer and heated at 100ºC for 10 minutes. Thereafter, the 
denatured protein samples were cooled on ice, briefly spun down and stored at -80ºC until further 
analysis. 
 
2.11 Western blotting 
 
Denatured proteins were resolved by SDS-PAGE using 12% tris-glycine polyacrylamide gels (see 
recipe in Table 2.11.1) in conjunction with the Bio-Rad Mini-Protean Tetra electrophoresis 
apparatus. Sample volume loaded per well ranged between 20 and 40 µl. Colour pre-stained broad 
range protein markers (Cell Signalling, 14208) were included on each gel. Electrophoresis was 














12% resolving gel 
Acrylamide 40% Sigma A6050 1.5 ml 
Milli-Q water N/A N/A N/A 2.15 ml 
Tris-HCl pH8.8 1.5 M Sigma T9503-5KG 1.25 ml 
SDS 10% Sigma L3771-100G 50 µl 
Ammonium-persulfate 10% Sigma A3678-25G 50 µl 
TEMED N/A Sigma T9281-25ml 2 µl 
5% stacking gel 
Acrylamide 40% Sigma A6050 250 µl 
Milli-Q water N/A N/A N/A 1.45 ml 
Tris-HCl pH8.8 1 M Sigma T9503-5KG 250 µl 
SDS 10% Sigma L3771-100G 20 µl 
Ammonium-persulfate 10% Sigma A3678-25G 20 µl 
TEMED N/A Sigma T9281-25ml 2 µl 
 
Table 2.11.1 SDS-PAGE resolving gel recipe. Information includes working concentration, 
supplier, catalogue number and volume. 
 
Resolved proteins were transferred to nitrocellulose membranes pre-soaked in transfer buffer by 
wet transfer overnight at 56 mA. Following transfer, each nitrocellulose membrane was washed 
once in TBS-T (1x TBS (50mM Tris-HCl and 150mM NaCl (Sigma Aldrich, S5886-1KG) in 
(Milli-Q H2O and 0.1% Tween-20) and subsequently blocked in 50 ml of 5% milk in TBS-T for 1 
hour at room temperature. Each membrane was transferred to a 50 ml Falcon tube and washed 
twice in TBS-T for 5 minutes/wash. Primary antibodies were diluted in 1% milk-TBS-T and were 
incubated with the membranes for two hours on a rotary mixer (Table 2.11.2). Membranes were 
washed five times in TBS-T for 5 minutes/wash and secondary antibody prepared in 1% milk/TBS-
T was added (Table 2.11.3). Membranes were incubated for an additional 2 hours on a rotary 
mixer. Thereafter, the membranes were washed with TBST (5 x 5 minutes) prior to detection of 
proteins by enhanced chemiluminescence (ECL). Western Lightning Plus-ECL Substrate (Perkin 
Elmer, NEL103E001EA) was prepared in 1:1 ratio according to the manufacturer’s instructions 
and 750 µl of the working reagent was added to each membrane and incubated for 4 minutes at 
room temperature. Protein bands were visualised using a GeneGnome chemiluminescence imager 













Life Sciences 1 mg/ml 1:500 - 
Anti-canine IL-1β goat  polyclonal AF3747  R&D Systems  0.2 mg/ml  1:500 - 
Anti-caspase-1 p10 (M-20) rabbit polyclonal sc-514 
Santa Cruz 
Biotechnology 100 µg/ml 1:500 - 
Anti-caspase-11 (17D9) rat monoclonal sc-56038 
Santa Cruz 
Biotechnology 200 µg/ml 1:500 - 
Anti-DDDDK tag (M2) mouse monoclonal ab49763 Abcam 100 µg/ml 1:1000 HRP 
Anti-GSDMD rabbit polyclonal STJ112203 
St. John's 
Laboratory   1:1000 - 
Anti-GSDMDC1 (64-Y) mouse monoclonal sc-81868 
Santa Cruz 




monoclonal ab209845 Abcam 
100 µl at 
0.588 mg/ml 1:500 - 
 
Table 2.11.2 List of primary antibodies used in western-blotting experiments. 
 
Antibody Host Catalogue number Manufacturer 
Original 
concentration Dilution Conjugate 
goat anti-rabbit IgG-HRP goat sc-2054 Santa Cruz Biotechnology 400 µg/ml 1:2000 HRP 
goat anti-rat IgG-HRP goat NB-7115 Novus Biologicals 1 mg/ml 1:1000 HRP 
mouse anti-rabbit IgG-HRP mouse sc-2357 Santa Cruz Biotechnology 400 µg/ml 1:200 HRP 
mouse IgG𝛋𝛋 BP-HRP mouse sc-516102 Santa Cruz Biotechnology 400 µg/ml 1:2000 HRP 
 
Table 2.11.3 List of secondary antibodies used in western-blotting experiments. 
 
2.12 Generation of CRISPR edited cell lines 
 
Schematic representation of the workflow for CRISPR-Cas9 gene editing and for Illumina MiSeq 






Figure 2.12.1 Workflow showing the major steps taken to perform gene editing using 
CRISPR-Cas9 technology. The first step involves RNP complex assembly consisting of target 
sequence specific crRNAs, tracrRNAs and recombinant Cas9 proteins. Assembled RNP 
complexes were then electroporated into wild-type DH82 cells. Following recovery, a large 
proportion of the bulk edited cells were frozen down and the remainder were retained for further 
analysis. This included Illumina MiSeq library preparation and sequencing to identify mutations 
and limiting dilution to obtain single cell colonies. Single cell colonies were divided in two, one 
half was frozen down and the other half was prepared for sequence analysis. Based on the 





Figure 2.12.2 Schematic representation of the workflow for Illumina Miseq library 
preparation. Following genomic DNA extraction, first level MiSeq PCR was preformed using 
locus-specific primers including elongated adapter sequences. During second level MiSeq PCR, 
Illumina unique adaptor sequences were attached to the first level MiSeq amplicons. Up to 96 
samples carrying unique identifiers were pooled and spiked with PhiX sequencing control prior to 
sequencing. Illumina MiSeq sequencing results were then analysed using the OutKnocker online 




2.12.1 Nucleofection Optimisation  
 
Adherent DH82 macrophages were harvested and centrifuged at 1000 rpm for 5 minutes prior to 
resuspension in DMEM+. Optimisation of conditions for nucleofection was carried out using the 
Amaxa Cell Line Optimization Nucleofector Kit (Lonza, VC0-1001N) as described in the 
manufacturer’s instructions. Resuspended cells were enumerated, and two cell suspension aliquots 
were prepared, each containing the number of cells required for 9 sample conditions (1.6x106 
cells/sample). Each cell preparation was centrifuged for 5 minutes at 1,000 rpm and the supernatant 
was discarded. One of the cell pellets was re-suspended in 900 µl of Solution L (100 µl/sample) 
including electroporation supplement and the other in 900 µl of Solution V (100 µl/sample) 
including electroporation supplement. 800 µl of each suspension aliquot was transferred into a 
sterile 1.5 ml Eppendorf tube and 16 µg pmaxGFP vector (2 µg/sample) was added to the mix. 
The two remaining 100 µl aliquots of cell suspension without GFP vector were kept and used later 
as negative controls. 100 µl of cell suspension aliquot was transferred into a sterile electroporation 
cuvette and the appropriate electroporation program was run. Immediately after electroporation, 
500 µl of pre-warmed DMEM+ was added to the cuvette and cells were transferred into 6-well 
culture plates containing 1.5 ml pre-warmed DMEM+ medium. The wash step of each cuvette was 
repeated with another 500 µl of DMEM+ medium to ensure all of the electroporated cells were 
collected. Electroporation was repeated for both solutions for each program (Table 2.12.1.1). 
Electroporated cells were incubated at 37ºC in 5% CO2. The following day, electroporated cells 
were harvested and re-suspended in FACS buffer (1% BSA in DPBS). GFP expression for each 
sample was analysed 24-hour post-electroporation. Intact cells were gated by plotting the forward 
scatter signal (FSC) on the x axis versus the side scatter signal on the y axis (SSC). Cells were 
excited with a 488-laser and GFP positive cells were gated by plotting GFP intensity on the x axis 









Program Solution L Solution V pmaxGFP 
1 A-020 A-020 + 
2 T-020 T-020 + 
3 T-030 T-030 + 
 4 X-001 X-001 + 
5 X-005 X-005 + 
6 L-029 L-029 + 
7 D-023 D-023 + 
8 - - + 
9 T020 T020 - 
 
Table 2.12.1.1 Nucleofection optimization conditions. 
 
2.12.2 crRNA, HDR template and Miseq PCR primer design 
 
crRNAs for gene knock-outs were designed to bind near the catalytic sites and identified catalytic 
residues of each gene of interest. For gene-tagging, crRNAs were designed to be immediately 
upstream of, or up to, 60 nucleotides from the stop codon of the targeted genes (Table 2.12.2.1). 
The crRNA designs were performed using Benchling online research platform 
(https://benchling.com) and crRNA sequences were confirmed using IDT’s Custom Alt-R® 
CRISPR-Cas9 guide RNA tool 
(https://eu.idtdna.com/site/order/designtool/index/CRISPR_CUSTOM). crRNAs and tracrRNAs 
(IDT, 1072534) were synthesised at 10 nmol and 100 nmol concentrations, respectively, both in 
lyophilized forms.  crRNAs and tracrRNA were reconstituted in IDTE (IDT, 11-01-02-02) to 200 
µM final concentration and were stored long term at -20°C. Homology-directed repair (HDR) 
templates were designed to include DDDDK-tag sequence immediately upstream of stop codons 
and were purchased as single stranded ultramer DNA oligonucleotides 
(https://eu.idtdna.com/site/order/oligoentry/index/ultra). The phosphate backbone of the first and 
last ten oligos of each HDR template were substituted with a phosphorothioate bond. This chemical 
modification increases the resistance of the inter-nucleotide linkage between oligos to 
endonucleolytic degradation. Pam sites (NGG sequence) of crRNAs were also mutated to prevent 
nucleolytic cleavage of HDRs by Cas9 endonuclease. Codons overlapping pam sites were altered 
so that the change in Pam sites would not affect codons encoding amino acid sequences. If pam 
site mutation resulted in a change in amino acid, a codon encoding a different amino acid within 
the same classification characterised by their side-chains was chosen (Table 2.12.2.2). HDR 
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templates were obtained at 4 nmol concentration in dry form. Upon arrival, HDR templates were 
re-suspended in IDTE buffer (IDT, 11-01-02-02) to 200 µM final concentration. For first level 
Miseq PCR, locus-specific primers were designed based on the canine reference genome 
(CanFam3.1) available on the Ensembl Genome Browser (https://www.ensembl.org/index.html), 
using Primer-blast online primer finding tool (https://www.ncbi.nlm.nih.gov/tools/primer-blast/). 
Genomic amplicons were designed to be a minimum of 175 base pairs and a maximum of 270 base 
pairs in length, with nuclease target sites and DDDDK-tag sequences positioned preferably in the 
centre. First level MiSeq PCR primers were also elongated with 5’ adaptor sequences that are 
required for the second level PCR [313] (Table 2.12.2.3). PAGE purified first level MiSeq primers 
were ordered at 100 µM stock concentration from Sigma-Aldrich and were reconstituted in 
UltraPure™ DNase/RNase-Free Distilled Water (Thermo Fisher, AM9916) upon arrival, 
according to the manufacturer’s instructions and were stored at -20°C. First level MiSeq primers 
were used at 10 µM final working concentration and primer melting temperatures were determined 
using the NEB online melting temperature calculator (https://tmcalculator.neb.com/#!/main). 
Universal, 96-well barcode primer dilutions for second level MiSeq PCRs were prepared by 
combining 8 unique forward and 12 unique reverse primers in a 96-well plate format at a final 


















 Caspase-1/4/11 crRNA sequence 1   CAACCTCAAGGACAAACCGA 
 Caspase-1/4/11 crRNA sequence 2   GCATCCTGAATGGAATCTGT 
 Caspase-8 crRNA sequence 1    TTTTATTCAGGCTTGTCAAG 
 Caspase-8 crRNA sequence 2     CCTACCGAAACCCCATGGAG 
 Caspase-15 crRNA sequence 1    TTTATCATCCAGGCCTGTAG 
 Caspase-15 crRNA sequence 2    ATCATCCAGGCCTGTAGAGG  
 Caspase-15 crRNA sequence 3    AGGCCTGTAGAGGAGGTAAG 
 GSDMD crRNA sequence 1    GTGTACACTCTATGCCTGTC 
 GSDMD crRNA sequence 2     ACTGCTGTTATGCCTGAGCG 
 GSDMD crRNA sequence 3    TGAGCGAGGACCCCTGTTA 
 RIPK1 crRNA sequence 1    TAATTATGGAGACCATTGAA 
 RIPK1 crRNA sequence 2    TGGAGAAGGCGTAATACACA 
 
Table 2.12.2.1 List of crRNAs design for gene knock-out and gene tagging experiments. A 
minimum of two crRNAs were designed for each gene of interest. 
 















Table 2.12.2.2 List of HDR templates for gene tagging experiments. Phosphorothioate 
modified nucleotides increasing resistance against endonuclease degradation are marked with a 








Caspase-1/4/11 PCR 1 forward primer 
ACACTCTTTCCCTACACGACGCTCTTCCGATCTCGCCCAGAGCATAAGTCCTC 
 
Caspase-1/4/11 PCR 1 reverse primer  
TGACTGGAGTTCAGACGTGTGCTCTTCCGATCTTCATGGCCTTTGGGGTTTCT 
 
Caspase-8 PCR 1 forward primer crRNA 1 
ACACTCTTTCCCTACACGACGCTCTTCCGATCTCTATGGCTCTGATGGGCAGG 
 
Caspase-8 PCR 1 reverse primer crRNA 1 
TGACTGGAGTTCAGACGTGTGCTCTTCCGATCTGCTGACTTTCTGCTGGGGAT 
 
Caspase-8 PCR 1 forward primer crRNA 2 
ACACTCTTTCCCTACACGACGCTCTTCCGATCTGCTGACTTTCTGCTGGGGAT 
 
Caspase-8 PCR 1 reverse primer crRNA 2 
TGACTGGAGTTCAGACGTGTGCTCTTCCGATCTAGAGGGGGTAAGTGCTCACA 
 
Caspase-15 PCR 1 forward primer 
ACACTCTTTCCCTACACGACGCTCTTCCGATCTTGGCTGTTGCCTCATTACCC 
 
Caspase-15 PCR 1 reverse primer 
TGACTGGAGTTCAGACGTGTGCTCTTCCGATCTATGTTTCGGGGATGCCTGAG 
 
GSDMD PCR 1 forward primer 
ACACTCTTTCCCTACACGACGCTCTTCCGATCTGTGTGCTGGGAGCCAGAG  
 
GSDMD PCR 1 reverse primer 
TGACTGGAGTTCAGACGTGTGCTCTTCCGATCTCAGCCAGGTGGGCATGAG 
 
RIPK1 PCR 1 forward primer 
ACACTCTTTCCCTACACGACGCTCTTCCGATCTACAGTTGCTTTGGCCTGTTTG  
 




Table 2.12.2.3 List of first level MiSeq PCR designs for gene knock-out and gene tagging 
experiments. Underlined sections are the locus-specific sequences, while nucleotides highlighted 




2.12.3 Electroporation of DH82 cell line 
 
Equimolar amounts of tracr- and crRNAs were mixed in clear PCR tubes at three different 
concentrations (100, 200 and 400 pmoles) and heated at 95˚C in a BIO-RAD T100TM thermocycler 
for 5 minutes. Prior to Cas9-crRNA-tracrRNA ternary complex assembly, crRNA-tracrRNA 
duplexes were allowed to cool to room temperature. Ribonucleoprotein (RNP) assembly reaction 
was performed on duplexes by adding an equimolar concentration of Cas9 endonuclease protein 
(IDT, 1074182) to the complex. Reactions were mixed and incubated at 21˚C in a BIO-RAD T100 
thermocycler for 15 minutes. RNP complex was then supplemented with equimolar concentration 
of Alt-R® Cas9 electroporation enhancer (IDT, 1075916). For endogenous gene tagging, HDR 
template was also added to the RNP complex. Electroporation enhancer is a Cas9 specific carrier 
DNA sequence which has been optimised to work with the Amaxa Nucleofector 2b (Lonza, AAB-
1001) to increase transfection efficiency thereby enhancing the rate of genome editing. For 
endogenous gene tagging, Alt-R® HDR Enhancer (IDT, 1081072) was added at a final 
concentration between 20 to 30 µM to cell culture medium following electroporation and the cells 
were incubated in the presence of HDR enhancer for 24 hours at 37°C, 5% CO2. Thereafter, cell 
culture medium containing HDR enhancer was replaced with fresh medium and further incubated 
overnight at 37°C, 5% CO2. This small molecule compound is used to improve rates for homology-
directed repair, therefore increasing the efficiency for endogenous gene tagging. In the meantime, 
DH82 cells were harvested and enumerated using trypan blue exclusion (Thermo Fisher Scientific, 
15250061) with a target cell number of 1.6x106 cells/condition. Cells were transferred into 50 ml 
falcon tubes (Sigma Aldrich, CLS430829-500EA) and centrifuged at 1000 rpm for 5 minutes. 
After centrifugation, the supernatant was carefully removed and the cells were re-suspended in 
100 µl of Nucleofector Solution V containing electroporation supplement (Lonza, VCA-1003). 10 
µl of RNP was introduced to a sterile 1.5 ml Eppendorf tube and 100 µl of cell/buffer suspension 
was added to the mix. The nucleofection buffer-cell-RNP mix was then transferred directly into 
an electroporation cuvette and a single electroporation was performed in an Amaxa Nucleofector 
2b (Lonza, AAB-1001) using the X-005 program following the manufacturer’s instructions. After 
electroporation, the cell suspensions were transferred into 6-well cell culture plates containing 2 
ml of pre-warmed DMEM+ culture medium and the cells were allowed to recover for 24 hours at 
37˚C in 5% CO2. The following day cells were harvested by gentle scraping and transferred into 
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T75 flasks containing DMEM+ medium. Cells were cultured at 37˚C in 5% CO2, until 80% 
confluency was attained. During splitting of bulk populations one third of the harvested cells was 
further cultured until 60% confluency and collected for genomic DNA extraction. The remaining 
two thirds of the cells were frozen down in triplicates in freezing medium.  
 
2.12.4 Preparation of DNA from bulk edited cell populations and single cell colonies 
 
DNA extraction of bulk edited cell populations was performed using the PureLink™ Genomic 
DNA Mini Kit (ThermoFischer Scientific, K1820-01). A minimum of 1x106 cells were transferred 
to a fresh 1.5 ml Eppendorf tube and centrifuged at 1000 rpm for 5 minutes. Pelleted cells were 
then re-suspended in 200 µl of DPBS and 20µl of proteinase K followed by 20 µl of RNAse A 
was added to the cell suspension. Samples were mixed by vortexing and then incubated at room 
temperature for 2 minutes. Thereafter, 200 µl of Genomic Lysis Buffer was added to the mix and 
vortexed until the solution became homogenous. Samples were then incubated in a 55°C water 
bath for 10 minutes prior to the addition of 200 µl of 100% ethanol to each sample and briefly 
vortexed. Lysates were transferred into spin columns and centrifuged at 10,000 x g for 1 minute. 
Spin columns were washed twice, first with 500 µl of Wash Buffer 1, centrifuged at 10,000 x g for 
1 minute. A second wash was performed with 500 µl of Wash Buffer 2 containing ethanol. 
Subsequently, the columns were centrifuged at maximum speed for 3 minutes and transferred into 
fresh 1.5 ml Eppendorf tubes. 30 µl of Elution Buffer was added and samples were incubated for 
1 minute prior to centrifugation at maximum speed for one minute. DNA was eluted twice in 25 
µl of UltraPure™ DNase/RNase-Free Distilled Water (Thermo Fisher, AM9916) resulting in a 
total volume of 25 µl in order to maximise DNA yield. Eluted DNA was then stored at -20°C until 
required. DNA extraction of single cell colonies was performed by first removing supernatant from 
cells followed by the addition of 20 µl of direct lysis buffer (1 mM CaCl2  (Sigma Aldrich, C3381-
500G), 3 mM MgCl2  (Sigma Aldrich,M2670-500G), 1 mM EDTA/10 mM Tris (pH 7.5) (Fisher 
Scientific, BP2477-500), 1 % Triton X-100, 0.2 mg/mL proteinase K (Thermo Fisher, AM2548)) 
to each well. Proteinase K was added fresh, immediately prior to lysis. Cells were gently re-
suspended and transferred into a 96-well PCR plate. Cell/lysate mix were then incubated for 10 
minutes at 65°C followed by 15 minutes at 95°C on a BIO-RAD T100TM Thermocycler. Cell 
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lysates directly used for first level MiSeq PCR reactions either immediately after lysis or 
alternatively samples could be stored at -20°C until required. 
 
2.12.5 Miseq PCR preparations and reactions 
 
For the analysis of bulk populations, genomic DNA was dispensed at two different concentrations 
(250- and 500 ng) into a 96-well PCR plate. For single cell colonies, 1 µl of each cell lysate was 
used. The PCR protocol for locus-specific amplification was performed as follows: 10 µl of 2X 
Phusion HF Buffer (ThermoFisher F531L), 1 µl of 10 µM of each, forward- and reverse primers 
and DNase/RNase-free distilled water to make a total of 20 µl reaction/sample. Each well was 














































Table 2.12.5.1 First level MiSeq PCR conditions. (A) includes conditions used for caspase-8 
crRNA 2, (B) conditions used for caspase-15 crRNA 1, -2 and GSDMD crRNA1, -2, -3, (C) 
conditions used for the hybrid caspase-1/4/11 crRNA 1, -2 and caspase-8 crRNA 1 and RIPK1 
crRNA 1, -2.  
 
Following first level MiSeq PCR, amplicons generated from bulk cell populations were assayed 
for correct size by PAGE. Briefly, DNA was mixed with Gel Loading Dye (Thermo Fisher, #F350) 
and resolved on a 3% agarose gel (BIO-RAD, #1613030). A lane containing DNA ladder (Bioline, 
#H5-417-105) was included on all gels. The second MiSeq PCR was performed as follows; 10 µl 
Step 1 98°C 30 seconds  
 
                   
30 repeats 
                   
 
Step 2 98°C 10 seconds 
Step 3 64°C 15 seconds 
Step 4 72°C 15 seconds 
Step 5 72°C 60 seconds 
Step 6 10° HOLD 
Step 1 98°C 30 seconds  
 
                   
30 repeats 
                   
 
Step 2 98°C 10 seconds 
Step 3 65°C 15 seconds 
Step 4 72°C 15 seconds 
Step 5 72°C 60 seconds 
Step 6 10° HOLD 
Step 1 98°C 30 seconds   
                   
 30 repeats 
 
Step 2 98°C 10 seconds 
Step 3 66°C 15 seconds 
Step 4 72°C 15 seconds 
Step 5 72°C 60 seconds 
Step 6 10° HOLD 
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of 2X Phusion HF Buffer (ThermoFisher F531L), 7µl of DNase/RNase-free distilled water, 1 µl 
of amplicon from first level Miseq PCR for each amplicon and 2 µl of universal 96-well Miseq 
barcode primers [313] (Table 2.12.5.2) were added to each sample. Samples were mixed 























Table 2.12.5.2 List of unique MiSeq sequencing barcodes for second level PCR. 96 unique 
primers were produced by plating barcodes A701-A712 horizontally (A1-A12) and barcodes 
A501-A508 vertically (A1-H1) on a 96-well plate. 
  
Step 1 98°C 30 seconds 
30 repeats 
 
Step 2 98°C 10 seconds 
Step 3 63°C 15 seconds 
Step 4 72°C 15 seconds 
Step 5 72°C 60 seconds 
Step 6 10° HOLD 
 




2.12.6 Miseq library preparations 
 
2 µl each of the second level MiSeq PCR products were pooled in a 1.5 ml Eppendorf tube and 
mixed thoroughly by pipetting up and down. Thereafter, 0.7x volume of Agencourt AmPure XP 
beads (Beckman Coulter, #A63880) was added to the library pool and incubated for 15 minutes at 
room temperature, then placed on a magnetic stand for five minutes. The supernatant was carefully 
removed, and the library pool was washed with 500 µL of 70% EtOH for 30 seconds by re-
suspending completely. The Eppendorf tube containing the library was placed back onto a 
magnetic stand and incubated for another 5 minutes. The ethanol was subsequently removed, and 
the washing step was repeated. Following the second wash, the bead pellet was allowed to air dry 
for 10 minutes with the lid of the Eppendorf tube left open at room temperature. The dried bead 
pellet was re-suspended in 35 µl of Elution Buffer (Qiagen, #19086) and incubated for 2 minutes 
at room temperature and then placed back onto the magnetic stand for another 5 minutes. After 
complete separation of the beads the supernatant was carefully removed and transferred into a 
fresh Eppendorf tube. Following elution, the DNA concentration was determined using Qubit™ 
dsDNA BR Assay Kit (Qubit, #Q32853) following the manufacturer’s instructions. Working 
solution (BR buffer:200 parts – BR reagent:1 part) was prepared for two standards and samples. 
For standards, 190 µl was aliquoted into a 0.5 ml clear PCR tube, whereas for samples, 199 µl of 
working solution was used and 10µl of each standard and 1µl of sample were added to the 
appropriate PCR tubes. Samples were vortexed and incubated for two minutes at room 
temperature. DNA concentrations were read on a Qubit Fluorometer by measuring the standards 
first. The library pool was then diluted in a final volume of 300 µl of DNase/RNase-free distilled 
water to yield a 4 nM final concentration. The library concentration was further determined using 
NEBNext® Library Quant Kit for Illumina® (NEB, #E7630S) according to the manufacturer’s 
instructions. Library dilution (1:1000) was prepared in 1x dilution buffer (10x dilution buffer 
diluted in nuclease-free water), then two further ten-fold serial dilutions were prepared in 1x 
dilution buffer (1:10,000 and 1: 100,000). QPCR assays for standards (10-, 1-, 0.1-, 0.01pM 
concentrations) and library were set up using master mix (100 µl primer mix, 1.5 ml master mix 
and 20 µl ROS normalisation dye). 4 µl of DNA standard/sample dilution was added to 16 µl 
master mix. A no template DNA control was also included (4 µl of library dilution buffer was 
added to 16 µl of master mix.) The qPCR plate was sealed and centrifuged for 2 minutes at 2500 
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rpm and ran using Applied Biosystems 7500 machine (Table 2.12.6.1). Actual library 
concentration was determined using the Ct values obtained from qPCR, analysed using 
NEBiocalculator qPCR Library Quantification (https://nebiocalculator.neb.com/#!/qPCRlibQnt) 
online tool, generating a standard curve using the Ct values obtained for the 4 standards. When 
necessary, library concentrations based on the Ct values were adjusted to obtain the actual 4 nM 
final concentration. The library was then further diluted to 20 pM concentration by adding 5 µl of 
0.2 N NaOH buffer and 900 µl of HT1 (Illumina MiSeq Reagent Nano Kit v2 300-cycles, #MS-
103-1001) buffer to 5 µl of 4 nM library. The 20 pM library was further diluted in HT1 buffer to 
obtain a 12 pM final concentration. A final volume of 600 µl of 12 pM library supplemented with 
12.5 pM PhiX Sequencing Control v3 spikes (Illumina, #FC-110-3001) was loaded into the MiSeq 










Table 2.12.6.1 QPCR assay conditions. 
 
2.12.7 Limiting dilution of bulk edited cell populations 
 
Frozen vials of bulk edited populations were thawed and grown to 60% confluency in DMEM+ 
medium. Cells were then gently scraped and centrifuged at 1000 rpm for 5 minutes. Cell number 
was calculated using trypan blue exclusion method and the cells were diluted to a density of 10 
cells/ml. 20% of the DMEM+ culture medium was replaced with DH82 conditional medium. A 
total volume of 100 µl of cell suspension was added to each well of a flat-bottom 96-well cell 
culture plate. To increase the number of single cell colonies, up to 10 plates were plated for single 
cell cloning. Cells were incubated for one week at 37°C in 5% CO2. At the end of the first week, 
100 µl of DMEM+ medium was added to each well and cells were incubated for an additional 7 
days at 37°C in 5% CO2. Thereafter, each well was assessed for colonies originating from a single 
cell. Cells in selected wells were washed once with 100 µl of pre-warmed DPBS, then trypsinized 





  30 repeats 
 
 
Step 2 98°C 15 seconds 
Step 3 63°C 45 seconds 
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with 50 µl of 1x trypsin solution for 5 minutes at 37°C in 5% CO2. After 5 minutes, trypsin was 
deactivated with 150 µl of pre-warmed DMEM+. Cells were gently pipetted up and down for a 
total of 5 times. Resulting cell suspensions were divided: 80 µl of cell suspension/well was 
dispensed across two 48-well cell culture plates and 40 µl of cell suspension/well into a flat-bottom 
96-well cell culture plate. Cells in 48-well plates were left to adhere overnight then 80 µl of filtered 
freezing medium was added to each well. Plates were then sealed, wrapped in bubble wrap, placed 
into a polystyrene box and transferred into -80°C freezer overnight. The next day, plates were 
transferred to a -150°C freezer and stored until further analysis. Cells in 96-well plates were further 
cultured until 60% confluency after which DNA extraction and MiSeq library preparation were 
performed for subsequent single cell clone sequencing analysis as discussed previously. 
 
2.12.8 Revival and expansion of single cell colonies 
 
48-well cell culture plates containing single cell colonies were thawed at 37°C in 5% CO2 and 1 
ml of DMEM+ medium was added to each well. Cells were allowed to settle for a minimum of 
four hours at 37°C in 5% CO2, prior to replacing the medium with 1 ml of fresh DMEM+ medium. 
Single cell colonies were left to recover for 48 hours at 37°C in 5% CO2, followed by trypsinisation 
and were then transferred into T25 cell culture flasks. Cells were grown to 80% confluency at 37°C 
in 5% CO2 and then harvested and transferred into T75 cell culture flasks. Upon reaching 80% 
confluency the cells were frozen down (in triplicates) in freezing medium. 
 
2.12.9 Analysis of sequencing output fastq files 
 
Sequences were analysed using the OutKnocker online analysis tool 
(http://www.outknocker.org/outknocker2.htm). Under Analyse Sequencing Data tab, crRNA 
sequences were added in capital letters into the Nuclease Target Site box in the same orientation 
as the reference genome, including Pam motifs. Up to 96 extracted fastq files were uploaded by 
using Select FASTQ files tab and evaluation of the results was executed by START ANALYSIS 
button. Under the Results tab, each clone is represented by a pie chart. The caspase-1/4/11 hybrid 
gene was utilised to illustrate the data output generated by the OutKnocker software for bulk-
edited and single cell colonies (Figures 2.12.9.1 and 2.12.9.2, respectively). The size of the pie 
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chart relates to the number of amplicon reads for each clone and the area and colour of the pie 
chart sections demonstrate the relative abundance and type of indels identified based on sequence 
analysis. Colours in the shade of red represents frameshift insertions and deletions, while the 















Figure 2.12.9.1 Sequencing analysis of bulk-edited DH82 cell populations for indels induced 
by CAACCTCAAGGACAAACCGA crRNA for the canine caspase-1/4/11 hybrid gene. 
DH82 cells were electroporated with RNP complexes prepared at three different concentrations 
(100, 200 and 400 nmol). crRNA was designed to be proximal to the catalytic site of the canine 
hybrid gene. Genotyping using Illumina MiSeq sequencing revealed that electroporated only wild-
type cells displayed no genome modification, while Cas9-edited cells showed a mixture of in-
frame and out-of-frame mutations. The size of each pie chart corresponds to the number of reads 
that were analysed for each sample (see legend in top right corner). Pie areas in the shade of red 
represents out-of-frame, areas in the shade of blue represents in-frame insertions and deletions, 
grey areas represent no indel calls (see legend in bottom right corner) while empty wedges show 






Figure 2.12.9.2 OutKnocker analysis of 96 DH82 single cell colonies electroporated with 
CRISPR crRNA targeting the canine caspase-1/4/11 hybrid gene. DH82 cells were 
electroporated with CRISPR crRNA GCATCCTGAATGGAATCTGT to target the canine hybrid 
caspase-1/4/11 gene. Following limiting dilution, up to 96 single cell colonies were selected and 
genotyped using Illumina MiSeq sequencing. Sequencing results were analysed using OutKnocker 
online analysis tool. Each pie chart represents a single colony, whereas the size of each pie chart 
corresponds to the number of reads that were analysed for each colony (see legend in top right 
corner). Pie areas in the shade of red represents out-of-frame, areas in the shade of blue represents 
in-frame insertions and deletions, while grey areas represent no indel calls (see legend in bottom 
right corner). Colony positions in red letters highlight knock-out colonies, while blue letters 
highlight heterozygous colonies for the canine caspase-1/4/11 hybrid gene. 
 
Individual clones were selected by clicking on those pie charts displaying frameshift mutations. 
The sequences of selected clones aligned to the reference genome can be found at the bottom of 
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the results page. The letter size of the amplicon bases linearly correlates with the relative 
abundance of that specific base. Nucleotides with reduced confidence are illustrated with smaller 
letters to that of other bases. Bases outlined in red indicate mismatches to the reference genome. 
The caspase-1/4/11 hybrid gene was used to illustrate the data output for the list of different indels 
identified by the OutKnocker software for bulk-edited and single cell colonies (Figures 2.12.9.3 

















Figure 2.12.9.3 List of different indels identified in bulk-edited DH82 cell populations by 
sequence analysis using GCATCCTGAATGGAATCTGT crRNA for the canine caspase-
1/4/11 hybrid gene. DH82 cells were electroporated with RNP complexes prepared at three 
different concentrations (100, 200 and 400 nmol). crRNA was designed to be near the catalytic 
site of the canine hybrid gene. Electroporated only wild-type DH82 cells yielded amplicon reads 
that matched exclusively the wild-type sequence, while Cas9 edited cells yielded amplicon reads 
that contained a mixture of in-frame and out-of-frame mutations. These results are indicative of 
the type, position, percentage and number of reads associated with each mutation present in the 
bulk edited population. The underscored nucleotide sequence represents the wild-type reference 
sequence, while nucleotides highlighted in yellow show CRISPR crRNA target site. Information 
including total percentage and total number of reads corresponding to each identified indel are 
shown underneath the reference sequence. Nucleotides shown in smaller font sizes are less 
confident calls based on the sequencing data, while nucleotides replaced with hyphens represents 
the position of nucleotides deleted by CRISPR Cas9. The software also provides information on 
the percentage and total number of reads that could not be aligned to the reference sequence and 






Figure 2.12.9.4 Illumina MiSeq sequencing of caspase-1/4/11 identified out-of-frame indel 
mutations for colonies A1 and C6 are depicted near the catalytic site in exon 6. DH82 cells 
were electroporated with CRISPR crRNA GCATCCTGAATGGAATCTGT to target the canine 
hybrid caspase-1/4/11 gene near the catalytic site. Following limiting dilution, up to 96 single cell 
colonies were selected and genotyped using Illumina MiSeq sequencing. Information displayed by 
the analysis software includes the file name, number of amplicon reads and indel frequency. The 
underscored nucleotide sequence represents the wild-type reference sequence, while nucleotides 
highlighted in yellow show CRISPR crRNA target sites. Information including total percentage 
and total number of reads corresponding to each identified indel are shown underneath the 
reference sequence. Nucleotides shown in smaller font sizes are less confident calls based on the 
sequencing data, while nucleotides replaced with hyphens represents the position of nucleotides 
deleted by CRISPR Cas9. The software also provides information on the percentage and total 
number of reads that could not be aligned to the reference sequence and the number of reads that 
were excluded from analysis (Phred score dropouts).  
 
2.13 Genotyping of DogMo cells provided by Vishva Dixit, Genentech Research Institute 
 
DNA extraction of murine DogMo and wild-type primary BMDMs were carried out on a minimum 
of 1x106 cells/genotype using PureLink™ Genomic DNA Mini Kit (ThermoFischer Scientific, 
K1820-01). PCR protocol for locus-specific amplification was performed as follows, 10 µl of 2X 
Phusion HF Buffer (ThermoFisher F531L), 1 µl of 10 µM of each primer (Table 2.13.1) and 
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DNase/RNase-free distilled water to make a total of 20 µl reaction/sample. The contents of each 
well was thoroughly re-suspended, and samples were run on a BIO-RAD T100TM thermocycler 
(Table 2.13.2). Following PCR, amplicons generated were assayed for correct size by PAGE. 5µl 
of amplicons from each sample were resolved on a 1% agarose gel supplemented with 5x GelPilot 
DNA Loading Dye, 5x (Qiagen, #151047521). DNA ladder (New England BioLabs, #N0551G) 
was included on each gel and gel electrophoresis was performed at 100V for 40 minutes.  
 
Primer 1 (5'-3') TTCTGTGTCATAGCCAAGTTC 
Primer 1 (5'-3') ATACTGTCTGTGTCCTTCTCA 
Primer 1 (5'-3') ACGAGTGGTTGTATTCATTATTG 
 









Table 2.13.2 Genotyping assay conditions. 
 
2.14 Phylogenetic tree building of mammalian caspases 
 
For this work the NCBI reference sequence was used for the catalytic domain of caspase-1 isoform 
alpha precursor (NP001244047). This sequence was used for Position Specific Iterated (PSI) – 
Basic Local Alignment Search Tool (BLAST) 
(https://blast.ncbi.nlm.nih.gov/Blast.cgi?CMD=Web&PAGE=Proteins&PROGRAM=blastp&R
UN_PSIBLAST=on) against the human protein reference database (protein_refseq) and 
downloaded sequences for caspases (1-10, 12 and 14).  Multiple Sequence Comparison by Log- 
Expectation (MUSCLE) (https://www.ebi.ac.uk/Tools/msa/muscle/) was used to generate a 
multiple sequence alignment of the human caspases and to identify the first and last fully conserved 
Step 1 94°C 4 minutes 
 
    30 repeats 
 
Step 2 94°C 1 minute 
Step 3 60°C 30 seconds 
Step 4 72°C 1 minute 
Step 5 72°C 10 minutes 
Step 6 4°C HOLD 
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residues. Using this identified conserved sequence, a Position-Specific Scoring Matrix (PSSM) 
was constructed using PSI-BLAST against the human reference protein database. Two iterations 
of PSI-BLAST were run with the default selected sequences to maximise the number of 
identifiable sequences with caspase catalytic domains. Sequences for each caspase displaying 
100% coverage to the query sequence were used to generate the PSSM. The human PSSM was 
uploaded and the PSI-BLAST was run against different mammalian species (Table 2.14.1). 
Putative and confirmed caspases were identified based on their query cover, percentage of 
alignment and e-values. Preparation of identified putative and confirmed caspase protein 
sequences for phylogenetic tree building was carried out using UGENE bioinformatics toolkit 
(http://ugene.net).  Protein sequences were aligned using ClustalW within the UGENE software. 
Identified misalignments were manually reviewed and first positions containing gaps at the start 
and at the end of the sequences were deleted and each column containing any sequence gaps were 
also removed. Once satisfied with the sequence alignment, a neighbour-joining phylogenetic tree 
was built using the PHYLIP phylogenetics package. Neighbour-joining allows a fast analysis 
generating a single possible phylogenetic tree to investigate sequence homology and therefore 
establish relationships. It also allows the assessment of confidence levels by bootstrapping where 
the higher the number displayed on each part of the tree means more confident grouping within 
the branch. The generated phylogenetic tree was displayed using FigTree graphical viewer of 
phylogenetic trees (http://tree.bio.ed.ac.uk/software/figtree/)  
 
Common name Scientific name Ensembl taxon ID 
Cat Felis catus 9685 
Chimpanzee Pan troglodytes 9598 
Dog Canis lupus familiaris 9615 
Human Homo sapiens 9606 
Mouse Mus musculus 10090 
Pig Sus scrofa 9823 
Platypus Ornithorhynchus anatinus 9258 
Tasmanian devil Sarcophilus harrisii 9305 
 





2.15 Statistical analysis 
 
The work described in Chapter 3 and Chapter 4 of this thesis was focused on the characterisation 
of inflammatory responses in the dog using a canine immortalised macrophage-like cell line, 
DH82. Responses to the chosen panel of ligands have previously been established in the murine 
equivalent. I therefore used these immortalised murine cells as internal experimental controls to 
ensure that the experimental results I obtained for the DH82 cells were reliable. However, there 
are a number of additional differences (including PRR and caspase repertoire) that exist between 
the two species which could potentially drive or influence the observed phenotypic differences. 
Consequently, I  chose not to perform statistical analysis but instead compare and contrast the 
overall trends observed between the murine and canine macrophages.  
 
In Chapter 5 I aimed to identify genes driving the DH82 cell lytic responses and IL-1β release 
following S. Typhimurium infection. In these experiments the objective was to prevent cell lysis 
and therefore abrogate IL-1β release. The observed difference between the genetically altered cell 
lines were either negligible or pronounced but due to time limitations, only a small proportion of 
recovered clones were characterised. Therefore, statistical analysis would not have yielded any 
valuable information but instead highlight variation within the selected clones. 
 
The primary aim of the work described in Chapter 6 of this thesis was to characterise Dog-Mouse 
(DogMo) primary bone marrow derived macrophages containing the hybrid caspase-1/4/11 fusion 
gene. However, due to the limited number of available frozen primary DogMo BMDMs, only a 
maximum of two independent experiments could be performed for each selected ligand. 
Consequently, statistical analysis therefore could not be performed on the limited datasets. 
 
Statistical analysis could be performed for each individual experiment where at least three 
independent experiments are available using the latest version of Prism software (currently version 
8.4.2, GraphPad). Depending on the number of experimental groups, the data type and the number 
of qualitative variables, statistical difference could be determined using either one-way analysis of 
variance (ordinary one-way ANOVA) with Tukey’s multiple comparison post-test or unpaired t-
test. The mean values of the triplicate wells within each independent experiment would be 
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calculated and the resulting three mean values would then be used for statistical analysis. For 
experiments using sterile ligands, cell line responses for each concentration would be compared 
separately while for infection assays the values for the different cell lines would be compared for 












Inflammasomes play a critical role in the defence against microbial infections [314]. Their 
assembly results in the activation of inflammatory caspases, which leads to the processing and 
maturation of the pro-inflammatory cytokines, pro-IL-1β and pro-IL-18 [6] and initiation of 
pyroptosis via GSDMD cleavage [43], [44] and subsequent membrane pore formation. 
Understanding mechanisms regulating inflammasome activation and regulation is an intense area 
of research and studies are predominantly carried out in rodent and human systems. Much less is 
known about inflammasomes in other species. Genomic and proteomic analysis of different 
species has identified significant differences in key genes that regulate innate immunity that raises 
questions about fundamental aspects of inflammasome evolution and its role in host immunity. 
Bioinformatics analysis of canine inflammatory caspases, for example, reveals that caspase-1 and 
canine caspase-4/11 equivalent has formed a fusion gene product whose function remains 
undetermined. In this chapter, I will describe the characterisation of putative canine inflammasome 
responses to a range of sterile insults in a canine cell line (DH82) and primary canine peripheral 
blood mononuclear cells (PBMCs).  
 
The canine DH82 macrophage-like cell line has been primarily used to investigate pathological 
disorders [315] and pathogenic infections [316]–[319] in the context of veterinary science. 
Ensembl genome browser (https://www.ensembl.org/index.html) contains reference genomes, 
including genes (ENSG) and their transcript (ENST) sequences for multiple species, including the 
dog (CanFam3.1). Many genes important in inflammatory responses in mice and humans are also 
annotated in the dog. This includes NLRP3 (ENSCAF00000010686), IL-1β 
(ENSCAF00000007249) and GSDMD (ENSCAF00000001301). There are, however, remarkable 
differences between some of the genes involved in inflammatory responses. Comparative genomic 
sequence analysis has shown that the NAIP gene is absent and the NLRC4 gene contains multiple 
premature stop-codons in the dog genome [41]. Genomic sequence analysis has further shown that 
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the dog caspase-1 gene has lost its 3’ end sequences, while the adjacent gene caspase-4 has lost its 
5’end regions [154]. This results in the expression of a hybrid gene, encoding the N-terminal 
CARD domain of caspase-1 and the C-terminal caspase domain of caspase-11 genes [154] (Figure 
3.1.1). Reverse transcription polymerase chain reaction (RT-PCR) analysis of PBMCs showed 
alternative mRNA splicing of the gene, producing two alternative transcripts [154]. The smaller 
transcript consists of the CARD domain similar of the human and mouse caspase-1 genes and the 
caspase domain similar of the human caspase-4/-5 and murine caspase-11 genes. By contrast, the 
larger transcript includes the CARD domain similar of the human caspase-4/-5 and murine 









Figure 3.1.1 Domain organisation of the dog caspase-1/4/11 hybrid protein. The gene encoding 
the canine hybrid protein can produce two alternative transcripts. (Transcript A) The larger 
transcript contains two tandem CARDs and a caspase domain. The first CARD domain shows high 
sequence homology to the CARD domain of human and murine caspase-1. While the second 
CARD domain shows high sequence similarities to the CARD domain of human caspase-4/-5 and 
murine caspase-11. The caspase domain shows high similarities to the caspase domain of human 
caspase-4/-5 and murine caspase-11. (Transcript B) By contrast, the shorter transcript excludes the 
second CARD domain, resulting in a gene sequence consisting of a CARD domain similar to 




Species-specific differences in caspases are present in both invertebrate and vertebrate species, but 
the functional consequence of these differences is unclear in the host response to infections and 
inflammatory stimuli. Here, I have performed multiple sequence alignment (MUSLCE) analysis 
of transcripts of the main inflammatory genes found in the human, mouse and dog genomes to 
assess the similarities in catalytic residues essential for function and therefore protein activity. I 
have also characterised a canine histiocytic macrophage-like DH82 cell line and its responses to 
well characterised inflammatory activators in a series of in vitro experiments. Canonical activation 
of the NLRP3 inflammasome was carried out using nigericin bacterial toxin, while non-canonical 
NLRP3 inflammasome was activated using cytosolic LPS. Inflammasome activity was determined 
by measuring cell lysis (relative LDH release), ASC speck formation, fluorescent caspase probe 
localisation and the production and maturation of IL-1β. Morphological changes induced by these 
activators were also monitored by live cell imaging using bright-field microscopy. 
 
3.2 Investigation of the dog hybrid caspase-1/4/11 gene using multiple sequence comparison 
by log-expectation (MUSCLE) analysis of its transcripts and mass spectrometry analysis 
of its protein expression 
 
Previous genomic analysis has shown the gene sequence organisation of the caspase-1/4/11 hybrid 
gene and the production of its two alternatively spliced mRNA transcripts [154]. Gene expression 
however at the protein level has not yet been shown. While the caspase-1 gene is constitutively 
expressed in cells [160], human caspase-5 [182] and murine caspase-11 [160] expression requires 
priming. To investigate whether the canine caspase-1/4/11 hybrid gene is expressed at the protein 
level and whether the expression requires priming, mass spectrometry analysis of full protein 
extracts was performed by the Cambridge Centre for Proteomics (CCP) Core Facility. Extracted 
proteins from DH82 cells were prepared without any treatment (medium only) (Figure 3.2.1A) or 
after LPS priming (200 ng/ml for 3 hours) (Figure 3.2.1B) and submitted for analysis. SDS/PAGE 
gel electrophoresis of each sample (12 µg) was run and gels were stained with Coomassie colloidal 
stain. Bands between the 32 kDa and 58 kDa molecular weight markers corresponding to the 







Figure 3.2.1 Gel image of full protein extractions from non-stimulated (medium only) and 
LPS primed DH82 cell lysates. Medium only (A) and LPS primed (B) samples were cut out 
between the 32 kDa and 58 kDa molecular weight markers (area marked with red rectangles) and 
prepared for mass spectrometry analysis by the Cambridge Centre for Proteomics (CCP) Core 
Facility.  
 
Analysis of mass spectrometry results using Mascot database showed the expression of the hybrid 
gene at the protein level in DH82 cells (Figure 3.2.2). The hybrid gene is constitutively expressed 
for the reason that the protein was detected in the non-stimulated (medium only) (Figure 3.2.2A), 
as well as the LPS primed samples (Figure 3.2.2B). The hybrid gene consisting of the 5’end of 
caspase-1 including the promoter region explains the constitutive expression of the protein [154]. 
Unfortunately, the analysis could not differentiate between the two transcripts as regions common 








Figure 3.2.2 Mass spectrometry analysis shows constitutive expression of the dog caspase-
1/4/11 hybrid gene. Mass spectrometry analysis of full protein extracts from (A) non-stimulated 
(medium only) and (B) LPS primed DH82 cell lysates showed constitutive expression of the hybrid 
gene. This detection method could not distinguish between the two transcripts as only amino acids 
common to both were detected. Proteins matching the same peptide sequence are highlighted in 
red rectangles.   
 
Multiple sequence alignment analysis of the dog fusion gene (ENSCAFG00000014860, 
ENSCAFT00000036213.3, ENSCAFT00000023587.3), human caspase-4 (ENSG00000196954, 
ENST00000393150.7) and mouse caspase-11 (ENSMUSG00000033538, 
ENSMUST00000027012.13) indicated high similarities in the caspase domains. The caspase 
family signature peptide QACRG (highlighted in red rectangle) including the catalytic residue 
(258-Cys) responsible for enzymatic activity and autocatalysis [320]–[322] is present and 
conserved in the dog (Figure 3.2.3). These results suggested that the canine caspase-1/4/11 hybrid 
protein is functional in the dog. 
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Figure 3.2.3 Multiple sequence alignment of transcripts of the dog fusion protein, human 
caspase-4 and mouse caspase-11 suggests catalytically active canine hybrid protein. Protein 
sequences in the caspase domain showed high degrees of similarity between mouse caspase-11, 
human caspase-4 and canine hybrid protein larger (dog1) and smaller transcripts (dog2). The 
catalytic residue at 258-Cys position appeared to be conserved. This suggested that the dog fusion 
protein possesses enzymatic activity and is capable of autocatalysis. 
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3.3 Investigation of the inflammasome regulator ASC and executor of pyroptosis GSDMD 
transcripts using multiple sequence comparison by log-expectation (MUSCLE) analysis of 
transcript sequences and western blot analysis of their protein expression  
 
One hallmark of inflammasome activation is the recruitment of the universal adapter protein ASC 
to the activated receptors [42]. Heteromeric aggregation of the ASC serves as a scaffold leading 
to caspase recruitment, activation and subsequent cytokine processing [57], [323]. The gene 
encoding ASC has not yet been annotated in the dog genome. Using Basic Local Alignment Search 
Tool (BLAST) analysis of human ASC protein sequence (ENSG00000103490, 
ENST00000247470.10) against the dog genome indicated that the gene has not yet been annotated 
as a whole 
(https://www.ensembl.org/Canis_familiaris/Tools/Blast/Results?db=core;tl=mUzCEkqzMWFnc
6wi-5421405). The presence of a short intermediate exon containing flexible residues can make it 
difficult for automated gene prediction. The human ASC protein sequence (ENSG00000103490, 
ENST00000247470.10) therefore was searched in translated BLAST nucleotide (tBLASTn) 
(https://blast.ncbi.nlm.nih.gov/Blast.cgi?PROGRAM=tblastn&PAGE_TYPE=BlastSearch&LIN
K_LOC=blasthome) against the canine Expressed Sequence Tag (EST) database (Figure 3.3.1). 
MUSCLE analysis of the predicted ASC (GR890948.1 and DN347564.1) protein sequence against 
the human (ENSG00000103490, ENST00000247470.10) and murine (ENSMUSG00000030793, 
ENSMUST00000033056.4) ASC amino acid sequences suggested the expression of functional 
ASC protein in the dog (Figure 3.3.1). Targeted mutagenesis of the human ASC protein identified 
a number of residues to be important in heteromeric aggregation [324]. The majority of these 
residues (highlighted with red rectangles in Figure 3.3.1) appeared to be conserved between 






Figure 3.3.1 Translated Basic Local Alignment Search Tool nucleotide (tBLASTn) and 
Multiple Sequence Comparison by Log Expectation (MUSCLE) analysis of human ASC 
protein sequence against the dog genome identified a not yet annotated gene encoding ASC 
(GR890948.1 and DN347564.1) in the dog. The identified dog ASC showed high sequence 
similarities to the murine (ENSMUSG00000030793, ENSMUST00000033056.4) and human ASC 
(ENSG00000103490, ENST00000247470.10) amino acid sequences. The majority of the residues 
found to be important in PYD filament formation (highlighted in red rectangles) are conserved 
among human, mouse and dog sequences. 
 
Western blotting analysis of cell lysates against ASC protein extracted from murine immortalised 
wild-type (Figure 3.3.2A and D), Asc-/- (Figure 3.3.2C) and canine DH82 (Figure 3.3. B and E) 
macrophages were carried out as described in Materials and Methods sections 2.9 and 2.11. Two-
fold protein dilution from each cell line was run and blotted against ASC using primary and HRP-
conjugated secondary antibodies. Primary ASC antibody includes a synthetic peptide sequence 
which corresponds to amino acids in the N-terminal PYD domain of human ASC. This similarity 
could result in cross reaction of the primary ASC antibody with the dog ASC protein. As expected, 
ASC protein in lysates of murine wild-type cells was detected at the 22 kDa [67] marker (Figure 
3.3.2A) while using secondary antibody only (Figure 3.3.2D) resulted in no protein detection, 
showing the specificity of the primary antibody. As a further control to secondary antibody only 
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staining, analysis of lysates from Asc-/- cells failed to show any ASC protein (Figure 3.3.2C). The 
secondary antibody only control for the DH82 cell lysates (Figure 3.3.2E) showed no protein 
detection, suggesting that any bands detected with the primary antibody was sequence specific. 
Based on the tBLASTn results (Figure 3.3.1) dog ASC also has an expected size of 22 kDa. The 
presence of multiple bands was identified, including a strong band just under the 46 kDa marker. 
This band can possibly be dimerized ASC protein which could potentially be the result of poor 












Figure 3.3.2 Western blotting analysis of full protein extracts of immortalised murine wild-
type, Asc-/- and DH82 cell lysates using primary anti-ASC and HRP-conjugated secondary 
antibodies. Two-fold serial dilution of full protein extracts were run for each cell line and blotted 
against ASC protein. (A) Murine ASC was detected at the expected 22 kDa size. (B) Multiple 
bands were detected in the cell lysate of DH82 cells, including a strong band just under the 46 kDa 
marker. (C) ASC could not be detected in full protein extracts of murine Asc-/- cells. (D-E) 
Secondary antibody controls showed no unspecific antibody binding in cell lysates from either (D) 
wild-type or (E) DH82 cells. Representative immunoblots are from three independent experiments. 
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Inflammasome formation and caspase activation drives maturation of inflammatory cytokines and 
their release due to pyroptotic cell death [42]. Members of the gasdermin protein family are 
important inflammatory caspase substrates, including the pyroptosis executioner protein GSDMD 
[228]. Genome wide CRISPR-Cas9 screens of murine BMDMs [44] and ethyl-N-nitrosourea-
mutagenized (ENU) mice [43] screens identified GSDMD as a human caspase-1/-4/-5 and murine 
caspase-1/-11 substrate. GSDMD cleavage by activated inflammatory caspases removes the 
inhibitory C-terminal domain, generating an active, effector N-terminal domain [44]. The active 
N-terminal domain has been shown to bind to cardiolipin, phosphatidylserine and 
phosphatidylinositol phosphates in the cell membrane causing pore formation that leads to 
pyroptotic cell death and the release of inflammatory cytokines [70], [72], [75]. The gene encoding 
GSDMD has been annotated in the dog genome. MUSCLE analysis of dog GSDMD 
(ENSCAFG00000001301, ENSCAFT00000038192.2) against human (ENSG00000104518, 
ENST00000262580.9) and murine (ENSMUSG00000022575, ENSMUST00000023238.5) 
protein sequences showed high similarities (Figure 3.3.3). Sequence analysis showed that the 
catalytic site (275-Asp) for caspase-1, caspase-4 and caspase-11 cleavage (marked with red 






Figure 3.3.3 Multiple sequence comparison by log-expectation (MUSCLE) analysis of dog 
against human and murine GSDMD amino acid sequences identified caspase-1 and caspase-
4 cleavage site to be conserved. Transcript analysis of dog (ENSCAFG00000001301, 
ENSCAFT00000038192.2), human (ENSG00000104518, ENST00000262580.9) and murine 
(ENSMUSG00000022575, ENSMUST00000023238.5) protein sequences encoding GSDMD 
showed high similarities between all three species with the catalytic residue (highlighted in red 
rectangle) in the caspase-1, caspase-4 and caspase-11 cleavage site being conserved.   
86 
 
Caspase activation and subsequent GSDMD cleavage results in the generation of an active N-
terminal domain responsible for the execution of pyroptotic cell death [70], [72], [75]. Western 
blotting analysis of S. Typhimurium infected DH82 cell lysates were carried out in order to 
investigate GSDMD cleavage. DH82 cells were infected with wild-type S. Typhimurium bacteria 
at an MOI of 1 for 24 hours as described in Materials and Methods section 2.5. Total cellular lysate 
protein extracts were prepared, subjected to SDS-PAGE and immune blotted with primary and 
HRP-conjugated secondary antibodies as described in Materials and Methods sections 2.9 and 
2.11. There is a deficit in available anti-sera for canine research, therefore I utilised three different 
primary antibodies that are commercially available and were raised against murine (Saint John’s 
and Abcam) or human (Santa Cruz) GSDMD protein. Western-blot analysis of cell lysates from 
DH82 cells infected with wild-type S. Typhimurium failed to detect any protein bands when a 
murine specific primary antibody from Abcam was used (Figure 3.3.4B). The remaining antisera 
from St John’s and Santa Cruz detected multiple protein bands (Figure 3.3.4A and C), none of 
which were in the region expected for the full length (~50 kDa) or N-terminal cleaved domain 
(~30 kDa) forms of GSDMD. Furthermore, secondary antibody only controls for the Saint John’s 
(Figure 3.3.4D) and Santa Cruz (Figure 3.3.4E) antibodies, detected the same bands, suggesting 
non-specific binding. These results unfortunately prevented further analysis of GSDMD 






Figure 3.3.4 Immuno blotting of GSDMD protein from DH82 cell lysates infected with S. 
Typhimurium with an MOI of 1 for 24 hours. Three different primary antibodies were used, 
two raised against murine GSDMD; one from Saint John’s (A) and one from Abcam (B). The third 
antibody was raised against human GSDMD from Santa Cruz (C). While Abcam antibody failed 
to detect any protein bands (B), bands detected with Saint John’s (A) and Santa Cruz (C) antibodies 
suggested non-specific binding based on the results obtained with HRP-conjugated secondary 




3.4 Multiple sequence comparison by log-expectation (MUSCLE) analysis of the dog, 
human and mouse NLRP3 and IL-1β sequences 
 
NLRP3 forms inflammasome complexes [78] in response to a wide range of stimuli [83], [325]. 
Upon canonical NLRP3 activation, NLRP3 recruits ASC and activates pro-caspase-1 within the 
complex. Although NLRP3 activation can occur also downstream of the non-canonical caspase-
11 inflammasome activation [60], [158], [326]. Multiple sequence alignment of canine 
(ENSCAFG00000010686, ENSCAFT170023), human (ENSG00000162711, 
ENST00000336119.7) and mouse (ENSMUSG00000032691, ENSMUST00000101148.8) 
NLRP3 protein sequences showed high level of homology suggesting conserved function 
throughout different species. Residues (amino acids: 15-Glu, 23-Lys, 24-Lys, 27-Met, 43-Arg, 64-
Glu and 82-Asp) which have been associated with roles in nucleation of the ASC aggregates [323] 
based on mutagenesis studies appeared to be conserved (Figure 3.4.1). Sequence alignment 






Figure 3.4.1 Multiple sequence alignment analysis of dog, human and mouse NLRP3 amino 
acid sequences suggest an NLRP3 homologue is present in the dog. Protein sequence alignment 
shows high similarity between the dog (ENSCAFG00000010686, ENSCAFT170023), human 
(ENSG00000162711, ENST00000336119.7) and mouse (ENSMUSG00000032691, 
ENSMUST00000101148.8) NLRP3. Amino acid residues (highlighted in red rectangles) 
associated with nucleation of ASC aggregates can be found, therefore appear to be conserved in 
the dogs.  
 
In addition to NLRP3 I also performed multiple sequence alignment analysis of the dog 
(ENSCAFG00000007249, ENSCAFT00000011613.3), human (ENSG00000125538, 
ENST00000263341.6) and mouse (ENSMUSG00000027398, ENSMUST00000028881.13) IL-
1β protein as this is a critical inflammatory mediator and substrate of active caspase-1 produced 
as a consequence of NLRP3 activation. Importantly, the sequence analysis demonstrated a high 
degree of sequence similarities between species, which like NLRP3 suggested conserved function 
in different mammalian species. Amino acid residues 27-Asp and 116-Asp functioning as caspase-
1 and caspase-1/-8 cleavage sites [327], respectively can also be found in the dog (Figure 3.4.2). 
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These results suggested potential pro-IL-1β cleavage and maturation by the activated canine 




Figure 3.4.2 Sequence alignment analysis of the dog, human and mouse IL-1β amino acid 
sequences shows conserved caspase-1 and caspase-8 cleavage sites. Sequence alignment shows 
high degree of similarities between the dog (ENSCAFG00000007249, 
ENSCAFT00000011613.3), human (ENSG00000125538, ENST00000263341.6) and mouse 
(ENSMUSG00000027398, ENSMUST00000028881.13) IL-1β protein sequences with catalytic 
residues (highlighted in red rectangle) acting as caspase-1, caspase-8 cleavage sites being 
conserved across the three species.  
 
3.5 Canonical NLPR3 inflammasome activation in DH82 cells using nigericin bacterial 
toxin 
 
NLRP3 inflammasome activation requires two distinct steps. First is priming with TLR ligands 
leading to upregulation of inflammatory genes, including NLRP3 itself, pro-IL-1β and pro-IL-18 
[98], [328]. While the second step results in the activation of the NLRP3 inflammasome [329], 
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[330]. The NLRP3 inflammasome responds to a wide range of stimuli, including the efflux of 
potassium [82], [85], generation of mitochondrial ROS [331], [332] and cathepsin B activity [333], 
[334]. Upon activation, NLPR3 oligomerises with pro-caspase-1 and ASC inflammasome 
components [42], [140]. Activation of caspase-1 results in the cleavage and maturation of 
inflammatory cytokines and GSDMD resulting in pyroptotic cell death [44].  
 
To characterise NLRP3 inflammasome activation in canine DH82 macrophages I compared DH82 
responses with well characterised wild-type and caspase-1-/-caspase-11-/- murine immortalised 
BMDMs in response to the canonical NLPR3 inflammasome activator, nigericin bacterial toxin. 
The aim of this experiment was to assess the functionality of canine NLRP3 and the hybrid 
caspase-1/4/11 proteins. In all experiments, cells were primed with ultrapure LPS (200 ng/ml for 
3 hours) to drive expression of inflammasome constituents and then stimulated with increasing 
concentration of nigericin bacterial toxin (20-200 µM for 1 hour) as described in Materials and 
Methods section 2.6. Extracellular LPS has been shown to induce NLRP3 and IL-1β expression 
via TLR4/MyD88 and NF-κβ signalling pathways in mouse BMDMs [98]. Nigericin is a bacterial 
toxin derived from Streptomyces hygroscopicus [335]. Being a potassium ionophore, it decreases 
intracellular levels of potassium which has been shown to be essential for NLRP3 inflammasome 
activation [82], [85]. Percentage of cell lysis induced was determined by directly measuring the 
relative amount of LDH released into the supernatant. LDH is a stable cytosolic enzyme, that is 
released upon cell lysis which can be found in animals, plants and bacteria and is therefore a good 
indicator of cell death as a consequence of membrane rupture and cell lysis [336]. Secretion of the 
inflammatory cytokine, IL-1β into the supernatant was measured by ELISA method and its 
cleavage was confirmed using western blotting to differentiate between pro-IL-1β which could be 
released into the supernatant upon cell lysis independent of caspase maturation.  
 
First, I used methanol vehicle control following LPS priming to eliminate any cell lysis contributed 
by the solvent (Figure 3.5.1A). Methanol induced a small percentage of cell lysis in wild-type 
murine cells, while DH82 cells showed no response. I, therefore, concluded that the observed 




Murine bone marrow derived macrophages lacking functional caspase-1 do not process pro-IL-1β 
and cannot induce pyroptosis in response to NLRP3 inflammasome activators [337]. As expected, 
LPS priming did not induce cell death in caspase-1-/-caspase-11-/- cells, while 20 µM final 
concentration of nigericin was sufficient to activate inflammasome formation and cell lysis in wild-
type cells (Figure 3.5.1B). In contrast, lytic responses of DH82 cells were refractory to nigericin 
treatment at 20 µM final concentration, resembling responses exhibited by caspase-1-/-caspase-11-
/- cells (Figure 3.5.1B).  
 
To investigate if higher concentrations of nigericin could stimulate cell lysis of DH82 cells I used 
increasing concentration of nigericin (Figure 3.5.1B) as described in Materials and Methods 
section 2.6. Treatment with elevated concentrations of nigericin induced a corresponding increase 
in cell lysis of DH82 and caspase-1-/-caspase-11-/- cells (Figure 3.5.1B). Treatment with 200 µM 
final concentration of nigericin resulted in equivalent cell lysis responses in DH82 and caspase-1-
/-caspase-11-/- murine cells (Figure 3.5.1B) and therefore suggested an inflammasome independent 
toxicity issue at this high dose. Thus, my data suggested that although canine cells have conserved 
NLRP3 and a caspase-1/4/11 hybrid gene that was expected to be functional, canine cells appeared 







Figure 3.5.1 High dose of nigericin drives NLRP3 independent cell lysis in DH82 cells. (A) 
Murine immortalised wild-type and DH82 cells were primed with LPS then stimulated with 
increasing concentration of nigericin, along with the equivalent concentration of methanol solvent. 
Nigericin induced cell lysis was assessed by directly measuring LDH release into the supernatant. 
Results are representative of a single experiment where error bars represent the standard error of 
means (SEM) of triplicate wells. (B) Murine immortalised wild-type, caspase-1-/-caspase-11-/- and 
DH82 cells were primed with LPS then stimulated with increasing concentration of nigericin. 
Nigericin induced cell lysis was assessed by directly measuring LDH release into the supernatant. 
Data shown is pooled from three independent experiments. Error bars represent the standard error 
of means (SEM) of triplicate wells. 
The amount of IL-1β released into the supernatant of nigericin stimulated immortalised murine 
wild-type and canine DH82 macrophages were also determined as described in Materials and 
Methods section 2.8. DH82 cells secreted increasing amount of IL-1β in response to increasing 
concentration of nigericin (Figure 3.5.2). The priming of cells via TLRs happens independently of 
inflammasome activation [98], in which case cell lysis would result in the release of unprocessed 
pro-IL-1β. On the contrary, wild-type cells showed higher IL-1β release in response to stimulation 
with lower concentrations of nigericin, while stimulation with high concentration of nigericin 
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resulted in the lowest amount of IL-1β release. This is presumably due to the rapid toxicity issue I 
demonstrated in Figure 3.5.1 above and is a reflection that rapid cell lysis did not allow sufficient 
time for IL-1β expression (Figure 3.5.2). In contrast and in agreement with the cell lysis data above, 
canine production of IL-1β was refractory to low dose nigericin but significant IL-1β was detected 
at high doses of nigericin and correlated with my cell lysis data. This suggested that although the 




Figure 3.5.2 The amount of IL-1β released into the supernatant of nigericin stimulated DH82 
cells is proportional to the nigericin concentration used. Murine wild-type and canine DH82 
cells were primed with LPS (200 ng/ml for 3 hours) then stimulated with nigericin bacterial toxin 
in an increasing concentration (20-200 µM). IL-1β release into the supernatant was quantified 
using canine and murine specific ELISA detection method. Data shown is pooled from three 
independent experiments. Error bars represent the standard error of means (SEM) of triplicate 
wells. 
 
Cleavage of the pre-form of IL-1β is a common read-out of inflammasome activation [42], [290], 
[338]. The ELISA kit used to measure canine IL-1β in the supernatant has only been validated to 
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recognise the full-length form of the protein. Therefore, western blot analysis was carried out to 
assess IL-1β cleavage. DH82 cells were primed with LPS (200 ng/ml for 3 hours) and stimulated 
with nigericin at 200 µM final concentration to maximise the amount of cell lysis induced as 
described in Materials and Methods section 2.6. Following protein precipitation of the supernatant, 
immunoblotting against canine IL-1β was performed (Figure 3.5.3) as described in Materials and 
Methods sections 2.10 and 2.11. Immunoblotting of precipitated protein from LPS and nigericin 
stimulated DH82 macrophages revealed significant amounts of pro-IL-1β (~33 kDa) and a small 
fraction of that appeared to be cleaved (~17 kDa) (Figure 3.5.3). These results suggested that 
inflammatory cytokine expression can be upregulated in the presence of TLR ligands. It also 
suggested, that the inflammasome can be activated in DH82 cells in response to nigericin to result 
in IL-1β cleavage, but the presence of significant pro-IL-1β would suggest that the ELISA results 
are largely based upon detection of this unprocessed form, possibly released as a consequence of 














Figure 3.5.3 Western blot analysis of the supernatant reveals small degree of IL-1β cleavage 
in nigericin stimulated DH82 cells. DH82 cells were primed with LPS (200 ng/ml for 3 hours), 
following stimulation with nigericin (200 µM for 1 hour). Total protein was precipitated from the 
supernatant and IL-1β cleavage was investigated using western blotting. A large amount of pro-
IL-1β was released into the supernatant, and a small fraction was in its mature form. Representative 
immunoblot is from three independent experiments. 
 
Another hallmark of inflammasome activation is ASC aggregate formation [57], [58] and caspase 
recruitment [42], [140], [145] which can be immunofluorescently labelled and visualised as an 
ASC-speck within the cytosol of cells [339]. In this experiment, DH82 cells were primed with LPS 
(200 ng/ml for 3 hours) and stimulated with nigericin (20 µM) for 1 hour as described in Materials 
and Methods section 2.6. Prior fixation, cells were stained for active caspases using FLICA reagent 
and cytosolic ASC as described in Materials and Methods section 2.7. FLICA is an 
immunofluorescent labelled caspase inhibitor that covalently binds to active caspases. Non-
stimulated cells were stained with poly-caspase stain, which binds to a sequence conserved in all 
caspases (Figure 3.5.4). As expected, non-stimulated (NS) cells did not show ASC-speck 
formation or caspase activation (Figure 3.5.4). In contrast, DH82 cells stimulated with nigericin at 
low concentrations, which I previously demonstrated did not result in inflammasome activation 
(20 µM) as characterised by IL-1β release and lytic cell death surprisingly displayed low level 
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ASC-speck formation and activate caspase recruitment of caspase-8 and presumably the hybrid 
caspase-1/4/11 to the specks (Figure 3.5.4). These results suggested that NLRP3 inflammasome 
can be activated causing recruitment, but presumably not activation, of caspases by low dose 
nigericin. This hypothesis was also in agreement with my previous data analysing cell lysis and 




Figure 3.5.4 NLRP3 activation induces ASC speck formation and both, hybrid caspase-
1/4/11 and caspase-8 recruitment. DH82 cells were primed with LPS (200 ng/ml) and stimulated 
with nigericin bacterial toxin (20 µM for one hour). Non-stimulated (NS) cells were left in cell 
culture medium. Live cells were stained for activated caspases (poly-caspase, caspase-1 or 
caspase-8). Following fixation cells were stained for cytoplasmic ASC and nuclei using DAPI 
staining. Representative immunofluorescent images are from three independent experiments. 
 
Cells undergoing pyroptosis can be characterised by a number of phenotypic and morphological 
features, including DNA damage [256], pore formation [246] and cell swelling [255] as a 
consequence of osmotic shock that ultimately results in cell lysis which can be visualised as a so 
called ‘popping’ event [255]. These events can be visualised by bright-field microscopy without 
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the need of any staining. To assess the morphological changes induced by nigericin, DH82 cells 
were primed with LPS (200 ng/ml) and were stimulated with nigericin (200 µM for 1 hour). Bright-
field images using a confocal microscope were taken every two minutes of the same focal point 
during the hour incubation. Representative images can be found in Figure 3.5.5, which shows 
DH82 cell swelling and rupturing. This morphology can be attributed to pyroptotic cell death or it 
could be a non-specific result of the nigericin ionophobic nature. Cells undergoing other types of 














Figure 3.5.5 Confocal imaging of LPS primed and nigericin stimulated DH82 cells shows 
characteristics of pyroptotic cell death. DH82 cells were primed with LPS (200 ng/ml) and 
stimulated with nigericin (200 µM for one hour). Bright field images were taken throughout the 
hour incubation on a confocal microscope. Cells displayed substantial swelling and rupturing. 
Representative images of the different morphological stages observed are shown above. 
Representative bright-field images are from a single experiment. 
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DH82 cells have been derived from a ten-year-old golden retriever with malignant histiocytosis 
[340]. To confirm that the lytic phenotype observed in DH82 cells (Figure 3.5.1) was not a 
consequence of being a cancerous cell line, I repeated the nigericin stimulation experiment using 
primary canine PBMCs isolated from patients attending the phlebotomy clinic at the Clinical 
Pathology Laboratory, Department of Veterinary Medicine, University of Cambridge (Table 2.2.1) 
as described in Materials and Methods sections 2.3 and 2.6. Due to extremely low sample 
availability, an experiment using only one concentration of nigericin could be performed. 
Percentage of cell lysis induced was determined by the amount of LDH release, while IL-1β 
secretion into the supernatant by using canine specific ELISA method as described in Materials 
and Methods section 2.8 (Figure 3.5.6). The amount of cell lysis induced and IL-1β was released 
into the supernatant were comparable between the DH82 cell line and blood PBMCs (Figure 3.5.6). 
This suggested, that the immortalised DH82 cell line responses can be directly related to how 
primary cells respond.  
Figure 3.5.6 DH82 and primary PBMC cells show similar cell lysis and IL-1β release 
responses following nigericin stimulation. DH82 and primary blood MNCs were primed with 
LPS (200ng/ml) and stimulated with nigericin (20 µM for 1 hour). (A) Cell lysis was measured by 
the relative amount of LDH released into the supernatant, while (B) IL-1β was quantified using 
ELISA method. Data shown is from a single experiment. Error bars represent the standard error of 
means (SEM) of triplicate wells. 
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3.6 Activation of the non-canonical inflammasome formation in DH82 cells 
 
Analogous to canonical NLRP3 inflammasome regulation, the first step in the activation of non-
canonical inflammasome formation is priming. TLR ligands (e.g. LPS) bind to TLRs (e.g. TLR4) 
[341] and induce transcriptional translation of several inflammatory genes, including caspase-11, 
NLRP3, pro-IL-1β and pro-IL-18 via the NF-κβ and IRF3 signalling pathways [98], [164], [328]. 
Followed by activation when the CARD domain of the murine caspase-11 [61] and human 
caspase-4/-5 [61], [342] recognise and directly bind the lipid A moiety of the LPS in the cytosol 
[163], [168]. This interaction results in proximity induced activation and autoproteolysis of 
caspase-4/-5/-11 leading to pyroptosis [60] and, eventually, NLRP3 [158] and caspase-1 dependent 
IL-β processing and release [60], [71], [163], [168]. GSDMD cleavage by inflammatory caspase-
1/-4/-5/-11 releases the N-terminal active fragment [43], [44], [229], [230] which then binds to 
cardiolipin of the cell membrane and the mitochondria to induce pore formation leading to 
pyroptotic cell death [70], [72], [74], [75] and mitochondrial damage to promote mitochondrial 
apoptotic pathway [233].  
 
My previous bioinformatic analysis suggested the presence of the LPS binding CARD domain of 
caspase-4 in the canine hybrid caspase-1/4/11 protein.  I therefore investigated whether this hybrid 
caspase could respond to intracellular LPS. Alternative splicing of the hybrid mRNA can produce 
two transcripts [154]. While the smaller transcript consists of a single CARD similar to that of 
human and murine caspase-1, the larger transcript contains two tandem CARDs with the second 
CARD similar to that of caspase-4/-11 [154] (Figure 3.1.1). Mass spectrometry analysis could not 
specifically identify which transcript is expressed in DH82 cells (Figure 3.2.1), therefore 
functional analysis was employed in vitro.  
 
Non-canonical inflammasome activation was performed as described in Materials and Methods 
section 2.6. wild-type murine, caspase-1-/-caspase-11-/- and canine DH82 macrophages were 
primed with Pam3CSK4 (10 µg/ml for 4 hours), a TLR1/2 ligand [343], driving caspase-11, 
NLRP3 and IL-1β expression via the NF-κβ [344] signalling pathway. Cytosolic LPS delivery 
was then performed using different concentrations of LPS (5-, 10- or 20 µg/ml) in conjunction 




In order to determine the contribution of the well documented cytotoxic effects of transfection 
reagents, I first performed an experiment to test the toxicity of each reagent in isolation (Figure 
3.6.1A). Individually, none of the reagents induced notable amount of cell lysis in either murine 
wild-type or dog DH82 cells (Figure 3.6.1A). Any cell lysis induced in subsequent experiments 
can be attributed to the effect of cytosolic LPS. TLR1/2 activation by Pam3CSK4 and TLR4 
activation by extracellular LPS induced IL-1β release into the supernatant of DH82 cells, but not 
wild-type murine cells, without concurrent LDH release (Figure 3.6.1B).  
Cytosolic delivery of LPS was required to drive IL-1β release in wild-type cells (Figure 3.6.1B), 
but DH82 cells did not release LDH or IL-1β in response to cytosolic LPS alone. This suggested 
the expression of the shorter transcript of the hybrid caspase1/11, consisting of the single CARD 
from caspase-1 is dominant in DH82 cells and therefore non-responsive to cytosolic LPS [154] 










Figure 3.6.1 Priming of TLR1/2 and TLR4 is sufficient to drive IL-1β release in DH82 cells. 
Wild-type murine and canine DH82 cells were stimulated individually with ligands and reagents 
used to activate the non-canonical inflammasome formation. (A) Percentage of cell lysis induced 
was determined by measuring LDH, while (B) IL-1β release was measured using ELISA method. 
Data shown is pooled from three independent experiments. Error bars represent the standard error 
of means (SEM) of triplicate wells. 
To further investigate the apparent resistance to intracellular LPS activation of the non-canonical 
inflammasome in canine cells, I investigated whether higher concentrations of LPS could induce 
non canonical inflammasome activation. To test this hypothesis, immortalised murine wild-type, 
caspase-1-/-caspase-11-/- and canine DH82 cells were primed with Pam3CSK4 (10 µg/ml for 4 
hours) and stimulated with increasing concentrations of transfected LPS (5-, 10- and 20 µg/ml) for 
16 hours (Figure 3.6.2). As expected, the delivery of cytosolic LPS induced LDH release in wild-
type murine macrophages [60], but not in caspase-1-/-caspase-11-/- cells [60]. DH82 cells failed to 
release LDH to cytosolic LPS even at the highest concentration (Figure 3.6.2A) resembling the 
phenotype of caspase-1-/-caspase-11-/- murine macrophages in terms of their cell lytic response 
(Figure 3.6.2A). Wild-type murine cells only released IL-1β with transfected LPS, in contrast, the 
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priming step of DH82 cells was sufficient for IL-1β secretion and occurred in the absence of LDH 
release (Figure 3.6.2 B). 
Figure 3.6.2 Canine macrophages do not activate non-canonical inflammasome death 
responses and priming alone induces IL-1β release into the supernatant in the absence of cell 
lysis. Murine wild-type, caspase-1-/-caspase-11-/- and canine DH82 cells were primed with 
Pam3CSK4 (10 µg/ml for 4 hours) then stimulated with either LPS (5 µg/ml) alone or in 
conjunction with FuGENEHD transfection reagent. (A) Percentage of cell lysis induced was 
determined by measuring LDH release into the supernatant, while (B) IL-1β release was measured 
using ELISA method. Data shown is pooled from three independent experiments. Error bars 
represent the standard error of means (SEM) of triplicate wells. 
To investigate IL-1β processing in the supernatant, protein precipitation and subsequent 
immunoblotting analysis was carried out on supernatants from non-stimulated (medium only), 
Pam3CSK3 (10 µg/ml for 4 hours) only, un-primed transfected LPS (5 µg/ml for 16 hours) and 
Pam3CSK4 (10 µg/ml for 4 hours) primed, transfected LPS (5 µg/ml for 16 hours) stimulated 
DH82 cells (Figure 3.6.3). With the exception of the medium only sample, all other stimulations 
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resulted in the expression and secretion of pro-IL-1β (Figure 3.6.3). However, cleavage was only 
observed in cells primed with Pam3CSK4 (Figure 3.6.3). These results suggested an alternative 




Figure 3.6.3 Priming only is sufficient to drive IL-1β secretion and cleavage in DH82 cells. 
Full protein precipitation of supernatants from DH82 cells primed with Pam3CSK4 (10 µg/ml for 
4 hours), transfected LPS (5 µg/ml for 16 hours) and Pam3CSK4 (10 µg/ml for 4 hours), LPS 
transfected (5 µg/ml for 16 hours). Samples were immune blotted against canine specific IL-1β. 
Representative immunofluorescent image is from two independent experiments. 
 
ASC speck formation and caspase recruitment were also assessed in DH82 cells following 
Pam3CSK4 (10 µg/ml for 4 hours) and transfected LPS (5 µg/ml for 16 hours). Prior to fixation, 
cells were stained for the presence of active caspases (FAM-FLICA). After fixation cells were 
stained for cytosolic ASC. Non-stimulated cells were stained with poly-caspase stain, while 
stimulated cells were either stained for active caspase-1 or caspase-8. Cells stimulated with 
cytosolic LPS did not display ASC-speck formation or activated caspase recruitment (Figure 
3.6.4). These results further pointed in the direction of an IL-1β processing pathway independent 
of inflammasome formation. While also providing further evidence that the canine hybrid caspase-
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1/4/11 protein is incapable of recognising cytoplasmic LPS, suggesting the expression of the 




Figure 3.6.4 Non-canonical inflammasome activation of DH82 cells fail to induce ASC-speck 
formation and activated caspase recruitment. DH82 cells were primed with Pam3CSK4 (10 
µg/ml for 4 hours) and transfected with LPS (5 µg/ml for 16 hours). Prior fixation, cells were 
stained for activated caspase-1 or caspase-8. After fixation cells were stained for cytosolic ASC. 
Non-stimulated cells were left in medium and were stained for cytoplasmic ASC and activated 
caspases. Representative immunofluorescent images are from three independent experiments. 
 
To investigate any substantial morphological changes occurring in response to non-canonical 
inflammasome activation, DH82 cells were primed with Pam3CSK4 (10 µg/ml for 4 hours), 
following LPS transfection (5 µg/ml) for 16 hours. Morphological changes were recorded using 
confocal microscopy, where bright field images were taken every 10 minutes of the 16-hour 
incubation. Representative images are shown in Figure 3.6.5. No obvious or gross morphological 





Figure 3.6.5 DH82 cells failed to show any distinct morphological changes in response to the 
non-canonical inflammasome activator, cytosolic LPS. DH82 cells were primed with 
Pam3CSK4 (10 µg/ml for 4 hours) and transfected LPS (5 µg/ml) for 16 hours. Bright field images 
were taken every 10 minutes during the 16 hours incubation on a confocal microscope. 
Representative bright-field images are from a single experiment. 
 
The effect of the non-canonical inflammasome activator intracellular LPS was also assessed on 
primary canine PBMCs isolated from patients attending the phlebotomy clinic at the Clinical 
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Pathology Laboratory, Department of Veterinary Medicine, University of Cambridge (Table 2.2.1) 
as described in Materials and Methods sections 2.3 and 2.6. Due to the limited access and volume 
of samples, only a single experiment could be performed (Figure 3.6.6). Primary PBMCs and 
DH82 cells were primed with Pam3CSK4 (10 µg/ml for 4 hours) or FuGENEHD transfection 
reagent alone and also Pam3CSK4 primed followed by LPS transfection (5 µg/ml) (Figure 3.6.6). 
Percentage of cell lysis induced was determined by the relative amount of LDH release (Figure 
3.6.6A), while IL-1β in the supernatant using canine specific ELISA method (Figure 3.6.6B). 
Canine primary cells mimicked the LDH and IL-1β responses of the DH82 cells. Regardless of 
the treatment no LDH release was observed, but Pam3CSK4 priming along was sufficient for IL-
β release into the supernatant (Figure 3.6.6). 
 
Experiments involving primary canine mononuclear cells (MNCs) could only be performed once 
due to the limited number of samples sourced from the Queen’s Veterinary School Hospital. 
Therefore, results obtained from these experiments should be interpreted with a degree of caution. 
Furthermore, residual blood samples were taken from patients who had undergone chemotherapy 
or suffer from autoimmune disease (Table 2.2.1). One can assume that these factors may introduce 
heterogeneity in the observed cellular responses to ligand stimulation. Furthermore, the blood 
samples were collected from multiple different breeds and therefore genetic influence cannot be 
eliminated. Therefore, my results can only be taken as an indication of what the responses of 














Figure 3.6.6 Pam3CSK4 priming alone induced IL-1β secretion in canine blood PBMCs. 
DH82 and primary blood PBMCs were primed with Pam3CSK4 (10 µg/ml for 4 hours) or 
transfection reagent alone and Pam3CSK4 (10 µg/ml for 4 hours) primed followed by LPS 
transfection (5 µg/ml) for 16 hours. (A) Percentage of cell lysis induced was determined by 
measuring LDH release into the supernatant, while (B) IL-1β release was measured using ELISA 
method. Data shown is from a single experiment. Error bars represent the standard error of means 
(SEM) of triplicate wells. 
 
TLR dependent IL-1β release has been reported previously [185], [345], [346]. Gaidt et al., has 
shown an NLRP3, ASC and caspase-1 dependent IL-1β secretion and maturation in LPS primed 
human and porcine monocytes. They have shown a RIPK1/FADD/caspase-8 dependent pathway 
upstream of NLRP3 activation. They have named it ‘alternative inflammasome’ activation given 
its independency of potassium concentration and the lack of pyroptosome formation [185]. 
Caspase-8 involvement has been suggested in the priming [347] and activation [104] of NLPR3 
inflammasome while it has been shown to directly cleave IL-1β using HEK293T and Raw264.7 
cells [216]. It is tempting to speculate that DH82 cells might engage in a similar, TLR/caspase-8 
dependent inflammasome activation.  
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3.7 Discussion  
 
Genomic analysis showed the presence of a caspase-1/4/11 fusion in the canine genome [154]. The 
genes encoding these proteins are located next to each other in the human and mouse genomes. 
Dogs have lost the 3’end of caspase-1 and the 5’end of caspase-4 (Figure 3.1.1). Mass spectrometry 
analysis of DH82 cell lysates have demonstrated the constitutive expression of the canine hybrid 
caspase-1/4/11 gene at the protein level (Figure 3.2.2). Multiple sequence comparison by log-
expectation (MUSCLE) analysis has also shown the presence of the catalytic residue (258-Cys) 
suggesting the presence of a functional protein (Figure 3.2.3).  
 
MUSCLE analysis of further genes also involved in inflammasome formation and function have 
been investigated. Amino acids sequence analysis of canine NLRP3, GSDMD and IL-1β against 
the human and mouse sequences showed conservation across these species. Residues suggested to 
play important roles in ASC nucleation are conserved in canine NLRP3, suggesting the presence 
of a functional protein (Figure 3.4.1). Analysis of GSDMD protein sequences identified the 
conserved caspase-1 cleavage site to be present in the dog (Figure 3.3.3). Although western 
blotting analysis of dog GSDMD using human and mouse antibodies did not work probably 
because of a lack of antibody cross reactivity (Figure 3.3.4), sequence analysis suggested the 
presence of a functional GSDMD (Figure 3.3.3). Sequence analysis of IL-1β showed the presence 
of the caspase-1 and caspase-8 cleavage sites in the dog (Figure 3.4.2). The presence of the adapter 
protein ASC has also been identified in the dog genome, but it has not yet been annotated as a 
single gene (Figure 3.3.1). Sequence comparison has identified both, the PYD and CARD domains 
with the residues important for filament nucleation being present in the identified sequences 
(Figure 3.3.1). Western blotting analysis using an ASC antibody that cross reacts with human and 
mouse ASC proteins, showed the possible presence of ASC at the protein level in DH82 cell lysates 
(Figure 3.3.2). These results suggested the presence of functional inflammatory proteins in the dog 
and their responses have been investigated in the second part of this chapter.  
 
DH82 cell responses to known inflammatory activators were determined by measuring cell lysis 
(LDH release and live cell imaging), ASC speck formation, fluorescent caspase probe localisation 
and the production of IL-1β. Canonical activation of the NLRP3 inflammasome using nigericin 
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bacterial toxin resulted in low level of ASC-speck formation and activated caspase-1 and caspase-
8 recruitment (Figure 3.5.4). To induce cell lysis and IL-1β release, DH82 cells required high 
concentration of the nigericin ligand, while they showed complete resistance to concentrations 
widely established in human and mouse cells (Figures 3.5.1 and 3.5.2). Based on the results 
obtained using murine caspase-1-/-caspase11-/- cells, the nigericin-induced cell lysis was most 
likely NLRP3-independent (Figure 3.5.1). The presence of bioactive IL-1β suggested a low level 
inflammasome activation or production of IL-1β induced by priming to LPS (Figure 3.5.3). Live 
cell imaging of nigericin stimulated DH82 cells suggested the induction of a lytic form of cell 
death (Figure 3.5.5 20’). The observed nigericin resistance to inducing cell lysis has also been 
validated in canine PBMCs, representing primary cell responses (Figure 3.5.6). 
 
Non-canonical NLRP3 inflammasome activation and cytosolic recognition by caspase-11 were 
also investigated. While transfection of LPS did not induce cell lysis in DH82 cells, large amount 
of bioactive IL-1β were present in cell supernatants (Figure 3.6.2). TLR priming events led to the 
release of processed IL-1β without concomitant cell lysis (Figure 3.6.3). This phenomenon has 
been reported in human monocytes, where TLR4 activation leads to IL-1β maturation with cell 
surviving [87], [185]. The lack of ASC speck formation and activated caspase recruitment 
observed in DH82 cells gives further evidence for potential TLR mediated inflammasome 
formation (Figure 3.6.4). Live cell imaging of TLR primed and LPS transfected DH82 cells also 
showed no obvious morphological changes throughout the treatment (Figure 3.6.5). IL-1β release 
and the lack of cell lysis have also been investigated using canine PBMCs, showing similar results 
to those observed in DH82 cells (Figure 3.6.6). Overall this suggests that canines have evolved 
refractory inflammasome responses to stimuli activating NLRP3 and raises important questions 










The NLRC4 inflammasome responds to evolutionarily conserved bacterial components of the 
T3SS [124], [348] (PrgI and PrgJ) and flagellin to initiate immune responses to clear bacterial 
infections [46]. Detection of these ligands requires NAIPs that have been identified as the 
intracellular sensor proteins that enable NLRC4 receptors activation and subsequent responses 
[46], [133], [135]. Upon ligand binding, NAIP recruits NLRC4 proteins [349] into an 
inflammasome complex leading to caspase-1 activation. Active caspase-1 mediates inflammatory 
cytokine maturation [350] and initiation of pyroptotic cell death by GSDMD cleavage [43], [44]. 
It has been shown that NLRP3, ASC, caspase-1 and caspase-8 can all be recruited to the NLRC4 
inflammasome [62]. ASC may be dispensable for caspase-1 recruitment because NLRC4 contains 
a CARD domain [121], its presence within the inflammasome however enhances cytokine 
processing [351]. This could be due to the presence of additional CARD domains recruiting 
additional caspase-1 proteins to the inflammasome complex.  
 
Genomic sequence analysis has shown that domesticated dogs and other species of the canine 
family entirely lack the NAIP genes and their NLRC4 gene contains two premature stop codons 
making it a non-functional, pseudogene [41]. I therefore investigated the consequences of this 
genotype and the role of the canine caspase-1/4/11 hybrid protein in DH82 cells in a series of in 
vitro infection assays using Salmonella enterica serovar Typhimurium – a well characterised 
bacterial pathogen that activates the NLRC4 inflammasome. 
 
In this chapter I monitored inflammasome activity by measuring cell lysis (relative LDH release) 
and the production and cleavage of IL-1β. Morphological changes induced by these activators 
were also monitored by live cell imaging using bright-field microscopy. 
 




Gentamicin protection assays (GPA) were used to investigate the inflammatory responses induced 
in DH82 cells by S. Typhimurium. During this assay, canine DH82 and murine iBMDMs were 
infected with different S. Typhimurium strains (SL1344 wild-type, ∆FliC/∆FliB, ∆PrgJ, 
∆FliC/∆FliB/∆PrgJ) as described in Materials and Methods section 2.5.  
 
Prior to infection experiments, growth curves for each S. Typhimurium strain were determined to 
ensure the uniformity of multiplicity of infection (MOI) used in this work (Figure 4.2.1). Optical 
density (OD) was measured and colony forming units (CFUs) were calculated after every hour for 
a total of 10 hours (Figure 4.2.1) as described in Materials and Methods section 2.4. To assess the 
number of CFUs at the incubation time-point used in infection assays, CFUs were also enumerated 
after the 17.5 + 2 hours culturing time-point (Figure 4.2.1B). Comparison of the ODs and CFUs 
showed that the wild-type S. Typhimurium strain displayed reduced growth kinetics compared to 
the mutants (Figure 4.2.1). This can be the result of reduced energy requirements as a consequence 
of not expressing large and complex proteins. I therefore used equal CFU’s from wild-type and 








Figure 4.2.1 Wild-type S. Typhimurium growth has reduced kinetics compared to mutant 
strains. (A) OD of S. Typhimurium inoculums was measured each hour for up to 10 hours as 
described in Materials and Methods section 2.4. (B) CFUs of S. Typhimurium inoculums were 
numerated each hour up to 10 hours incubation and at 17.5 + 2 hours culturing time-point as 
described in Materials and Methods section 2.4. Data shown is pooled from two independent 
experiments. Error bars represent the standard error of means (SEM) of triplicate wells. 
A consequence of NLCR4 activation by S. Typhimurium infection is the rapid induction of 
caspase-1 dependent host cell pyroptosis [62], [123]. In the bioinformatics analysis there was no 
canine NAIP genes and premature stop codons are present in the NLRC4 gene [41], so I 
hypothesised that canine macrophages would be resistant to S. Typhimurium induced cell death. 
To investigate this I compared the inflammasome responses of immortalised murine wild-type, 
Nlrc4-/-, caspase1-/-caspase11-/- with canine DH82 cells infected with wild-type SL1344 S. 
Typhimurium at MOI 1, 10 and 50. Percentage of cytotoxicity (Figure 4.2.2) and cytokine release 
(Figure 4.2.3) were determined at 1, 2, 6 and 24 hours post infection by LDH release and ELISA, 
respectively. Importantly, the cytotoxicity responses in DH82 cells at all MOIs were similar to that 
of murine Nlrc4-/- and caspase1-/-caspase11-/- cells (Figure 4.2.2) and was in agreement with my 
initial hypothesis. The NLRC4 inflammasome is rapidly activated upon S. Typhimurium infection 
and murine Nlrc4-/- macrophages fail to activate pro-caspase-1 and cell death in response to S. 
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Typhimurium infection [123], results that I also confirmed in my experiments. Regardless of the 
MOI used, DH82 cells in contrast to wild-type iBMDMs did not release detectable amount of LDH 
in the first 6 hours post infection (Figure 4.2.2) and resembled responses observed in Nlrc4-/- or 
caspase1-/-caspase11-/- iBMDMs (Figure 4.2.2). DH82 cells infected with S. Typhimurium 
SL1344 MOI of 1 (Figure 4.2.2A) induced a maximum of about 20% cell lysis by 24 hours post 
infection in comparison to wild-type iBMDMs which induced higher responses (40% cell lysis). 
A lytic response was observed in all murine cell genotypes and DH82 cells at higher MOI’s at later 
time-points (Figure 4.2.2). The kinetics of DH82 cell lysis at MOI of 1 was similar to what I 
observed in Nlrc4-/- and caspase-1-/-caspase-11-/- murine cells but was reduced at the MOI of 10 
and 50 used (Figure 4.2.2C). Based upon my data in the previous chapter, it could indicate that the 
hybrid caspase-1/4/11 gene is not activated in response to S. Typhimurium.  
 
S. Typhimurium can activate different NLRs and caspases, which can be recruited to the same 
inflammasome complex [352]. Both, NLRP3 and caspase-8 have been shown to be recruited to 
the NLRC4 inflammasome in response to S. Typhimurium infection [62], [292]. Further 
investigation would be required to determine if the delayed lytic responses observed in DH82 cells 
during S. Typhimurium infection are primarily NLRP3 and/or caspase-8 driven.  
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Figure 4.2.2 DH82 cells show delayed cell lysis responses when infected with wild-type S. 
Typhimurium. Murine wild-type, Nlrc4-/-, caspase1-/-caspase11-/- and DH82 cells were infected 
with S. Typhimurium with three different MOIs; (A) 1, (B) 10 and (C) 50. Percentage of cell lysis 
at 1, 2, 6 and 24 hour post infections was determined via the measurement of relative LDH release. 
Data shown is pooled from three independent experiments. Error bars represent the standard error 
of means (SEM) of triplicate wells. 
IL-1β release into the supernatant was also measured in DH82 cells infected with S. Typhimurium 
with MOI of 1 (Figure 4.2.3A), 10 (Figure 4.2.3B) and 50 (Figure 4.2.3C) at 1, 2, 6 and 24 hour 
time-points. Murine wild-type cells released lower amounts of IL-1β than DH82 cells at later time 
points. This could be attributed to the high levels of pyroptotic cell death (Figure 4.2.3) in the wild-
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type cells presumably through GSDMD terminating the infected cells capacity to express and 
release the cytokine. In contrast, DH82 cells, which underwent a slower cytotoxic response 
released very small amounts of IL-1β at earlier time-points (1, 2 and 6 hours post infection) 
irrespective of the MOI used (Figure 4.2.3) but significantly increased amounts by 24 hours post 
infection at all MOIs investigated (Figure 4.2.3). There is an inverse relationship between the 
amount of IL-1β released and the increasing MOI used. This could be a result of the reduced cell 
lysis effect at lower MOIs permitting inflammatory cytokines expression (Figure 4.2.2), but other 
published studies indicate that the amount of IL-1β released correlates with the amount of cell 
lysis induced, as IL-1β release requires membrane pore formation or cell lysis [353], [354]. My 
analysis of canine cells during infection therefore raises some important questions about the 
processing and release of IL-1β in these cells. I have demonstrated that DH82 cells have 
significantly reduced early cell lysis responses compared to murine cells but significantly 
increased inflammatory cytokine production at later time-points. Given the apparent lack of 
functional inflammasome components in canines, it would be important to understand which 








Figure 4.2.3 DH82 cells release large amount of IL-1β into the supernatant in response to S. 
Typhimurium infection. Murine wild-type and canine DH82 cells were infected with S. 
Typhimurium with three different MOIs; (A) 1, (B) 10 and (C) 50. IL-1β release in the supernatant 
was measured by ELISA method at 1, 2, 6 and 24 hour post infections. Data shown is pooled from 
three independent experiments. Error bars represent the standard error of means (SEM) of triplicate 
wells. 
My previous chapter indicated that canine cells released unprocessed pro-IL-1β into the 
supernatant only with high amounts nigericin stimulation (Figure 3.5.3). In order to investigate 
whether the IL-1β in the supernatant following S. Typhimurium infection was in a pro or 
proteolytically activated form, protein precipitates of supernatants from DH82 cells infected with 
S. Typhimurium (MOI 1 for 24 hours) was performed as described in Materials and Methods
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section 2.10. Infection with MOI of 1 only resulted in a small percentage of cell lysis (Figure 
4.2.2), but the greatest amount of IL-1β release when measured by ELISA (Figure 4.2.3). 
Immunoblotting against canine IL-1β showed evidence of IL-1β processing (Figure 4.2.4). 
Importantly and in contrast to infection of murine cells with S. Typhimurium, the apparent cleaved 
form of IL-1β appeared smaller than the P17 form associated with caspase-1 cleavage [355]. I 
have demonstrated that the canine caspase hybrid has reduced activity during inflammasome 
activation, so the presence of a smaller molecular weight form of IL-1β could indicate processing 
by an alternative proteolytic system. Elastase, cathepsin G and collagenase have been shown to 
process recombinant IL-1β in activated human monocytes, however these proteases produced 
bioactive IL-1β at around 17 kDa [356], [357]. Chymotrypsin-like serine proteinase chymase in 
human mast cells was shown to process IL-1β into its bioactive form resulting in a slightly larger 
18 kDa product [358].  While proteinase-3 (PR-3) has also been suggested to cleave IL-1β in vitro 
in human monocytes [359]. Further investigation is required to identify which protease(s) is/are 











Figure 4.2.4 S. Typhimurium infection of DH82 cells results in the maturation of pro-IL-1β. 
DH82 cells were infected with S. Typhimurium MOI of 1 for 24 hours. Full protein precipitation 
and immune blotting against dog IL-1β showed the presence of both, pre- and cleaved form of the 
cytokine. Representative immunoblot is from two independent experiments. 
 
During pyroptosis caspase cleaved GSDMD induces pore formation in the cell membrane resulting 
in a rapid osmotic shock causing cell swelling and eventually rupture of the cell membrane [72], 
[75], [234]. These characteristics can be visualised by bright field microscopy. DH82 cells were 
infected with S. Typhimurium MOI of 50 for 24 hours and bright field images using confocal 
microscope were taken every 5 minutes of the same focal point during the entire time of the 
infection (Figure 4.2.5). Representative images can be found in Figure 4.2.5, which shows DH82 
cell swelling and later rupturing. Cells undergoing other types of lytic cell death than pyroptosis, 
for example necroptosis, can also display similar morphology [253]. One interesting observation 
was that cells appeared to be locked in the swollen phase with rupture only happening at a much 
later time-point. Given that cell swelling during pyroptosis is a direct result of GSDMD pore 
forming activity [75], this could perhaps be a result of suboptimal inflammasome activation and 
therefore reduced GSDMD processing and pore formation. Inefficient GSDMD cleavage could 
mean that it takes cells much longer time to reach a certain ‘threshold’ in the number of pores 
being formed in the membrane [238]. Alternatively, it may be that DH82 cells can actively repair 
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pores in the membrane [360], [361], delaying the reach of the ‘threshold’ for the number of pores.  




Figure 4.2.5 DH82 cells display characteristics of lytic form of cell death in response to S. 
Typhimurium infection. DH82 cells were infected with wild-type S. Typhimurium MOI of 50 
for 24 hours. Bright field images were taken every 5 minutes during the 24 hours infection on a 




Despite DH82 cells resistance to cell lysis with infection at early time points, the cells succumbed 
to a lytic cell death at later time-points post infection. I therefore investigated which bacterial 
components may trigger this delayed death response in canine cells. Using DH82 cells infected 
with wild-type, ∆PrgJ, ∆FliC/∆FliB or ∆PrgJ/∆FliC/∆FliB S. Typhimurium strains (Figure 4.2.6) 
at two different MOIs, 10 (Figure 4.2.6A) and 50 (Figure 4.2.6B) I examined cell lysis by LDH 
release (Figure 4.2.6). DH82 cells died when infected with wild-type S. Typhimurium at MOI of 
10 by 24 hour post infection (Figure 4.2.6A). Interestingly, S. Typhimurium strain lacking flagellin 
proteins FliC and FliB but expressing type III secretion system protein PrgJ showed similar 
responses to that of SL1344 wild-type strain (Figure 4.2.6A). S. Typhimurium strain lacking PrgJ 
but expressing FliC and FliB proteins induced significantly reduced lytic responses, most similar 
to the one observed with S. Typhimurium strain ∆PrgJ/∆FliC/∆FliB (Figure 4.2.6A). These results 
suggested that the late response is primarily mediated via mechanism dependant on the type III 
secretion proteins. This is an important observation as it may indicate which PRR(s) are detecting 
infection in canines in the apparent absence of NAIP and NLRC4. The phenotype observed with 
MOI of 10 failed to hold when cells were infected with MOI of 50 (Figure 4.2.6B). S. 
Typhimurium strain lacking PrgJ induced the same amount of cell lysis as the strain deficient for 
FliC and FliB proteins (Figure 4.2.6B). This loss of specificity in the cell death mechanism could 
be the result of an overwhelming bacterial infection response, with multiple types of recognition, 
metabolic and signalling pathways being activated at the same time.    
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Figure 4.2.6 S. Typhimurium induced delayed cell lysis is reduced in the absence of the type 
III secretion protein PrgJ. DH82 cells were infected with S. Typhimurium wild-type, ∆PrgJ, 
∆FliC/∆FliB and ∆PrgJ/∆FliC/∆FliB strains with MOI (A) 1, (B) 10 and (C) 50. LDH release into 
the supernatant was measured at 1, 2, 6 and 24 hour post infection. Data shown is pooled from 
three independent experiments. Error bars represent the standard error of means (SEM) of triplicate 
wells. 
As seen in previous experiments, there was no detectable IL-1β in the supernatant of S. 
Typhimurium infected DH82 cells at early time-points and only a small amount could be detected 
at 6 hours post infection (Figure 4.2.3). By 24 hours, DH82 cells infected with MOI of 10 (Figure 
4.2.7) with either wild-type or FliC/FliB-deficient S. Typhimurium strains induced large amount 
of IL-1β release into the supernatant (Figure 4.2.7A). By contrast, cells infected with either PrgJ 
or FliC/FliB/PrgJ-deficient strains induced 3-fold less IL-1β release into the supernatant (Figure 
4.2.7A) and was a reflection of the cell lysis observations with these mutant bacteria. These results 
provided further evidence that the cell lysis response observed is primarily mediated by type III 
secretion proteins. In concert with the cell lysis data (Figure 4.2.6C), DH82 cells infected with 
wild-type S. Typhimurium (MOI 50) produced four times less IL-1β compared to the cells infected 
with any of the deficient strains (Figure 4.2.7B). This could be explained by the fact that cells 
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infected with wild-type S. Typhimurium underwent cell lysis with faster kinetics and therefore had 
less time to express and process IL-1β.  
Figure 4.2.7 Type III secretion system protein PrgJ drives IL-1β release in DH82 cells in 
response to S. Typhimurium infection. DH82 cells were infected with S. Typhimurium wild-
type, ∆PrgJ, ∆FliC/∆FliB and ∆PrgJ/∆FliC/∆FliB strains with MOI (A) 10 and (B) 50. IL-1β 
release was measured at 1, 2, 6 and 24 hours post infection. Data shown is pooled from three 
independent experiments. Error bars represent the standard error of means (SEM) of triplicate 
wells. 
To confirm my data obtained with an immortalised cell line was representative of primary canine 
cells, cell lysis and cytokine responses to canonical inflammasome activator S. Typhimurium were 
also investigated in canine primary PBMCs. In these in vitro experiments PBMCs were isolated 
from patients attending the phlebotomy clinic at the Clinical Pathology Laboratory, Department 
of Veterinary Medicine, University of Cambridge (Table 2.2.1) as described in Materials and 
Methods sections 2.3 and 2.6. Canine primary and DH82 cells were infected with wild-type S. 
Typhimurium at three different MOIs; MOI 1 (Figure 4.2.8A), MOI 10 (Figure 4.2.8B) and MOI 
50 (Figure 4.2.8C). Canine primary cells infected with lower MOI of S. Typhimurium showed 
delayed cell lysis responses, similar to that of seen with DH82 cells (Figure 4.2.8A and B). 
Infection with MOI of 1 induced negligible amount of cell lysis even at 24 hour time-point (Figure 
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4.2.8A). While infection with MOI of 10 induced slightly higher percentage of cell lysis, lysing 
around 70% of the cells by 24 hours (Figure 4.2.8B). Greater differences were observed when cells 
were infected with MOI of 50 (Figure 4.2.8C). Dog primary cells infected with lower MOIs did 
not release LDH until 6 hour post infection but high MOIs resulted in nearly all of the cells to lyse 
by 6 hour post infection with significant lysis being observed as early as 2 hour time-point (Figure 
4.2.8C). These results suggested that PBMCs and DH82 cells respond to S. Typhimurium infection 
in a similar manner with PBMCs somewhat more responsive than DH82 cells which would not be 
unexpected given the immortalised status of the DH82 cells. Nevertheless, this suggested, that 
conclusions drawn from DH82 cell line responses are a good indication of primary cell behaviour 
and that canines display refractory responses in terms of cell death to other species when 
challenged with pathogenic S. Typhimurium.  
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Figure 4.2.8 Canine PBMC cell lysis responses are similar to that of DH82 cells in response 
to S. Typhimurium infection. Canine PBMCs and DH82 cells were infected with wild-type S. 
Typhimurium strain at MOI of (A) 1, (B) 10 and (C) 50. Cell lysis was quantified by the relative 
amount of LDH released at 1, 2, 6 and 24 hour time-points. Data shown is from a single 
experiment. Error bars represent the standard error of means (SEM) of triplicate wells. 
I also investigated the inflammatory capacity of primary canine PBMCs compared to DH82 cells 
during infection using IL-1β as a read-out. Cells were infected with wild-type S. Typhimurium at 
MOI 1 (Figure 4.2.9A), 10 (Figure 4.2.9B) and 50 (Figure 4.2.9C) at 1, 2, 6 and 24 hour post 
infection. Although IL-1β was detected in the supernatant of canine primary cells, it was much 
reduced compared to that of detected of DH82 cells (Figure 4.2.9). This could potentially be 
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attributed to the presence of a heterogenic population in the isolated PBMCs with some cells such 
as B and T-cells producing none or very little inflammasome dependent cytokine. Also, some of 
the samples were from patients who had undergone chemotherapy or suffer from autoimmune 
disease (Table 2.2.1). It can be assumed that these conditions can create heterogeneity in cell 
responses and even in their genetic background.  Experiments need to be repeated in primary cells 









Figure 4.2.9 Canine PBMCs release IL-1β in response to S. Typhimurium infection. Canine 
PBMCs and DH82 cells were infected with wild-type S. Typhimurium strain at MOI of (A) 1, (B) 
10 and (C) 50. IL-1β released into the supernatant was quantified at 1, 2, 6 and 24 hour time-points 
using ELISA method. Data shown is from a single experiment. Error bars represent the standard 
error of means (SEM) of triplicate wells. 
4.3 Discussion
In this chapter I have investigated the inflammatory responses of the canine DH82 macrophage-
like cell line and primary canine PBMCs. As I had previously demonstrated that canine cells were 
refractory to NLRP3 inflammasome agonists (Chapter 3), genomic sequence analysis has shown 
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additional major differences in canines when compared to the human and mouse genomes. The 
NLRC4 receptor predominantly responsible for the recognition of conserved components of the 
type III secretion system and [46] flagellin contains multiple premature stop codons [41]. These 
mutations result in the presence of a non-functional NLRC4 pseudogene [41]. Sequence analysis 
has also demonstrated a total absence of NAIP genes [41]. NAIPs can directly sense these bacterial 
components and are crucial for the activation of the NLRC4 receptors [133], [135]. I have 
investigated the fate of canine cells when challenged with a canonical NLRC4 infectious agent S. 
Typhimurium. Cells infected with wild-type S. Typhimurium showed delayed cell lysis responses, 
similar to that observed in murine Nrlc4-/- and caspase-1-/-caspase11-/- cells (Figure 4.2.2). 
Processed IL-1β in the supernatant of DH82 cells was also detected which occurred in conjunction 
with cell lysis but was significantly increased in comparison to murine cells (Figure 4.2.3). This 
was of a smaller molecular weight than caspase-1 mediated processing would produce and 
suggested alternate protease maturation of IL-1β in canines (Figure 4.2.4). Further work is required 
to identify this protease and whether its activation is dependent on inflammasome components. 
Live cell imaging of S. Typhimurium infected DH82 cells showed morphological features 
characteristic to lytic form of cell death, but with delayed kinetics compared to infected mouse 
cells (Figure 4.2.5). In this chapter I also examined cell lysis (Figure 4.2.8) and IL-1β (Figure 
4.2.9) responses in canine PBMCs. These responses were largely similar to DH82 cells, thus 
further validating observations in DH82 cells, although there were slight differences in the degree 
of death seen.  
 
Bacterial components driving the observed late cell lysis was also investigated using different S. 
Typhimurium mutant strains. To my surprise, the cell lysis (Figure 4.2.6) and IL-1β (Figure 4.2.7) 
responses were largely dependent on the type III secretion proteins. The type III secretory system 
protein PrgJ in mouse and PrgI in humans has been shown to be directly recognised by NAIPs 
[133].  No NAIPs are present in dogs yet S. Typhimurium lacking PrgJ still drove cell lysis in 
DH82 cells (Figure 4.2.6). This suggests the presence of another, perhaps not yet identified, 
receptor present in the dog, is responsible for recognising S. Typhimurium PrgJ or other type III 
secretory component. NLRP3 may be able to sense the homeostatic changes (e.g. potassium efflux) 
induced by the bacterial encoded effector proteins delivered via the type III secretion system. To 
test this DH82 cell responses following S. Typhimurium infection could be investigated in the 
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presence of raised extracellular potassium level which has been shown to inhibit NLRP3 
inflammasome formation [83]. I have also shown in Chapter 3 that DH82 cells did not undergo 
lysis in response to transfected LPS (Figure 3.6.2A), therefore LPS-mediated non-canonical 
activation of NLRP3 through the activation of caspase-11/4/5 activation will not drive S. 




Chapter 5  
The role of caspase-1/4/11, caspase-8 and RIPK1 in S. Typhimurium-induced cell death 




Over the past 30 years extensive research has resulted in the development of genome engineering 
techniques that allow direct editing of target gene sequences at specific locations. The discovery 
and further development of the prokaryotic adaptive immune system CRISPR-Cas9 [362]–[365] 
has revolutionised genome editing. This approach makes use of the bacterial endonuclease Cas9 
that introduces double-stranded DNA breaks (DSB) which, in turn, will activate host-derived 
endogenous DNA repair mechanisms. 
 
The bacterial CRISPR locus consists of 4 protein-coding genes and CRISPR arrays. CRISPR 
arrays consist of spacer regions containing foreign, pathogenic (e.g. bacteriophage) DNA 
fragments integrated in between short palindromic repeats [365]–[370]. CRISPR-associated 
endonuclease 1 (cas1), -2 and conserved non-coding DNA sequences 2 (cns2) are required for the 
acquisition of new DNA fragments from invading pathogens into the spacer regions [362], [371]. 
These spacer regions are transcribed into CRISPR RNA (crRNA) that recognise and anneal to 
spacers matching sequences from invading pathogens [372]. While a small scaffold RNA called 
trans-activating CRISPR RNA (tracrRNA) is responsible for guiding the Cas9 protein to the 
complementary sequence recognised by the crRNA [373], [374]. Cas9 protein activity results in 
blunt-end cleavage of target DNA sequences, that match the already existing spacers, 3 nucleotides 
upstream of a so called protospacer adjacent motif (Pam) [372], [375]–[377]. Cas9 nuclease 
recognises a so-called NGG sequence, where the first base can be any of the four known 
nucleotides followed by two guanine nucleobases.  
 
This system allows accurate and highly efficient gene engineering [378], [379]. In comparison to 
other available techniques, CRISPR-Cas9 allows genome editing in a high-throughput, 
multiplexed manner [380], minimising off-target effects while reducing the length and cost of the 
process. Different CRISPR adaptive immune systems can be found in different bacterial species. 
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All of them, however, serve the same purpose that is acquiring, storing and recognising invading 
pathogenic DNA sequences.  
 
As shown in Chapter 4 (Figure 4.1.5), canine DH82 macrophages infected with S. Typhimurium 
underwent a lytic form of cell death (Figure 4.1.5). In this chapter I aimed to identify the 
mechanism via which DH82 cells lyse in response to S. Typhimurium infection.  
 
Previous in vitro studies have investigated the recruitment of different NLRs and caspases to the 
inflammasome in macrophages. Super resolution imaging of differentiated THP1 cells infected 
with S. Typhimurium, for example, has shown that NLRC4, ASC and caspase-1 are recruited into 
the same inflammasome complex [62]. NLRP3 and caspase-8 recruitment to the same 
inflammasome complex was also shown in primary murine macrophages [62], [140]. Activated 
caspase-1 drives pyroptotic cell death by the cleavage of an executioner protein GSDMD [44], 
while caspase-8 has been shown to modulate IL-1β processing [140], but can also process GSDMD 
under certain conditions [223]–[225]. My previous results showed that active caspase-1 and 
caspase-8 were recruited to the ASC speck in DH82 cells in response to canonical NLRP3 
activation following stimulation with nigericin (Figure 3.5.4). Necroptosis, another form of lytic 
cell death, can display morphological features similar to those displayed by pyroptosis [253]. To 
investigate whether DH82 cells undergo necroptosis in response to S. Typhimurium infection, I 
disrupted the canine RIPK1 gene whose kinase activity has been shown to be an essential 
component of necroptotic cell death initiation [208].  
 
In this chapter, I used CRISPR-Cas9 technology to disrupt the canine hybrid caspase-1/4/11, 
caspase-8 and RIPK1 in DH82 cells in an attempt to investigate their role in driving cell death and 
IL-1β processing in response to S. Typhimurium. I have interrupted gene function by introducing 
INDELS (insertions and deletions) at the identified catalytic site for each gene as described in 
Materials and Methods section 2.12. This work was divided into two parts, both of which are 
covered in this chapter. In the first part, I described the process of cell electroporation with RNP 
complexes (including target sequence specific crRNA, tracrRNA and Cas9 protein) to introduce 
genetic mutations followed by identification of these mutations via Illumina MiSeq sequencing. 
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In the second part, I have investigated cell death mechanisms that could drive cell death responses 
in DH82 cells following S. Typhimurium infection.  
 
5.2 Results - Optimisation of nucleofection for DH82 cells 
 
I assessed the tolerance and efficiency of DH82 cells to physical transfection. In this work, I used 
a Nucleofector 2b device to perform electroporations. Nucleofection allows the introduction of 
DNA, RNA and proteins directly into the cell cytoplasm and nucleus. Madin-Darby Canine Kidney 
(MDCK) cells have been shown to successfully uptake cDNA [381], [382] and siRNAs [383], but 
successful electroporation of DH82 cells using this device has not yet been reported. I therefore 
first optimised the parameters for electroporation of the DH82 cell line by transfecting a Green 
Fluorescence Protein (GFP) vector into the cytoplasm. 
 
I performed all transfections as described in Materials and Methods section 2.12.1. In short, DH82 
cells were resuspended in either L or V nucleofection solutions containing supplements to promote 
cell survival. Samples for each type of solution were transfected with pmaxGFP® vector using 7 
different, pre-defined electrical parameters (Table 2.6). The electrical pulse permeabilizes the cell 
membrane and moves molecules into the cytosol and nuclei via an electrical field. Cells that were 
electroporated without the presence of the GFP vector and cells that were not electroporated in the 
presence of GFP vector were also included for each electroporation solution as controls in the 
analysis (Table 2.6).  
 
Following electroporation, cells were left to recover overnight and analysed the next day. I 
assessed the transfection efficiency of several programmes by measuring GFP expression in single 
cells by flow cytometry 24 hours post-electroporation (Table 2.6). A forward (FSC) versus side 
scatter (SSC) scatter plot of the data was generated and a gate was drawn to include intact/viable 
cells and exclude debris (Figure 5.2.1 A and C). GFP expression and the percentage of GFP+ cells 
in the gated population was then calculated by plotting GFP intensity versus cell count (Figure 
5.2.1 B and D). 
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Figure 5.2.1 Gating strategy used to assess GFP expression in DH82 cells following 
electroporation. DH82 cells were resuspended in either nucleofection solution L or V and were 
electroporated using (A) X005 and T020 settings in the presence of and without GFP vector for 
both solutions. DH82 cells were also electroporated using 7 different, pre-defined electrical 
programs in the presence of pmaxGFP® vector for each solution.  For reasons of simplicity, data 
shown in this graph was acquired by cells resuspended in nucleofector solution V and 
electroporated using programs A020 and X005 (B and D). Debris and dead cells were excluded by 
gating cells on a forward scatter (FSC) versus side scatter (SSC) plot. (C, E) GFP expression was 
then assessed on the gated population by plotting GFP intensity versus cell count.  
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The use of different solutions (L or V) did not have an effect on the transfection efficiency (Figure 
5.2.2). The decisive factor in determining transfection efficiency was the specific nucleofector 
program used to transfect the plasmid into the cells. In particular, the lowest percentage of cells 
expressing GFP (less than 30%) was obtained following electroporation using program A020 
(Figure 5.2.2C and G), while the highest percentage (over 60%) of cells expressing GFP was 
observed in cells electroporated with program X005 (Figure 5.2.2D and H). Subsequent 




Figure 5.2.2 Transfection efficiency is determined by the nucleofector program rather than 
the nucleofection solution. DH82 cells were resuspended in either nucleofection solution L or V 
and were (C, D, G, H) electroporated using 7 different, pre-defined electrical programs in the 
presence of pmaxGFP® vector. Cells electroporated (B, F) without the presence of the GFP vector 
and (A, E) non-electroporated cells in the presence of the GFP were also included for each solution. 
GFP expression was assessed on FSC versus SSC gated population using the GFP signal versus 
cell count. The graph includes representative data for programs resulted in the (C, G) lowest and 
(D, H) highest GFP expression rate.  
 




Genomic sequence analysis has previously revealed the presence of the hybrid caspase-1/4/11 gene 
in the canine genome [154]. The presence of two alternative transcripts has also been reported in 
canine PBMCs [154]. My previous results using mass spectrometry analysis of DH82 cell lysates 
showed the presence and constitutive expression of the canine hybrid gene (Figure 3.2.2). Using 
the MUSLCE analysis software, I additionally identified an evolutionarily conserved catalytic 
cleavage site (Figure 3.2.3) shared between the canine hybrid, human caspase-4 and mouse 
caspase-11 transcripts [322]. This suggested the presence of a functional hybrid protein in the dog, 
its role in driving cell death and cytokine maturation in response to intracellular pathogens has not 
yet been investigated. I therefore used CRISPR-Cas9 technology to induce out-of-frame mutations 





Figure 5.3.1 Ensembl gene organisation of the hybrid caspase-1/4/11 gene. Ensembl gene build 
annotation of the hybrid gene (ENSCAFG00000014860) shows the predicted protein coding 
exons. The identified catalytic residue is present in both transcripts in exon 6, highlighted by red 
rectangles.  
 
Target sequence specific crRNAs were designed as described in Materials and Methods section 
2.12.2. In short, crRNAs 20-nucleotide in length were designed immediately upstream of the Cas9 
recognition Pam sequence (NGG) using Benchling online platform. To maximise efficiency and 
specificity, I chose the guide RNAs with the highest combined on- and off-target scores as 
calculated by the software. Their value can range from 0 to 100 and the higher it is the more 
effective the crRNA will be [384], [385]. I therefore selected two guide RNAs targeting sequences 
in exon 6 upstream of the catalytic reside (285-Cys). crRNA AACCTCAAGGACAAACCGA 
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targeted the coding strand of exon 6 and had an on-target score of 81.5 and off-target score of 70.3. 
The second crRNA GCATCCTGAATGGAATCTGT also targeted the coding strand of exon 6 
but had lower on-target and off-target scores (62.4 and 67.2, respectively). To maximise the 
number of editing events, I performed three rounds of electroporation using three different 
concentrations of RNP complex (100-, 200 and 400nmol) for each crRNA as described in Materials 
and Methods section 2.12.3. Genomic DNA extraction and first level locus-specific PCR were 
performed as described in Materials and Methods sections 2.12.4 and 2.12.5, respectively. I then 
confirmed amplicon sizes on an agarose gel (Figure 5.3.2). The predicted amplicon size for the 




Figure 5.3.2 Amplicon sizes following first level PCR for the caspase-1/4/11 gene were 
confirmed on an agarose gel. After locus-specific PCR, two samples (10µl each) for each guide 
RNA were run in an agarose gel to confirm that the amplification resulted in the predicted amplicon 
size of 368bp. Samples 8 and 9 correspond to guide CAACCTCAAGGACAAACCGA, while 
samples 11 and 12 to guide GCATCCTGAATGGAATCTGT. Sample 20 contains negative (dH2O 
only) PCR control. Samples 1-7 and 13-19 corresponds to canine caspase-8 and RIPK1 genes, 
respectively, and are discussed later in this chapter.  
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After confirming the correct amplicon sizes, second level PCR and MiSeq library preparations 
were performed as described in Materials and Methods sections 2.15 and 2.16, respectively. To 
determine gene editing efficiency and the type of indels induced, I genotyped bulk-edited cell 
populations via Illumina sequencing followed by sequence analysis using the OutKnocker online 
analysis tool. Sequence analysis showed highly efficient editing for both crRNAs independent of 
the RNP complex concentration (Appendices 1 and 2). Over 50% of the reads aligned contained 
indels regardless of the concentration used (Appendices 1 and 2). These results showed that DH82 
cells tolerated electroporation well, allowing efficient genome editing.    
 
Insertions and deletions of one or more nucleotides by non-homologous end-joining can induce 
in-frame or out-of-frame mutations. Generally, in-frame mutations occur when the addition or loss 
of nucleotides happen in multiples of three. This can result in addition or loss of amino acids 
without affecting the translation of downstream sequences. When the addition or loss of 
nucleotides does not happen in multiples of three, out-of-frame mutations occur that disrupt the 
reading frame of the genetic code and can result in the installation of pre-mature termination 
codons (PTC). A process known as nonsense-mediated decay, is an evolutionarily conserved 
mRNA surveillance pathway [386] and its role is to suppress aberrant transcription expression of 
mRNA sequences that acquired PTCs [387]–[389]. 
 
I therefore compared the proportion of in-frame and out-of-frame indels induced by each crRNA 
used. While the gene editing efficiencies of the two crRNAs were comparable (Appendices 1 and 
2), GCATCCTGAATGGAATCTGT crRNA induced larger proportion of out-of-frame mutations 
(Appendix 2). Based on these results, bulk-edited cell populations obtained after using this 
particular crRNA were then diluted to obtain single cell colonies. I set up limiting dilutions as 
described in Materials and Methods section 2.12.7 for the chosen bulk population (crRNA 
GCATCCTGAATGGAATCTGT, 100nmol). I aimed to obtain colonies originating from a single 
cell to ensure identical genetic composition. I collected up to 96 single cell colonies and used 
Illumina MiSeq to genotype each colony for indels in the region of the crRNA target sequence. 
OutKnocker identified colonies A1 and C6 to harbour out-of-frame mutations (Appendix 3) which 




Clone A1 contained only a single type of deletion (11 nucleotides), while clone C6 harboured 8 
and 5 nucleotide deletions in each allele, respectively (Figure 5.3.3). Next, I used these clones to 
investigate the role of the caspase-1/4/11 in cell death and IL-1β processing in response to S. 
Typhimurium infection. In addition to the chosen knock-out clones, wild-type non-electroporated 
and electroporated only DH82 cells were also included in these experiments. I carried out 
gentamicin protection assay with wild-type S. Typhimurium at three different MOIs (1, 10 and 50) 
as described in Materials and Methods section 2.5. Percentage of cell lysis induced and the amount 




Figure 5.3.3 Illumina MiSeq sequencing of caspase-1/4/11 identified out-of-frame indel 
mutations for colonies A1 and C6 near the catalytic site in exon 6. DH82 cells were 
electroporated with CRISPR crRNA GCATCCTGAATGGAATCTGT to target the canine hybrid 
caspase-1/4/11 gene near the catalytic site. Following limiting dilution, up to 96 single cell 
colonies were selected and genotyped using Illumina MiSeq sequencing. Information displayed by 
the analysis software includes the file name, number of amplicon reads and indel frequency. The 
underscored nucleotide sequence represents the wild-type reference sequence, while nucleotides 
highlighted in yellow show CRISPR crRNA target sites. Information including total percentage 
and total number of reads corresponding to each identified indel are shown underneath the 
reference sequence. Nucleotides shown in smaller font sizes are less confident calls based on the 
sequencing data, while deleted nucleotides have been replaced by hyphens. The software also 
provides information on the percentage and total number of reads that could not be aligned to the 
reference sequence and the number of reads that were excluded from analysis (Phred score 
dropouts). Two colonies, A1 and C6 were chosen for subsequent phenotypic characterisation. 
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The amount of LDH released in response to infection did not differ between the knock-out clones 
and wild-type (electroporated or not) DH82 cells (Figure 5.3.4). The lack of catalytically active 
hybrid caspase-1/4/11 protein did not prevent the cell death observed between 6 and 24 hours 
(Figure 5.3.4). There is still a possibility that, despite the large deletion near the catalytic site, the 
protein function was not totally abolished. Perhaps exons encoding the CARD domain of the 
protein were still translated into a partially functional protein that could be potentially recruited or 
even drive the recruitment of other proteins to the inflammasome. Cas9 targeted gene editing 
should, therefore, be repeated using crRNAs targeting the first few N-terminal exons of the hybrid 
caspase-1/4/11 gene. Further experiments are required to eliminate conclusively the involvement 




5.3.4 Genetic deletion of the catalytic site of the canine hybrid caspase-1/4/11 did not affect 
cell death in response to S. Typhimurium infection. Caspase-1/4/11 knock-out clones A1, C6, 
non-electroporated and electroporated only wild-type DH82 cells were infected with S. 
Typhimurium at three different MOIs; (A) 1, (B) 10  and (C) 50. Percentage of cell lysis at 1, 2, 6 
and 24 hours post infection was determined via measuring the amount of LDH released in the cell 
culture supernatant as described in Materials and Methods section 2.5. Data shown is pooled from 
three independent experiments. Error bars represent the standard error of means (SEM) of triplicate 
wells. 
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I also measured the amount of IL-1β released in response to infection with S. Typhimurium (Figure 
5.3.5) and found that cells did not release any IL-1β at 1, 2 and 6 hours. It was only at 24 hours 
after infection that substantial levels of IL-1β were detected in the cell supernatant (Figure 5.3.5). 
These results agreed with my previous observations (Figure 4.2.3) where S. Typhimurium-infected 
wild-type DH82 macrophages released negligible amounts of IL-1β in the first 6 hours post 
infection while large amounts were detected in the supernatant 24 hours post infection (Figure 
4.2.3). Similarly to the cell lysis data, both clones were not impaired in secreting IL-1β in response 
to S. Typhimurium infection. On the contrary, cells from clone C6 released significantly higher 
amounts of IL-1β than that from wild-type cells (Figure 5.3.5). Further experiments are, however, 
required to confirm the amount, source and form of the IL-1β in the supernatant.  
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5.3.5 Genetic deletion of the catalytic site of the canine hybrid caspase-1/4/11 did not impair 
IL-1β release in response to S. Typhimurium infection. Caspase-1/4/11 knock-out clones A1, 
C6, non-electroporated and electroporated only wild-type DH82 cells were infected with S. 
Typhimurium at three different MOIs; (A) 1, (B) 10  and (C) 50. The amount of IL-1β released 
into the supernatant was determined at 1, 2, 6 and 24 hours post infection as described in Materials 
and Methods section 2.8. Data shown is pooled from three independent experiments. Error bars 
represent the standard error of means (SEM) of triplicate wells. 
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To confirm genotypes, I repeated Illumina sequencing on caspase-1/4/11 clones A1 and C6. 
OutKnocker analysis of sequencing results confirmed the same genotypes as previously described 
(Appendix 4).   
 
5.4 MUSLCE analysis of caspase-8 and RIPK1 transcript sequences 
 
I performed MUSCLE analysis of human, mouse and canine caspase-8 and RIPK1 transcripts to 
identify similarities in catalytic residues essential for function (Figures 5.4.1 and 5.4.2). I found 
the key catalytic residue identified in human caspase-8 (377-Cys)  [322] essential for function to 
be also conserved in the dog (367-Cys) (Figure 5.4.1). I also identified key catalytic residues shown 
to be essential for kinase activity of the human RIPKl at positions 45-Lys [265], [390] and 138-
Asp [391] to be conserved in dogs (41-Lys, 134-Asp, respectively) (Figure 5.4.2). Additional 
residues for caspase-8 cleavage 324-Asp [392] and RIP-mediated NF-κβ activation 377-Lys [272] 
were also found to be conserved in canine RIPK1 transcript at positions 322-Asp and 375-Lys, 
respectively (Figure 5.4.2). These results suggested the presence of enzymatically functional, 
active caspase-8 and RIPK1 proteins in the dog. I therefore proceeded to design target sequence 









Figure 5.4.1 Multiple sequence alignment comparison between canine, human and mouse 
caspase-8 transcripts indicate the presence of catalytically active caspase-8 protein in the 
dog. Protein sequences of the caspase domain p20 subunit showed high degree of similarity 
between human, mouse and dog caspase-8. The catalytic residue found in human caspase-8 at 377-
Cys position (highlighted in red rectangles) appeared to be conserved in the dog (367-Cys). This 






Figure 5.4.2 Multiple sequence alignment comparison between canine, human and mouse 
RIPK1 transcripts indicate the presence of catalytically active RIPK1 protein in the dog. 
Protein sequences in the kinase domain showed high degrees of similarity between human, mouse 
and dog RIPK1 transcripts. Catalytic residues (highlighted in red rectangles) found in human 
RIPK1 at position 45-Lys and 138-Asp responsible for kinase activity, the caspase-8 cleavage site 
at 325-Asp and 377-Lys important for RIPK1-mediated NF-κβ activation are conserved in the dog. 
This supports the likely presence of enzymatically active RIPK1 protein in the dog. 
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5.5 Disruption of the canine caspase-8 and RIPK1 genes using CRISPR-Cas9 technology 
 
Both the canine caspase-8 (ENSCAFG00000025192) and RIPK1 (ENSCAFG00000009321) 
genes have only one single transcript (ENSCAFT00000019300.2, ENSCAFT00000014829.3, 
respectively) annotated in Ensembl genome browser [393]. I have identified the catalytic residue 
(367-Cys) of canine caspase-8 (Figure 5.4.1) to be positioned in exon 7 and for RIPK1 kinase 
activity (134-Asp) (Figure 5.4.2) in exon 3. I therefore designed crRNAs specific for the exon 7 
of the canine caspase-8 and the exon 3 of the canine RIPK1 DNA sequences.  
 
For caspase-8, I chose two crRNAs targeting the coding DNA strand of the caspase domain.  
crRNA (TTTTATTCAGGCTTGTCAAG) directly overlapped, while crRNA 
(CCTACCGAAACCCCAATGGAG) targeted downstream of the identified catalytic residue. For 
RIPK1, I chose two crRNAs (TAATTATGGAGACCATTGAA, 
TGGAGAAGGCGTAATACACA) targeting the coding DNA strand of the proteinase domain 
immediately upstream of the residue suspected to be essential for kinase activity.  
 
I performed three rounds of electroporation using three different concentrations of RNP complex 
(100, 200 and 400nmol) for both crRNAs for each gene as described in Materials and Methods 
section 2.12.3. After the third electroporation, bulk-edited cells were left to recover, and genomic 
DNA was extracted from a subset of cells for genotyping purposes as described in Materials and 
Methods section 2.12.4. Genotyping of the bulk-edited cell population was carried out using 
Illumina MiSeq sequencing method. In short, the first step was to perform a locus-specific PCR 
reaction, where the DNA sequence including the crRNA target site was amplified as described in 
Materials and Methods section 2.12.5. I also confirmed amplicon sizes from the locus-specific 
PCR via agarose gel electrophoresis (Figure 5.5.1). The predicted amplicon size for caspase-8 for 
crRNA sequence TTTTATTCAGGCTTGTCAAG was 296 base pairs while for crRNA sequence 
CCTACCGAAACCCCAATGGAG was 306 base pairs (Figure 5.5.1). A single pair of primers was 
designed to amplify both crRNAs (TAATTATGGAGACCATTGAA, 
TGGAGAAGGCGTAATACACA) for RIPK1 with a predicted amplicon size of 266 base pairs 
(Figure 5.5.1). I also included wild-type and negative (dH2O) controls for PCR amplification 






Figure 5.5.1 Amplicon sizes following first level PCR for RIPK1 and caspase-8 were 
confirmed on an agarose gel. After the locus-specific PCR, a minimum of two samples for each 
crRNA were run in an agarose gel to confirm amplicon sizes. Wells 1-7 contained amplicons for 
RIPK1. Of these, wells 1-3 contained amplicons for crRNA TAATTATGGAGACCATTGAA, 
wells 4-6 for crRNA TGGAGAAGGCGTAATACACA and well 7 for wild-type DNA. Wells 14-
19 contained amplicons for caspase-8. Of these, wells 14-15 contained amplicons for crRNA 
TTTTATTCAGGCTTGTCAAG, wells 16 and 19 for wild-type DNA, wells 17-18 for crRNA 
CCTACCGAAACCCCAATGGAG and well 20 contained the negative PCR amplification control. 
Samples 8, 9, 11 and 12 correspond to canine caspase-1/4/11 and were discussed earlier in this 
chapter (Figure 5.3.2) 
 





Upon confirmation of the correct amplicon size for each set of PCR primers (Figure 5.5.1), second 
level PCR and MiSeq library preparations were performed as described in Materials and Methods 
sections 2.15 and 2.16, respectively. Using Illumina sequencing, I genotyped the bulk-edited 
populations for the canine caspase-8 gene. I used OutKnocker online analysis tool to determine 
gene editing efficiency (Appendices 5 and 6) and identify the insertions and deletions (indels) 
induced in the bulk populations for both crRNAs (Appendices 7 and 8).  
 
Sequence analysis of CRISPR-Cas9 edited DH82 cells for the caspase-8 gene showed varying 
gene editing efficiency for crRNA TTTTATTCAGGCTTGTCAAG (Appendix 5). Repeated 
electroporation using 400nmol of the RNP complex resulted in the highest, over 60% indel 
frequency (Appendix 5). Regardless of the RNP concentration, the same type of mutations were 
observed (Appendix 7). Repeated electroporation of RNP complex using crRNA 
CCTACCGAAACCCCAATGGAG induced highly efficient gene editing (Appendices 6 and 8). 
While 100nmol RNP complex induced around 30% indel frequency, both, 200 and 400 nmol RNP 
complexes resulted in over 70% gene editing events (Figure 5.6.1). crRNA 
CCTACCGAAACCCCAATGGAG generally showed better gene editing properties compared to 
crRNA TTTTATTCAGGCTTGTCAAG. Benchling online crRNA designing tool generates on- 
and off-target scores for each crRNA. Higher on-target scores indicate higher efficiency, while 
higher off-target scores indicate higher specificity. CrRNA CCTACCGAAACCCCAATGGAG 
had a higher combined on- and off-target scores (76.27 and 64.51, respectively) compared to 
crRNA TTTTATTCAGGCTTGTCAAG (62.04 and 53.15, respectively). This could explain the 
differences observed between the two crRNAs. I therefore used bulk cell populations edited using 
crRNA CCTACCGAAACCCCAATGGAG in subsequent experiments. It is important to mention 
that the number of reads identified for the Illumina unique adapter pair was suboptimal in this 








Figure 5.6.1 List of indels identified by sequence analysis in CRISPR-Cas9 edited DH82 cells 
for caspase-8 gene using crRNA CCTACCGAAACCCCAATGGAG. DH82 cells were 
electroporated with RNP complexes at three different concentrations (100, 200 and 400 nmol). 
crRNA was designed to be near the catalytic site of the canine caspase-8 gene. Electroporated only 
wild-type DH82 cells yielded amplicon reads that matched exclusively the wild-type sequence, 
while Cas9 edited cells yielded amplicon reads that contained a mixture of in-frame and out-of-
frame mutations. The underscored nucleotide sequence represents the wild-type reference 
sequence, while nucleotides highlighted in yellow show CRISPR crRNA target site. Information 
including total percentage and total number of reads corresponding to each identified indel are 
shown underneath the reference sequence. Nucleotides shown in smaller font sizes are less 
confident calls based on the sequencing data, while nucleotides replaced with hyphens represents 
the position of nucleotides deleted by CRISPR Cas9. The software also provides information on 
the percentage and total number of reads that could not be aligned to the reference sequence and 
the number of reads that were excluded from analysis (Phred score dropouts). 
 




Caspase-8 is a functionally diverse protein. It has been shown to have essential roles during 
embryonic development and in host defence against invading pathogens. I have investigated the 
role of caspase-8 in promoting cell lysis and IL-1β production in response to S. Typhimurium 
infection. Preliminary screening was performed on bulk edited populations using crRNA 
CCTACCGAAACCCCAATGGAG (Figures 5.7.1 and 5.7.2). Based on the results obtained using 
OutKnocker analysis, over 70% of the amplicons screened contained genomic alterations. A large 
proportion of the observed indels were also identified as out-of-frame mutations (Figure 5.6.1).  
 
In these experiments, I infected caspase-8 bulk-edited, wild-type and electroporated only DH82 
cells with wild-type S. Typhimurium at three different MOIs (1, 10 and 50) (Figures 5.7.1 and 
5.7.2). I measured the percentage of cell lysis and the amount of IL-1β released at 1, 2, 6 and 24 
hours post infection (Figures 5.7.1 and 5.7.2). I observed no difference in cell lysis in response to 
S. Typhimurium infection in caspase-8 bulk edited compared to wild type cell populations (Figure 
5.7.1).  
 
Caspase-8 was also shown to be recruited to the NLRC4 inflammasome in S. Tyhpimurium 
infected mouse BMDMs where it was shown to primarily mediate pro-IL-1β expression without 
affecting cell lysis [140]. In line with this, I also observed lower amounts of IL-1β in the 









Figure 5.7.1 Genetic abolition of caspase-8 gene in DH82 cells did not alter lytic cell death 
processes in response to S. Typhimurium infection. Bulk-edited caspase-8-deficient cells, wild-
type and electroporated only wild-type cells were infected with S. Typhimurium at three different 
MOIs; (A) 1, (B) 10 and (C) 50. Percentage of cell lysis at 1, 2, 6 and 24 hours post infection was 
determined via the measurement of relative LDH release. Data shown is pooled from three 
independent experiments. Error bars represent the standard error of mean (SEM) of triplicate wells. 
Figure 5.7.2 Genetic abolition of caspase-8 gene resulted in reduced IL-1β release in response 
to wild-type S. Typhimurium infection. Bulk-edited caspase-8-deficient DH82 cells, wild-type 
and electroporated only DH82 cells were infected with S. Typhimurium at three different MOIs; 1 
(A), 10 (B) and 50 (C). IL-1β release in the supernatant was measured by ELISA at 1, 2, 6 and 24 
hours post infections. Data shown is pooled from three independent experiments. Error bars 
represent the standard error of mean (SEM) of triplicate wells. 
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5.8 Illumina sequence analysis of CRISPR-Cas9 edited bulk populations for the canine 
RIPK1 gene 
 
Illumina sequence analysis showed highly efficient gene editing of the RIPK1 gene using crRNA 
TAATTATGGAGACCATTGAA (Appendix 9). Regardless of the RNP concentration, over 90% 
indel frequency was detected (Appendix 10).  
 
I have also identified high indel frequency in the bulk edited cell populations using crRNA 
TGGAGAAGGCGTAATACACA for the canine RIPK1 gene (Appendix 11). Sequence analysis 
showed that the RNP complex as low as 100nmol resulted in gene editing events in over 70% of 
the cells (Appendix 12) with repeated electroporation using 400nmol of the RNP complex inducing 
over 90% indel frequency (Appendix 12). Overall, my results showed that both crRNA induced 
large amount of editing events in the canine RIPK1 gene. This high efficiency genome editing 
could be explained by the high on- and off-target scores calculated for crRNA 
TAATTATGGAGACCATTGAA and TGGAGAAGGCGTAATACACA (64.7, 64.1 and 76.8, 
69.1, respectively). 
 
These results suggested that the gene editing efficiency of crRNAs with low on- and off-target 
scores can be augmented by increasing the concentration of the RNP complex. CrRNA sequences 
with higher on- and off-target scores can induce a large number of editing events even at low RNP 
complex concentrations.    
 
5.9 Functional characterisation of RIPK1 mutant clones 
 
In this section I aimed to investigate the role of canine RIPK1 in cell lysis and IL-1β processing 
in response to S. Typhimurium infection. I chose bulk-edited cells generated using crRNA 
TGGAGAAGGCGTAATACACA for subsequent analysis. Using this guide RNA, I have 
identified deletions up to 14 nucleotides in length in the RIPK1 gene. I therefore set up limiting 
dilutions and carried out subsequent Illumina sequencing of 96 clones each originating from a 




I chose single cell colonies C9 and D7 (Figure 5.9.1) to perform a series of in vitro S. Typhimurium 
infection assays. RIPK1 colony C9 contained biallelic deletions, consisting of a 1- and 2-nucleotide 
deletions, while RIPK1 D7 colony also contained biallelic mutations, consisting of a 16-nucleotide 
deletion and 1-nucleotide insertion (Figure 5.9.1). Based on the sequencing results, the canine 




Figure 5.9.1 Illumina MiSeq sequencing of RIPK1 knock-out clones C9 and D7 show large 
deletions in the targeted exon 3. Following limiting dilution, up to 96 colonies each originating 
from a single cell were selected and genotyped using Illumina MiSeq sequencing. Based on the 
Illumina sequencing results using OutKnocker online analysis tool two colonies, C9 and D7 were 
chosen for subsequent characterisation. Colony C9 contained biallelic, 1- and 2-nucleotide 
deletions. Colony D7 also contained biallelic mutations, 16-nucleotide deletion and 1-nucleotide 
insertion in length. Information displayed by the analysis software includes the file name, number 
of amplicon reads and indel frequency. The underscored nucleotide sequence represents the wild-
type reference sequence, while nucleotides highlighted in yellow show CRISPR crRNA target 
sites. Information including total percentage and total number of reads corresponding to each 
identified indel are shown underneath the reference sequence. Nucleotides shown in smaller font 
sizes are less confident calls based on the sequencing data, while nucleotides replaced with 
hyphens represents the position of nucleotides deleted by CRISPR Cas9. The software also 
provides information on the percentage and total number of reads that could not be aligned to the 
reference sequence and the number of reads that were excluded from analysis (Phred score 
dropouts).  
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To assess the functional consequences of the loss of RIPK1 gene, I performed gentamicin 
protection assay as described in Materials and Methods section 2.5. In these experiments, RIPK1 
clones C9 and D7 together with wild-type and electroporated only DH82 cells were infected with 
wild-type S. Typhimurium using three different MOIs (MOI 1, 10 and 50). I calculated the 
percentage of cell lysis (Figure 5.9.2) and the amount of IL-1β released (Figure 5.9.3) into the 
supernatant at 1, 2, 6 and 24 hours post infection.  
As I have previously shown, wild-type DH82 cells responded to S. Typhimurium infection at later 
time points, with the strongest response observed at 24 hours post infection (Figures 4.1.1 and 
4.1.2). Neither of the selected clones (C9 and D7) lacking functional RIPK1 gene showed altered 
cell lysis responses (Figure 5.9.2), since the relative amount of LDH released was comparable 
between knock-out, wild-type and electroporated only DH82 cells (Figure 5.9.2). In contrast, I 
failed to detect any IL-1β present in the supernatant in either of the RIPK1 clones (Figure 5.9.3).  
Figure 5.9.2 Genetic abolition of RIPK1 gene did not alter cell death responses following 
infection with wild-type S. Typhimurium. RIPK1 clones C9, D7, wild-type and electroporated 
only DH82 cells were infected with S. Typhimurium at three different MOIs; (A) 1, (B) 10 and 
(C) 50. Percentage of cell lysis at 1, 2, 6 and 24 hours post infection for clone C9 and 24 hours
post infection for clone D7 was determined via measuring relative LDH release. Data shown for
clone C9 is pooled from three independent experiments, while for clone D7 is from a single
experiment. Error bars represent the standard error of mean (SEM) of triplicate wells.
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Figure 5.9.3 Genetic abolition of RIPK1 gene prevented IL-1β production by cells of the 
RIPK1 clones C9 and D7 when infected with wild-type S. Typhimurium. RIPK1 clones C9, 
D7, wild-type and electroporated only DH82 cells were infected with S. Typhimurium with three 
different MOIs; (A) 1, (B) 10 and (C) 50. IL-1β release in the supernatant was measured by ELISA 
at 1, 2, 6 and 24 hours post infection for clone C9 and 24 hours post infection for clone D7. Data 
shown for clone C9 is pooled from three independent experiments, while for clone D7 is from a 
single experiment. Error bars represent the standard error of mean (SEM) of triplicate wells. 
These experiments confirmed the RIPK1-dependent effect on pro-inflammatory cytokine pro-IL-
1β production in response S. Typhimurium infection (Figures 5.9.3). 
I further investigated the effect of RIPK1 in the induction of pro-IL-1β expression. Following 
gentamicin protection assay (MOI 1) of RIPK1 clone C9 and wild-type DH82 cells, I have blotted 
their full protein extracts (24-hour post infection) against canine IL-1β (Figure 5.9.4). My results 
showed the presence of pro- and mature IL-1β in DH82 cell extracts, while RIPK1 clone C9 was 





Figure 5.9.4 RIPK1 is essential for inflammatory cytokine pro-IL-1β expression in response 
to S. Typhimurium infection in the dog. Wild-type DH82 and RIPK1 clone C9 cells were 
infected with wild-type S. Typhimurium at MOI of 1 for 24 hours. Full protein extraction of cell 
lysates was performed, and samples were blotted against canine specific IL-1β. Non-infected 
controls (shown as medium only) were also included for each cell line. Representative immunoblot 
is from a single experiment. 
 
My results therefore indicated an essential role for RIPK1 in pro-inflammatory cytokine IL-1β 




To the best of my knowledge, DH82 cells have not yet been genetically altered using the CRISPR 
Cas9 technology. To this end, in the first part of this chapter I optimised the electroporation 
conditions by electroporating DH82 cells with pmaxGFP vectors using two solutions and 7 
different pre-defined electrical parameters for each solution. I assessed electroporation efficiency 
by measuring GFP protein expression via flow cytometry and found that it was the electrical 
parameters, rather than the type of solution, that determined the level of GFP expression. My 
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results showed that the use of program X-005 resulted in the highest percentage of intact cells 
expressing GFP protein.  
 
In the second part of this chapter I have investigated different cell death mechanisms that could 
drive the late cell lysis seen in canine DH82 cells in response to S. Typhimurium infection. I have 
targeted three major programmed cell death pathways, namely pyroptosis, necroptosis and 
apoptosis (Figure 3.1). First, I compared the amino acid sequences of canine hybrid caspase-
1/4/11, caspase-8 and RIPK1 transcripts against the human and mouse sequences to identify 
catalytic residues essential for function (Figures 3.2.3, 5.4.1 and 5.4.2, respectively). Sequence 
analysis showed high amino acid sequence conservation across human, mouse and dog species. 
Residues suggested to play a role in the catalytic activity of caspase-1/4/11 and caspase-8 and the 
kinase activity of RIPK1 appeared to be conserved in the dog, indicating the presence of functional 
proteins (Figures 3.2.3, 5.4.1 and 5.4.2, respectively).  
 
Following the identification of the catalytic residues, I described the generation of knock-out 
DH82 macrophages lacking functional caspase-1/4/11, caspase-8 and RIPK1 genes using 
CRISPR-Cas9 genome editing system. For each gene I chose two crRNAs and used each crRNA 
at three different concentrations to perform CRISPR-Cas9 gene editing. Guide RNA positions, as 
well as on- and off-target values, were taken into consideration when choosing guides. My results 
showed that gene editing efficiency can be increased using higher concentration of the RNP 
complex for guide RNAs with lower on- and off-target scores. My results also suggested that the 
size of indels induced by guide RNAs cannot be predicted based on their on- and off-target values.  
 
I then proceeded to investigate the effect of these genetic disruptions on cell lysis (via the 
measurement of LDH release) and IL-1β release in DH82 cells infected with wild type S. 
Typhimurium. In line with my previous observations (Chapter 4, Figure 4.2.2 and 4.2.3), cell lysis 
and IL-1β release was only seen at 24 hours after infection (Figure 5.3.4 and 5.3.5). The amount 
of cell lysis however was comparable between knock-out, wild-type and electroporated only 
control cells (Figure 5.3.4). This suggested that S. Typhimurium-induced cell lysis occurs 
independently of the catalytic activity of the canine hybrid protein. Interestingly, cells of one of 
the clones secreted significantly larger amount of IL-1β than that secreted by wild-type cells 
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(Figure 5.3.5). Perhaps the lack of caspase-1/4/11 fusion protein allows the recruitment of other 
caspases, for example caspase-8 to drive IL-1β production in response to S. Typhimurium infection 
[140]. While the transcriptional priming of pro-IL-1β was unaltered (Figure 5.3.5), further 
experiments examining the presence of mature IL-1β should be carried out.  
 
In the last part of this chapter, I investigated the functional consequences of the loss of caspase-8 
and RIPK1 genes in response to S. Typhimurium infection. I have obtained single cell colonies for 
RIPK1-deficient cells, due to time limitations, experiments were only performed on canine 
caspase-8-deficient bulk edited cell populations. Caspase-8 and RIPK1 knock-out cells infected 
with wild-type S. Typhimurium showed cell lysis responses comparable to those of DH82 wild-
type and electroporated only control cells (Figures 5.7.1 and 5.9.2, respectively). My results 
suggested that the absence of functional caspase-8 or RIPK1 proteins alone did not prevent late 
cell lysis observed in response to S. Typhimurium infection. Secretion of IL-1β was completely 
abolished in RIPK1-deficient cells (Figure 5.9.3), while western blotting analysis of S. 
Typhimurium infected DH82 wild-type and RIPK1-deficient cell lysates confirmed the total 
absence of pro-IL-1β expression (Figure 5.9.4). My results therefore identified canine RIPK1 to 
be essential in the induction of pro-inflammatory cytokine expression in response to S. 
Typhimurium infection in DH82 cells. Several other studies suggest TLR-mediated RIPK1 
activation to be essential for cytokine expression. Murine macrophages deficient for either RIPK1, 
RIPK3 or caspase-8 showed impaired NF-κβ activation and reduced IL-1β production in response 
to Yersinia Pestis [394]. Human monocytes in the presence of extracellular LPS can form an 
“alternative” inflammasome which drives IL-1β secretion without apparent ASC speck formation 
or pyroptotic cell death. This is a TLR4/TRIF-mediated pathway engaging RIPK1, FADD and 
caspase-8 upstream of the NLRP3 inflammasome [185]. Bulk edited caspase-8 deficient cells also 
showed a reduction in the amount of IL-1β detected in the supernatant when compared to DH82 
wild-type and electroporated only control cells (Figure 5.7.2). Caspase-8 mediated atypical IL-1β 
processing in murine BMDCs in response to LPS stimulation relies on the presence of intact 
RIPK1, RIPK3 and FADD proteins [217]. While caspase-8 has been shown to promote IL-1β 
production in murine BMDMs following S. Typhimurium infection, it is dispensable for cell death 
[140]. Other studies also suggested an essential role for caspase-8 in expression and processing of 
inflammatory pro-IL-1β [220], [222]. Murine BMDMs deficient for either GSDMD or 
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proteolytically active caspase-1 has been shown to recruit and activate caspase-8 within the ASC 
speck to induce a so called secondary pyroptosis and delayed Il-1β release [213]. Caspase-8/FADD 
complex has been shown to play a necroptosis inhibitory role, while cells lacking caspase-8 or 
FADD undergo necroptotic cell death in response to death receptor ligand binding [187]. Both, 
RIPK1 and RIPK3 contain cleavage sites which have been shown to act as caspase-8 substrates 
[392], [395], [396]. It has also been shown that RIPK3 can mediate necroptosis following TLR 
activation only [397]. Further experiments however are required to investigate the true effect of 
caspase-8 in DH82 cells. I therefore aim to perform limiting dilution and genotyping of single cell 





Characterisation of Dog-Mouse primary bone marrow derived macrophages containing the 




Comparative genome analysis has identified differences in a number of key genes involved in 
inflammasome formation and regulation between humans and dogs [41], [154]. Members of the 
order Carnivora, which includes both cats and dogs, lack NAIP genes [41] which have evolved for 
the recognition of flagellin [46] and type III secretion system components of bacteria [124], [348]. 
Furthermore, NLRC4, which is principally involved in flagellin detection, exists as a pseudogene, 
containing multiple stop codons [41]. Marked differences are also evident in their caspase 
repertoire, namely fusion of caspase-1, -4 and -11 to generate a novel hybrid gene in dogs and cats, 
consisting of the CARD domain and the CASP domain of caspase-1 and caspase-11, respectively 
[154].  
 
In chapter 3 of this thesis the cellular responses of the canine DH82 cell line to well established 
inflammatory activators were investigated. Cell lysis and IL-1β responses following challenge 
with whole organisms using wild-type and mutant S. Typhimurium strains were also investigated 
(Chapter 4). Collectively the results obtained from these series of experiments questioned the 
functionality of the canine caspase-1/4/11 hybrid protein and its role in driving cell death and 
cytokine processing (Chapter 3).  
 
The genes encoding caspase-1 and caspase-11 are located within close proximity on chromosome 
9 of the mouse genome. Using CRISPR-Cas9 technology a large deletion was introduced into wild 
type mouse embryos which encompassed the CASP domain of caspase-1 and the CARD domain 
of caspase-11 (unpublished data Vishva Dixit’s research group, Genentech Research Facility, 
South San Francisco, California). Consequently, this deletion resulted in the generation of progeny 
(designated DogMo) with the same genomic arrangement of mouse caspase-1 and caspase-11 




The work in this chapter describes a series of in vitro cell culture assays carried out using primary 
DogMo bone marrow derived macrophages. I characterised the responses of the hybrid caspase-
1/4/11 gene to the canonical NLRP3 inflammasome ligand, nigericin [82], [85] and the non-
canonical inflammasome caspase-11 activator, intracellular LPS [163], [168]. The role of this  
gene fusion was also characterised in response to in vitro S. Typhimurium infection assays [123]. 
Inflammasome activation was assessed by the measurement of LDH and pro-inflammatory 
cytokine IL-1β released into the culture supernatant following stimulation of macrophage cell 
lines. Hybrid caspase protein expression and the processing of the pyroptotic cell death executioner 
GSDMD were also assessed by western blotting.  
 
6.2 Genotyping of DogMo cells for the caspase-1/4/11 fusion gene  
 
Whole genome sequencing of the DogMo CRISPR-Cas9 edited mice revealed a large deleted 
region of 20,524 bp in length (Appendix 14) in multiple mouse pups (unpublished data from Dixit 
group). The deletion encompassed regions of both caspase-1 and caspase-11 genes (Figure 6.2.1). 
Consequently the CASP domain of caspase-1, the CARD domain of caspase-11 together with the 
intermediate sequences were deleted (Figure 6.2.1). The genotype of the DogMo primary BMDM 
cells was confirmed by PCR using the primer set designed by the Dixit group (Table 2.14 and 
2.15). PCR was performed using the conditions as outlined in Materials and Methods section 2.13. 
Briefly, genomic DNA was extracted from differentiated primary mouse wild-type and DogMo 
primary BMDM cells. Following PCR, amplicon products were analysed by agarose gel 
electrophoresis (Figure 6.2.2). The predicted amplicon sizes for wild-type and hybrid sequences 









Figure 6.2.1 Mouse caspase-1 and caspase-11 chromosomal regions targeted by CRISPR-
Cas9. Caspase-1 and caspase-11 genes are located next to each other on chromosome 9 of the 
mouse genome. Two guide RNAs (AATTTAGATCAACACTAGGA, 
GGAACTTTGACTAGGTACTA) were designed to target the third exon of mouse caspase-1 and 




Figure 6.2.2 Genotyping of differentiated primary wild-type and DogMo macrophages by 
PCR. Genomic DNA was extracted from a subset of primary murine wild-type and DogMo 
macrophages. Genotyping was performed by PCR using the primer set described in Materials and 
Methods section 2.13. PCR products were resolved by PAGE using 1% agarose gel. Expected 




6.3 Canonical NLRP3 inflammasome activation in DogMo cells containing the hybrid 
caspase-1/4/11 gene 
 
It has been shown at the cellular level that exposure to nigericin induces potassium efflux which 
triggers the activation of the canonical NLRP3 inflammasome [82]. Moreover, the subsequent 
activation of caspase-1 leads to inflammatory cytokine IL-1β maturation [42] and to the cleavage 
and liberation of the active N-terminal domain of GSDMD protein responsible for inducing 
pyroptotic cell death. In brief, murine wild-type and DogMo cells were differentiated for 5 days 
as described in Materials and Methods section 2.3. Murine wild-type, DogMo and DH82 cells 
were subsequently primed with LPS and stimulated with 20 µM nigericin for a period of 1 hour. 
 
Results previously described in this thesis revealed that murine macrophages lacking caspase-1 
and caspase-11 genes failed to undergo pyroptotic cell death in response to standard nigericin 
stimulation (Figure 3.5.1). DH82 cells stimulated with nigericin at standard concentration (20 µM) 
however displayed ASC speck formation and activated caspase recruitment to the ASC speck 
suggesting NLRP3 activation (Figure 3.5.4). Cell lysis in DH82 macrophages was only seen at 
high concentrations of nigericin (200 µM) (Figure 3.5.1), suggesting that the hybrid caspase is 
inactive and that the cell lysis occurred through an NLRP3 independent cell death mechanism 
(Figure 3.5.1). In this experiment I investigated whether the mouse hybrid caspase-1/4/11 protein 
could be activated within the context of the NLRP3 inflammasome leading to pyroptotic cell death 
via GSDMD cleavage. DogMo cells responded to standard concentrations of nigericin (20 µM 
final concentration) producing LDH (Figure 6.3.1). The relative level of response however was 
marginally lower than that observed in similarly stimulated wild-type murine cells (Figure 6.3.1).  
These data suggested that the CARD domain of the DogMo caspase-1/4/11 fusion was sufficient 
to facilitate its’ recruitment to the NLRP3 inflammasome and capable of initiating pyroptotic cell 
death via the CARD domain of caspase-11. IL-1β processing however was significantly reduced, 
supporting the literature that IL-1β is not a substrate of caspase-11.     
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Figure 6.3.1 Activation of canonical inflammasome in DogMo cells by nigericin causes cell 
lysis but not IL-1β release. Murine wild-type, DogMo and canine DH82 cells were primed with 
LPS (200 ng/ml for 3 hours) prior to incubation with nigericin (20 µM final concentration). 
Nigericin induced cell lysis was assessed by direct measurement of LDH release into the 
supernatant. IL-1β release was quantified using canine and murine specific ELISAs, respectively. 
Data shown is pooled from two independent experiments. Error bars represent the standard error 
of means (SEM) of triplicate wells. 
In 2016, two independent studies identified the GSDMD protein as a substrate of activated 
inflammatory caspases [70], [72] and underpinned it’s  key role as the executioner of pyroptotic 
cell death in response to pathogenic infections [70], [72]. In resting cells, the catalytically active 
N-terminal domain of GSDMD is locked in an autoinhibited form by its C-terminal anchor [44].
Following cleavage by activated caspases, the N-terminal domain of GSDMD (GSDMD-N) is
liberated and upon its oligomerisation induces pore formation in the plasma membrane. I therefore
investigated whether GSDMD cleavage in DogMo macrophages occurs in response to canonical
NLRP3 inflammasome activation (Figure 6.3.2). Lysates derived from LPS primed cells
stimulated with nigericin (Figure 6.3.1) were immunoblotted for evidence of GSDMD cleavage
using a murine specific anti-GSDMD antibody (Figures 6.3.2 and 6.3.3) as described in Materials
and Methods sections 2.9 and 2.11. Western blot of cell lysates prepared from both medium only
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and LPS primed murine wild-type and DogMo primary BMDMs detected a single band of 
approximately 53 kDa which corresponds to full length GSDMD protein (Figures 6.3.2 and 6.3.3). 
In contrast, immunoblotting of lysate prepared from LPS primed/nigericin stimulated cells 
revealed a protein band migrating at approximately 30 kDa which corresponds to GSDMD-N 
(Figures 6.3.2 and 6.3.3). These results suggested the hybrid protein consisting of caspase-1 CARD 
domain and caspase-11 CASP domain drives GSDMD cleavage in response to NLRP3 activation. 
The cell death process triggered by nigericin stimulation of the DogMo macrophages could, 




Figure 6.3.2 NLRP3 activation drives GSDMD cleavage in wild-type macrophages. Murine 
primary wild-type macrophages were primed with LPS (200 ng/ml for 3 hours) followed by 
stimulation with nigericin (20 µM for 1 hour). GSDMD cleavage was determined by western 







Figure 6.3.3 Murine hybrid caspase-1/4/11 protein is capable of initiating pyroptosis via 
GSDMD cleavage. Murine DogMo cells were primed with LPS (200 ng/ml for 3 hours) followed 
by stimulation with nigericin bacterial toxin (20 µM for 1 hour). GSDMD cleavage was 
investigated by western blotting of cell lysates using murine specific GSDMD antibody following 
protein extraction. Representative immunoblot is from a single experiment. 
 
The expression pattern of the murine hybrid caspase protein following inflammasome activation 
was also investigated (Figures 6.3.4 and 6.3.5). While murine caspase-11 expression requires 
priming via TLR/NF-κβ pathways, murine caspase-1 has been shown to be constitutively 
expressed in murine bone marrow derived macrophages [160]. Consequently, expression of the 
caspase fusion protein was investigated by a combination of mass spectrometry and western 
blotting. Mass spectrometry analysis of non-stimulated DH82 cells revealed that the canine hybrid 
caspase-1/4/11 protein was constitutively expressed in macrophages (Figure 3.2.2). I therefore 
carried out western blot analysis of protein extracts prepared from cell lysates of non-stimulated 
(medium only), LPS primed (200 ng/ml for 3 hours) and LPS primed and nigericin (20 µM for 1 
hour) stimulated DogMo cells. In accordance with my previous results, western blotting analysis 
confirmed the constitutive expression of the murine hybrid protein in the DogMo cells (Figure 




   
 
Figure 6.3.4 Caspase-1 is constitutively expressed in wild-type macrophages. Murine primary 
wild-type cells were primed with LPS (200 ng/ml for 3 hours) followed by incubation with 
nigericin (20 µM for 1 hour). The presence of constitutively expressed caspase-1 protein was 
confirmed by western blotting of cell lysates using murine specific caspase-1 antibody. 












Figure 6.3.5 Western blotting analysis of DogMo hybrid caspase-1/4/11 protein shows 
constitutive expression reminiscent of wild-type caspase-1 protein. Murine primary DogMo 
cells were primed with LPS (200 ng/ml for 3 hours) followed by stimulation with nigericin 
bacterial toxin (20 µM for 1 hour). The presence of the hybrid caspase-1/4/11 protein was 
confirmed by western blotting of cell lysates using murine specific caspase-11 antibody. 
Representative immunoblot is from a single experiment. 
 
6.4 Non-canonical inflammasome formation in DogMo cells containing hybrid caspase-
1/4/11 gene  
 
The CARD domain of caspase-11 has been shown to directly bind the lipid A moiety of bacterial 
LPS [61], [163], [168]. In the following experiments I investigated cell death responses of murine 
wild-type, DogMo and DH82 cells following transfection of LPS into the cytosol. Briefly, the 
respective cells were primed using TLR1/2 ligand Pam3CSK4 to initiate cytokine expression 
[343]. Cells were subsequently transfected with 5 µg or 10 µg LPS using FuGene HD transfection 
reagent as described in Materials and Methods section 2.6.  
 
My results confirmed the essential role of the CARD domain of caspase-11 in driving pyroptotic 
cell lysis in response to cytosolic LPS delivery (Figure 6.4.1A). Wild-type murine primary BMDM 
cells exhibited 20% cell lysis (based on LDH release) in response to cytosolic LPS (Figure 6.4.1A). 
In accordance with previously described results in this thesis (Figure 3.6.2), canine DH82 cells did 
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not undergo cell lysis following cytosolic LPS treatment (Figure 6.4.1A). As expected, DogMo 
cells containing the hybrid protein (lacking the CARD domain of caspase-11), similarly to DH82 
cells, did not undergo cell lysis in response to cytosolic LPS (Figure 6.4.1A).  
Despite the absence of the caspase-11 CARD domain in DogMo macrophages, a small amount of 
IL-1β was detected in the culture supernatant post LPS transfection (Figure 6.4.1B). In contrast, 
wild-type murine and DH82 cells released large amounts of IL-1β into the supernatant (Figure 
6.4.1B). These results suggested that despite the lack of caspase-11 CARD domain, either the 
murine hybrid protein was able to recognise cytosolic LPS, albeit less efficiently compared to 
wild-type caspase-11 or an alternative mechanism exists to recognise cytosolic LPS. 
Figure 6.4.1 Diminished IL-1β release occurs from DogMo cells in response to non-canonical 
inflammasome activation. Murine wild-type, DogMo and canine DH82 cells were primed with 
Pam3CSK4 (10 µg/ml for 4 hours) then transfected with LPS at 5- and 10 µg/ml final 
concentrations using Fugene HD. (A) Percentage of cell lysis was determined by the measurement 
of LDH release into the culture supernatant. (B) IL-1β release was measured using murine specific 
ELISA. Results are representative of two independent experiments. Error bars represent the 
standard error of means (SEM) of triplicate wells. 
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I also investigated whether GSDMD cleavage occurs in cell lysates prepared from non-stimulated 
(medium only), Pam3 primed only (10 µg/ml for 4 hours) and LPS transfected murine wild-type 
and DogMo primary macrophages (Figure 6.4.1). Previous attempts at western blot to detect 
canine GSDMD using murine specific anti-GSDMD antibody proved inconclusive (3.3.4). As 
expected, full length GSDMD (~53 kDa) was detected in both wild-type and DogMo macrophages 
however, faint protein bands corresponding to the expected size of GSDMD N-terminal domain 




Figure 6.4.2 Constitutive expression of GSDMD in murine wild-type and DogMo cells. 
Murine primary wild-type and DogMo cells were primed with Pam3 (10 µg/ml for 4 hours) 
followed by LPS transfection (5 µg/ml for 16 hours). The presence of constitutively expressed 
GSDMD protein was confirmed by western blotting of cell lysates using murine specific GSDMD 
antibody. Representative immunoblot is from a single experiment. 
 
To investigate whether the relatively small amount of IL-1β released by DogMo cells occurs as a 
consequence of caspase-1/4/11 hybrid protein activation, cell lysates from non-stimulated 
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(medium only), Pam3 primed and LPS transfected murine primary wild-type and DogMo cells 
were prepared for western blot analysis (Figure 6.4.2). Immunoblotting for murine caspase-11 
identified the full-length hybrid and wild-type caspase-11 protein, but not the cleaved forms in 
DogMo cells, but full length and cleaved caspase-11 was seen in wild-type cell lysates (Figure 
6.4.3). 
Figure 6.4.3 Western blotting analysis reveals the presence of full length wild-type caspase-
11 and hybrid caspase-1/4/11 proteins following LPS transfection of DogMo cells. Murine 
primary wild-type and DogMo cells were primed with Pam3 (10 µg/ml for 4 hours) followed by 
LPS transfection (5 µg/ml for 16 hours). The presence of caspase-11 expression was confirmed by 
western blotting of cell lysates using murine specific caspase-11 antibody. Representative 
immunoblot is from a single experiment. 
6.5 Functional characterisation of DogMo macrophages in response to S. Typhimurium 
infection 
Mouse primary wild-type and DogMo macrophages were differentiated for 5 days and 
subsequently infected with wild-type S. Typhimurium (SL1344) using increasing MOIs (1-, 10-, 
and 50) as described in Materials and Methods section 2.5. Inflammasome activation was 
determined by measuring the percentage of cell lysis induced and the amount of IL-1β released 
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into the supernatant of S. Typhimurium infected cells at different time-points post infection (1, 2, 
6 and 24 hours). Cell lysis was determined by measuring the relative amount of LDH released into 
the supernatant. While the presence of IL-1β was determined using canine and murine specific 
ELISA kits, respectively.  
 
Using these in vitro infection assays I investigated the function of the mouse caspase-1/4/11 fusion 
protein in response to whole organism challenge using S. Typhimurium. Surprisingly, my results 
showed that DogMo cells, similarly to wild-type murine cells, readily recognised intracellular S. 
Typhimurium (Figure 6.5.1A). While DogMo cells lysis was reduced compared to wild-type cells, 
their cell death responses exhibited similar kinetics (Figure 6.5.1A). These results suggested the 
hybrid caspase-1/4/11 in murine cells was functional and was capable of driving pyroptotic cell 
death in response to S. Typhimurium infection. 
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Figure 6.5.1 Murine caspase-1/4/11 hybrid protein drives cell lysis in response to S. 
Typhimurium infection. Murine primary wild-type, DogMo and canine immortalised DH82 cells 
were infected with S. Typhimurium with three different MOIs; (A) 1, (B) 10  and (C) 50. 
Percentage of cell lysis at 1, 2, 6 and 24 hours post infection was determined via the measurement 
of relative LDH release. Results are representative of two independent experiments. Error bars 
represent the standard error of means (SEM) of triplicate wells. 
Following infection, cell lysates were analysed for GSDMD cleavage by western blotting using 
murine specific GSDMD antibody (Figures 6.5.2 and 6.5.3). GSDMD-N was observed in both 
wild-type and DogMo macrophages infected with S. Typhimurium (Figures 6.5.2 and 6.5.3). These 
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results confirmed that the murine caspase-1/4/11 hybrid protein was able to cleave GSDMD in the 
DogMo macrophages, a role undertaken by caspase-1 in the wild-type counterpart (Figures 6.5.2 
and 6.5.3). In summary, the hybrid caspase protein expressed in the DogMo macrophages is 




Figure 6.5.2 GSDMD is cleaved in wild-type murine macrophages in response to S. 
Typhimurium infection. Murine primary wild-type cells were infected with S. Typhimurium 
using MOI of 10 for 6 hours. GSDMD cleavage was determined by western blotting of cell lysates 









Figure 6.5.3 DogMo macrophages containing the hybrid caspase-1/4/11 protein can cleave 
GSDMD following S. Typhimurium infection. Murine primary DogMo cells were infected with 
S. Typhimurium using MOI of 10 for 6 hours. GSDMD cleavage was investigated by western 
blotting of cell lysates using murine specific GSDMD antibody following full protein extraction. 
Representative immunoblot is from a single experiment. 
 
Wild-type murine primary and canine DH82 cells underwent cell lysis (Figure 6.5.1) and released 
large amounts of IL-1β into the supernatant (Figure 6.5.4) following S. Typhimurium infection. 
While IL-1β release from DogMo cells was diminished (Figure 6.5.4), a small amount of IL-1β 
was detected in the cell culture supernatant. These results suggested that, similarly to what I 
observed following stimulation with nigericin and cytosolic LPS, the CARD domain of the DogMo 
fusion protein was capable of driving cell lysis. 
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Figure 6.5.4 Diminished IL-1β release occurs from DogMo cells in response to S. 
Typhimurium infection. Murine wild-type, DogMo and canine DH82 cells were infected with S. 
Typhimurium with three different MOIs; (A) 1, (B) 10 and (C) 50. IL-1β release in the supernatant 
was measured by ELISA at 1, 2, 6 and 24 hours post infection. Results are representative of two 
independent experiments. Error bars represent the standard error of means (SEM) of triplicate 
wells. 
6.6 Pharmacological inhibition of caspase-8 activity within the inflammasome 
It has been shown that in addition to caspase-1, caspase-8 can also be recruited to the 
inflammasome in S. Typhimurium infected murine BMDMs [140]. Its activation has been 
proposed to play an important role in regulating IL-1β expression and maturation [140]. I therefore 
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investigated whether caspase-8 activity was driving the lytic cell response seen in DogMo 
macrophages in response to canonical and non-canonical inflammasome activators. Caspase-8 was 
pharmacologically inhibited using Z-IETD-FMK at a final concentration of 10µM and 
inflammasome activation was assessed by measuring the relative amount of LDH and IL-1β 
released into the culture supernatant.  
 
Stimulation of DogMo macrophages with nigericin in the presence of the caspase-8 inhibitor 
resulted in approximately 50% reduction in cell lysis when compared to cells in the absence of the 
inhibitor (Figure 6.6.1A). Only a small reduction in cell lysis was observed with wild-type mouse 
macrophages is response to nigericin stimulation in the presence of the caspase-8 inhibitor (Figure 
6.6.1A). This suggested that in the DogMo cells, caspase-8 played a key role in driving cell lysis 
in response to nigericin. A marked reduction in IL-1β release was also evident in wild-type murine 
macrophages stimulated with nigericin and caspase-8 inhibitor (Figure 6.6.1B). Taken together 
these data suggested that in the absence of bonifide caspase-1, as is the case for the DogMo cells, 
caspase-8 played a key role in driving cell lysis in response to nigericin induced NLRP3 activation. 
These conclusions however were made with the caveat that interpreting results involving the 











Figure 6.6.1 Pharmacological inhibition of caspase-8 reduces cell lysis in response to 
nigericin. Murine wild-type, DogMo and canine DH82 cells were primed with LPS (200 ng/ml 
for 3 hours) then stimulated with nigericin bacterial toxin (20 µM) and caspase-8 inhibitor (Z-
IETD-FMK) at 10µM final concentration. Nigericin induced cell lysis was assessed by directly 
measuring LDH released into the supernatant. IL-1β release was quantified using canine and 
murine specific ELISAs, respectively. Results are representative of a single experiment. Error bars 
represent the standard error of means (SEM) of triplicate wells. 
Pharmacological inhibition of caspase-8 in LPS transfected wild-type murine macrophages 
resulted in reduced cell lysis compared to those cells transfected with LPS alone (Figure 6.6.2). 
Independent studies have shown that pyroptotic cell death following cytosolic LPS recognition is 
driven by inflammatory caspase-11 [61], [163], [168], [342]. The reduced cell lysis observed in 
wild-type murine macrophages suggested that either caspase-8 was also recruited to the non-
canonical inflammasome or the caspase-8 inhibitor could also inhibit caspase-11. Lack of 
specificity in the caspase-8 inhibitor has been suggested [398], [399]. An alternative approach to 
investigate the role of caspase-8 in the context of cell lytic response would be to repeat these 
experiments in caspase-8/RIPK3 double knock-out mice. Unfortunately in this experiment LPS 
transfection did not result in either LDH or IL-1β release into the supernatant of DogMo cells 
therefore, the effect of pharmacological inhibition of caspase-8 could not be investigated.  
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Figure 6.6.2 The effect of pharmacological inhibition of caspase-8 activity on cell lysis and 
IL-1β production in LPS transfected DogMo cells could not be investigated. Murine wild-
type, DogMo and canine DH82 cells were primed with Pam3CSK4 (10 µg/ml for 4 hours) then 
transfected with LPS at 5 µg/ml final concentration and stimulated with caspase-8 inhibitor (Z-
IETD-FMK) at 10 µM final concentration. (A) Percentage of cell lysis induced was determined by 
measuring LDH released into the supernatant, while (B) IL-1β release was measured using murine 
and canine specific ELISA kits. Results are representative of a single experiment. Error bars 
represent the standard error of means (SEM) of triplicate wells. 
Inhibition of caspase-8 using Z-IETD-FMK in S. Typhimurium (MOI of 10) infected wild-type 
murine BMDMs had little, if any, effect on cell lysis at any of the time-points post infection (Figure 
6.6.3). In contrast to wild-type cells, inhibition of caspase-8 significantly reduced the percentage 
of cell lysis induced at early time-points, 1 and 2 hours post infection (Figure 6.6.3A and B) in 
DogMo cells containing the hybrid caspase-1/4/11 protein. Marginal inhibition was observed at 
later time-points (6 and 24 hours post infection). I therefore aim to confirm these results in a cell 
line containing the hybrid caspase-1/4/11 gene in a caspase-8-deficient background.  
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Figure 6.6.3 Pharmacological inhibition of caspase-8 reduced cell lysis induced at early time-
points following S. Typhimurium infection in DogMo cells. Murine primary wild-type, DogMo 
and canine DH82 cells were infected with S. Typhimurium with MOI of 10 and stimulated with 
caspase-8 inhibitor (Z-IETD-FMK) at 10 µM final concentration. Percentage of cell lysis at (A) 1, 
(B) 2, (C) 6 and (D) 24 hours post infection was determined by measurement of LDH release into
the culture supernatant. Results are representative of a single experiment. Error bars represent the
standard error of means (SEM) of triplicate wells.
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Pharmacological inhibition of caspase-8 in wild-type murine BMDMs reduced the amount of IL-
1β detected in the supernatant at all time-points investigated while it showed no effect on canine 
DH82 cells (Figure 6.6.3). In contrast to wild-type cells, no IL-1β was detected in the supernatant 
of DogMo cells at early time-points, therefore the effect of caspase-8 inhibition could not be 
investigated (Figure 6.6.4A and B). At later time-points (6 and 24 hour post infection) however 
the inhibition of caspase-8 reduced the amount of IL-1β detected in the supernatant of DogMo 
cells (Figure 6.6.4C and D). These results suggested that the small amount of IL-1β in the 
supernatant could be processed by caspase-8 activity.  
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Figure 6.6.4 The effect of pharmacological inhibition of caspase-8 activity on IL-1β release 
could not be investigated in DogMo cells. Murine wild-type, DogMo and canine DH82 cells 
were infected with S. Typhimurium using MOI of 10 and stimulated with caspase-8 inhibitor (Z-
IETD-FMK) at 10 µM final concentration. IL-1β release in the supernatant was measured by 
ELISA method at (A) 1, (B) 2, (C) 6 and (D) 24 hours post infection. Results are representative of 





MUSCLE analysis of the canine caspase-1/4/11 transcript suggested the presence of a functional 
caspase protein (Figure 3.2.3) and mass spectrometry provided confirmation of its constitutive 
expression in DH82 cells (Figure 3.2.2). Genetic deletion of the catalytic residue of the caspase 
domain of the canine hybrid protein failed to rescue the late cell death phenotype observed during 
infection of DH82 macrophages with S. Typhimurium. In this chapter I have therefore carried out 
a series of functional assays on murine primary BMDM cells which have been genetically 
engineered to contain the hybrid caspase-1/4/11gene (DogMo cells) in order to determine whether 
the caspase1/11 fusion is not functional or whether there is something unique about its functional 
activity in dogs. Wild-type mice were genetically modified by the Dixit lab using CRISPR-Cas9 
gene editing technology to induce a large deletion extending to the caspase domain of caspase-1 
and the CARD domain of caspase-11. This 20,524 bp deletion (Figure 6.2.2) generated a similar 
gene organisation to that of the shorter transcript of the canine hybrid caspase-1/4/11 gene (Figure 
3.1.1).  
 
The results obtained from a series of in vitro experiments to characterise inflammasomes revealed 
that wild-type and DogMo cells exhibited similar lytic responses to canonical NLRP3 (nigericin) 
and NLRC4 (S. Typhimurium infection) (Figures 6.3.1 and 6.5.1) activators albeit with marginally 
lower responses in DogMo cells compared to wild-type murine macrophages (Figures 6.3.1 and 
6.5.1). These results were in contrast to what I observed and have previously shown in canine 
DH82 cells (Figure 3.7.2). Mouse hybrid caspase-1/4/11 harbours the normal NAIP/NLRC4 
receptor repertoire whereas DH82 cells lack NAIP genes and their NLRC4 gene is a pseudogene 
due to two stop codons [41] The intact NAIP/NLRC4 inflammasome must, therefore, either 
activate the hybrid caspase-1/4/11 to drive cell death albeit at a lower efficiency than that driven 
by full length caspase-1 or other caspases e.g. caspase-8 could drive cell death [224]. The hybrid 
protein could function as a scaffold protein rather than an effector molecule, to recruit additional 
effector proteins to the inflammasome. These data showing pyroptosis in response to S. 
Typhimurium infection in the DogMo cells are in contrast to the results seen in DH82 macrophages 
where inflammasome activation downstream of ASC is almost absent. My data shows the 
NLRP3/ASC/active FLICA-caspase 1 speck is formed, but this complex cannot process IL-1β or 
185 
 
drive cell death.  It is possible that the canine caspase-1/4/11 protein is, in some way, switched off 
although mechanisms by which this may occur are unclear. 
 
I have shown that GSDMD was processed in DogMo cells in response to both nigericin stimulation 
and S. Typhimurium infection (Figures 6.3.3 and 6.5.3). The expression of caspase-1, caspase-11 
and the hybrid caspase-1/4/11 proteins was confirmed by western blotting. To date caspase-11 is 
thought to only detect intracellular LPS, cleave GSDMD and activate a non-canonical 
inflammasome [168]. Wild-type murine macrophages, as expected, processed IL-1β in response 
to nigericin stimulation and S. Typhimurium infection, whilst DogMo cells were not able to 
process IL-1β (Figures 6.3.1, 6.5.1 and 6.5.4). Taken together, these data suggested that the hybrid 
caspase-1/4/11 protein expressed in murine cells was functional for GSDMD driven cell death, but 
not for IL-1β processing.  
 
The CARD domain of caspase-11 has been shown to directly recognise and bind the outer 
membrane component lipid A moiety of LPS [61]. Wild-type murine cells released LDH and IL-
1β in response to LPS transfection (Figure 6.4.1). Despite the apparent lack of DogMo cell 
responsiveness to transfected LPS (no LDH or IL-1β release) (Figure 6.4.1) protein bands 
corresponding to full length and cleaved GSDMD were detected by western blotting (Figure 6.4.2) 
Both protein bands however were also present in medium only (non-stimulated) samples (Figure 
6.4.2). These results, therefore require further investigation. These observations provided 
supportive evidence for the importance of the CARD domain of caspase-11 in the recognition of 
cytosolic LPS. As discussed in Chapter 3 of this thesis, murine GSDMD antibodies were 
unsuitable for the detection of canine GSDMD (Figure 3.3.4). Preliminary results suggested that 
the mouse hybrid caspase-1/4/11 protein was able to cleave GSDMD to yield GSDMD-N. To 
investigate the processing of canine GSDMD, I have subsequently utilized CRISPR-Cas9 gene 
editing approaches to introduce a FLAG-tag onto the endogenous canine GSDMD gene 
immediately upstream of the STOP codon as described in Materials and Methods section 2.12. 
Sequencing confirmed the insertion of the FLAG-tag motif for one of the guide RNAs 
(CTGAGCGAGGACCCCTGTTA) used and subsequent single cell cloning and further 





Surprisingly, pharmacological inhibition of caspase-8 reduced the extent of cell lysis in DogMo 
cells following both nigericin stimulation (Figure 6.6.1) and at early time-points post S. 
Typhimurium infection (Figure 6.6.3). Caspase-8 has been shown to play an important role in the 
priming and modulation of IL-1β production, but not cell death, in response to S. Typhimurium 
infection [140]. Results obtained here suggest a crucial role of caspase-8 in driving cell lysis in 





Discussion and Future Work 
 
Inflammasomes are macromolecular multiprotein complexes that assemble in response to a wide 
range of inflammatory stimuli. Inflammasomes are composed of a receptor (e.g. NLRP3, NLRC4), 
an adaptor (ASC) and effector proteins (e.g. caspase-1). Inflammasome activation leads to the 
processing of inflammatory cytokines IL-1β and IL-18 into their bioactive forms and cleavage of 
GSDMD to execute pyroptotic cell death. Their assembly and activation is thought to be essential 
to mount effective host defence responses against invading pathogens. Their putative importance 
established in human and mouse systems suggest that their components should be conserved across 
different animal species. There are however major differences in inflammatory receptors and 
particularly in caspase repertoire found in different species, raising questions about their function 
and importance in host defence.  
 
The primary aim of my research was, originally, to investigate the role of the inflammatory 
caspase-1/4/11 isoform found in the dog (Canis lupus familiaris). Little is known about how this 
unique gene organization affects inflammasome formation and ultimately innate immune 
responses in the dog. In this work I have characterized inflammasome functions using a canine 
immortalized DH82 macrophage-like cell line. For that, I investigated DH82 cell responses to well 
established inflammatory activator ligands and in response to infectious whole organism, 
Salmonella enterica serovar Typhimurium. I have also validated some of the major responses 
observed in DH82 cells using canine PBMCs. Inflammasome activation was measured by 
immunofluorescent detection of ASC and active caspase speck formation, IL-1β production and 
maturation and the morphological analysis of cell lysis using live cell imaging. I have also 
generated DH82 cell lines deficient for pivotal genes involved in inflammasome formation, while 
also attempting to endogenously tag target genes using recombinant CRISPR-Cas9 technology.  
 
Results that were obtained using primary canine blood MNCs suggested responses observed in the 
immortalised DH82 cell line to be a true representation of how primary dog cells behave in 
response to canonical/non-canonical activators. However, due to the low number of blood samples 
available from the clinic, only a single replicate could be performed for each inflammatory stimuli 
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used (Figures 3.5.6, 3.6.6 and 4.2.8). The nature of the samples (Figure 2.2.1 ) could possibly 
affect cell responses, it is therefore essential that additional experiments are performed on blood 
MNCs derived from healthy volunteers. In order to gain access to fresh blood samples from healthy 
volunteers, I have set up an informal collaboration with a charity called Pet Blood Bank UK 
(https://www.petbloodbankuk.org/) that provides a canine blood bank service for all veterinary 
practitioners throughout the UK. There are known breed-specific predispositions to diseases, 
therefore it would be of interest to investigate the responses of different dog breeds to various 
inflammasome activators.  
 
In this thesis, the initial responses of caspase-1/4/11-  (Figures 5.3.4 and 5.3.5) and RIPK1-
deficient (Figures 5.9.2, 5.9.3) DH82 CRISPR generated DH82 macrophages to S. Typhimurium 
challenge were investigated. For completeness, further characterisation of responses to sterile 
inflammatory ligands should also be addressed through cell lysis quantification (LDH release and 
live cell imaging), ASC speck formation, fluorescent caspase localisation (FLICA staining) and 
the production and maturation  of IL-1β. 
 
In vitro cleavage of the canine hybrid protein in an overexpression system provided evidence that 
the protein was fully functional and was able to cleave classic caspase-1 substrates; IL-1β and 
GSDMD (Guy Salvesen’s lab, unpublished data). As expected, cytosolic LPS transfection of 
primary murine BMDMs harvested from the genetically engineered DogMo mice harbouring the 
hybrid gene fusion (that is a functional equivalent of the canine caspase1/4/11 gene) failed to 
activate non-canonical inflammasome formation (Figure 7.4.1). For completeness, it would be of 
interest to apply microscopy to rule out ASC speck formation and active caspase recruitment in 
DogMo cells following LPS transfection. 
 
Due to the limited resource of frozen DogMo primary BMDMs, only a small number of 
experiments could be performed. To fully characterise DogMo cells I aimed to generate the 
equivalent caspase-1/4/11 hybrid gene organisation in both wild-type and NLRC4-deficient mouse 
iBMDMs. For this, I have successfully performed electroporation for CRISPR-Cas9 gene editing 




Bulk-edited DH82 cells for the caspase-8 gene exhibited a reduction in the amount of IL-1β 
released into the supernatant following S. Typhimurium infection (Figure 5.7.2) despite no change 
in cell lytic responses (Figure 5.7.1). Caspase-8 has been shown to regulate transcriptional priming 
of pro-IL-1β and has also been implicated in pro-IL-1β cleavage, and therefore maturation. In 
order to investigate the role of caspase-8, single cell dilution of bulk CRISPR-Cas9 edited DH82 
cells for the caspase-8 gene should be performed. Thereafter, infection with S. Typhimurium  can 
then be repeated on selected clones harbouring out-of-frame indels in the caspase-8 gene. IL-1β 
release and cleavage should be assessed using ELISA and western-blot, respectively. 
 
Results described in Chapter 4 of this thesis suggested that cell lysis (Figure 4.2.6) and IL-1β 
(Figure 4.2.7) responses following S. Typhimurium infection were largely dependent on the type 
III secretion system. PrgJ, a component of the type III secretory system has been shown to be 
directly recognised by NAIPs [133]. However, NAIPs are absent in the dog genome, yet S. 
Typhimurium lacking PrgJ still drove cell lysis in DH82 cells (Figure 4.2.6). A possible 
explanation for this result is that NLRP3 is able to sense the homeostatic changes (e.g. potassium 
efflux) induced by the delivery of bacterial effector proteins into the dog macrophage via the type 
III secretion system. It would be of interest to investigate DH82 cell responses following S. 
Typhimurium infection in the presence of elevated levels of extracellular potassium which has 
been reported to inhibit NLRP3 inflammasome formation [83, 126] 
 
Based on previous genomic sequence analysis, the NLRC4 inflammasome should not be functional 
in the dog [41]. DH82 cells infected with wild-type S. Typhimurium did not show ASC speck 
formation or activated caspase recruitment. Interestingly, DH82 cells showed delayed cell lysis 
responses, similarly to what I observed with their Nlrc4-/- and caspase-1-/-caspase-11-/- mouse 
counterparts (Figure 4.2.2). The presence of cleaved IL-1β in the supernatant of S. Typhimurium 
infected DH82 cells, which coincided with cell lysis at 24 hour post infection suggested 
inflammasome activation (Figures 4.2.3 and 4.2.4). The processed IL-1β in response to S. 
Typhimurium infection appeared to be smaller than the p17 fragment normally observed following 
caspase-1 mediated cleavage (Figure 4.4.4). Other proteins including elastase, cathepsin G and 
collagenase have been shown to process recombinant IL-1β. These proteases however produced 
cleaved IL-1β at around or larger than 17 kDa [356], [357]. This suggested the presence of a 
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perhaps not yet discovered protease driving pro-IL-1β maturation in the dog. For that, genome-
scale loss-of-function screens could be utilized to identify the protease responsible for the 
generation of mature IL-1β [400], [401]. In an effort to narrow down the search, it would also be 
useful to determine the different cleavage sites of the canine pro-IL-1β. For that, mass 
spectrometry analysis of S. Typhimurium infected and nigericin stimulated DH82 cells containing 
endogenously tagged IL-1β could be utilised to identify potential cleavage sites. 
 
Genomic sequence analysis suggested the total absence of the NAIP gene and the presence of 
multiple stop codons in the gene encoding the canine NLRC4 receptor. Analysis showed the genes 
flanking human NAIP to be direct neighbours in the dog genome, the genome sequence however 
was not contiguous in that region [41]. The lack of NAIP gene was further confirmed by blasting 
the human NAIP transcript against the canine Expressed Sequence Tag (EST) database. The 
assembly level of the canine reference genome on Ensembl is still incomplete, potentially 
containing gaps in the genome sequence 
(https://www.ncbi.nlm.nih.gov/assembly/GCF_000002285.3/). It would therefore be interesting to 
complete the reference genome of this region and confirm the total absence of NAIP genes. 
NAIP/NLRC4 receptors have been shown to be essential in controlling S. Typhimurium infections 
at early stages [402], [403]. The presence of the NLRC4 pseudogene suggests that the protein used 
to be functional. It would be intriguing to investigate whether the correction of the early stop 
codons present in the dog NLRC4 gene (equivalent of the human NLRC4 at positions Trp 30 and 
Arg 35) could restore early S. Typhimurium detection in DH82 macrophages. This could be carried 
out by introducing double-stranded DNA breaks (DSB) followed by either homology-directed 
repair (HDR) or base-editing system utilizing CRISPR-Cas9 gene editing systems [404].  
 
Sequence analysis of the known NLRP3 inflammasome constituents suggested the presence of 
functional NLRP3 inflammasome in the dog (Figures 3.2.3, 3.3.1, 3.4.3 and 3.4.1). DH82 
macrophages however appeared to be refractory to the NLRP3 inflammasome activator, nigericin 
bacterial toxin. The rate of inflammasome formation measured by ASC speck formation and active 
caspase recruitment was reduced compared to wild-type murine macrophages (Figure 3.5.4). My 
results suggested that canine DH82 macrophages are not responsive to NLRP3 inflammasome 
activation by nigericin at concentrations generally reported to be potent activators of human and 
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mouse NLRP3. NLRP3 is a promiscuous receptor, without a clear direct ligand, but research so 
far has identified K+ efflux as a common trigger for its activation [82]. It would therefore be 
interesting to investigate cell lysis and IL-1β maturation in cells incubated in low-K+ media [82]. 
To fully characterize NLRP3 inflammasome activation of canine macrophages, other well 
established NLRP3 inflammasome activators such as extracellular ATP [78], [85], uric acid 
crystals [116], silica crystals and aluminum salts [91] should also be explored in a range of 
concentrations. The adapter protein ASC facilitates pro-caspase-1 recruitment to the 
inflammasome, therefore, it is required for NLRP3 inflammasome formation which only has a 
pyrin domain and requires ASC to recruit CARD domain containing proteins [405]. Cells deficient 
for ASC fail to activate the NLRP3 inflammasome [123]. I observed only very limited NLRP3 
activation in response to high concentration of nigericin bacterial toxin (Figure 3.5.3). NEK7 
promotes NLRP3 oligomerisation and it is an essential regulator of the NLRP3 inflammasome 
[108]. NEK7 is present in canine macrophages, but whether it is an important regulatory of NLRP3 
activation in dog cells is unknown. Its’ role in NLRP3 inflammasome regulation could be 
investigated by the generation of NEK7-deficient canine macrophages. [406].           
 
Eckhart et al has predicted the presence of two alternative transcripts for the dog hybrid gene [154]. 
The larger transcript contains the CARD domain of the caspase-1 gene and the entirety of the 
caspase-4/-11 equivalent genes. While the shorter transcript of the dog hybrid gene lacks the 
CARD domain of the caspase-4 gene [154] which has been shown to directly recognize and bind 
the lipid A moiety of Gram-negative bacterial LPS [168], [170]. Non-canonical inflammasome 
formation did not induce ASC speck formation or activated caspase recruitment in dog cells, which 
suggested the expression of the shorter transcript of the canine hybrid gene. TLR priming alone 
induced large amount of mature IL-1β release without concomitant cell lysis (Figure 3.6.2). This 
phenomenon has been reported in primary human monocytes following incubation with 
extracellular LPS [185]. The authors claimed this pathway to be dependent on TLR4, RIPK1, 
FADD and caspase-8 upstream of the NLRP3 inflammasome. It would therefore be interesting to 
investigate IL-1β maturation following priming with TLR4 ligands in the presence of TAK-242, 
a TLR4 specific small molecule inhibitor [407] or caspase-8 specific inhibitors (e.g. Z-IETD-
FMK). Alternatively, non-canonical inflammasome activation could be re-examined using DH82 
cells lacking functional RIPK1 or caspase-8. RIPK1-deficient DH82 cells failed to express pro-
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IL-1β (Figure 5.9.5), while caspase-8-deficient bulk population showed it’s a large reduction 
following S. Typhimurium infection supporting the possible formation of this alternative 
inflammasome (Figure 5.7.2).  
 
Different inflammatory caspases could also be activated in the DH82 cells where the caspase 
1/4/11 fusion is poorly active. I therefore looked to identify additional caspases present in the dog 
genome, which may have functional roles that are distinct to those imparted to the hybrid caspase-
1/4/11 protein as described in Materials and Methods section 2.13. I have generated a phylogenetic 
tree for the analysis of putative and confirmed caspases for different species investigated 
(Appendix 29). Phylogenetic tree analysis showed the presence of different clusters within the 
caspase-1-like and caspase-14-like clusters. Caspases within these clusters showed pronounced 
species-based differences (Appendix 30). The caspase-1 like cluster contained the unique hybrid 
caspase-1/4/11 gene whereas the caspase-14 like cluster contained caspase-15 which is present in 
the dog, but absent in mouse and humans (Appendix 30) [408]. Analysis showed the presence of 
a putative PYRIN domain, which could potentially facilitate recruitment of caspase-15 to the 
inflammasome [409] and the presence of a caspase domain containing both large and small caspase 
catalytic subunits including amino acid residues in caspase 15 essential for its activity [408]. Using 
CRISPR-Cas9 technology I aimed to generate a caspase-15 knock-out DH82 cell line as described 
in Materials and Methods section 2.12.2 (Appendix 31). It will therefore be interesting to 
investigate the possible role of caspase-15 in DH82 cell lytic responses to S. Typhimurium 
infection. 
 
Overall, functional characterisation of the canine hybrid caspase-1/4/11 hybrid protein in DH82 
cells in response to well established canonical NLRP3, NLRC4 and non-canonical inflammasome 
activators could suggest that the hybrid protein has significantly reduced activity or perhaps is 
actively downregulated. This was also validated in DH82 cells deficient for the hybrid gene 
generated by CRISPR-Cas9 gene editing technology. The lack of catalytically active hybrid 
protein did not alter cell lytic responses or IL-1β production (Figures 5.3.4 and 5.3.5) however 
further experiments should be performed to validate the total disruption of the hybrid gene. 
Nigericin stimulated wild-type DH82 cells showed low level of ASC speck formation and active 
caspase recruitment (Figure 3.5.4). To confirm gene disruption, nigericin experiment could be 
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performed on canine caspase-1/4/11 deficient clones followed by immunofluorescent labelling for 
active caspases.  
 
DogMo cells retained their ability to induce cell death in response to NLRP3 inflammasome 
activation using nigericin (Figure 7.3.1). The amount of cell lysis induced was slightly less than 
that of wild-type murine macrophages (Figure 7.3.1). This data provided in vitro evidence that the 
protein encoded by the hybrid caspase-1/4/11 gene is indeed functional and is capable of driving 
pyroptotic cell death by cleaving GSDMD (Figure 7.3.3) [43], [44]. The lack of IL-1β however 
observed in the supernatant suggested that the hybrid protein, as expected, showed functional 
characteristics more similar to caspase-11 rather than caspase-1 (Figure 7.3.1B). It would be very 
interesting to generate additional hybrid caspases containing different CARD and caspase 
domains. For example; the CARD domain of caspase-11 and the caspase domain of caspase-1, or 
including CARD and caspase domains of apoptotic caspases. It would be fascinating to 
characterise their specificity, function and the type of stimuli they are activated by along with their 
potential substrates. We could then perhaps reprogram the type of cell death pathway that is 
induced in response to well established inflammatory stimuli. Furthermore, it would be an 
interesting tool to compare caspase specificity between different species and to investigate whether 
caspases present in different species have alternative cleavage sites.   
 
One of the major differences between canine and DogMo cells is that DogMo cells express 
NAIP/NLRC4 receptors. NLRC4 inflammasome activation was also reconstituted in DogMo cells 
(Figures 7.5.1 and 7.5.4). These responses were slightly lower to that of their wild-type 
counterpart, but not ablated as seen in either murine Nlrc4-/- or caspase-1-/-caspase-11-/- 
macrophages (Figure 4.2.2). There was no detectable IL-1β present, as expected, in the supernatant 
of wild-type S. Typhimurium infected DogMo cells (Figure 7.5.2). Further experiments confirming 
the lytic form of cell death of DogMo macrophages using bright field live cell imaging would be 
useful. Other carnivore species for example the cat (Felis Catus) contains this unique caspase-
1/4/11 hybrid gene organisation [154]. Genomic sequence analysis suggested the presence of 
functional NLRC4 receptor in the cat, but NAIP is absent [41]. It would be rather interesting to 
investigate the kinetics of S. Typhimurium induced cell lysis in an immortalised feline 
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macrophage-like cell line (Fcwf-4) and also in primary PBMCs and compare their responses to 
what I observed in the canine DH82 cells [410], [411].   
 
DogMo cells containing the hybrid caspase-1/4/11 gene completely lost their ability to process 
pro-IL-1β, but retained their functionality to induce pyroptotic cell lysis in response to NLRP3 and 
NLRC4 inflammasome activators (Chapter 6). The functional differences between the canine 
DH82 and murine DogMo cells are intriguing. While DH82 cells failed to induce rapid cell lysis 
but produced large amount of bioactive IL-1β, DogMo cells retained their capability to induce 
rapid cell lysis without the ability to process pro-Il-1β (Chapters 3, 4 and 6). This really raises 
questions about the functionality and perhaps the cellular regulation of the canine hybrid protein.  
Caspase-8 can compensate for the absence of caspase-1 and the percentage of cell lysis induced in 
DogMo cells following NLRP3 and NLRC4 inflammasome stimulation was reduced when cells 
were pre-incubated with Z-VAD-IEDT caspase-8 inhibitor (Figures 6.6.1A, 6.6.2A and 6.6.3). In 
caspase-8-deficient DH82 cells lytic responses were intact, but IL-1β processing was affected 
(Figures 5.7.1 and 5.7.2). Previous studies documented in S. Typhimurium infected murine 
macrophages lacking caspase-1 and -11 [352] showed that caspase-8 modulates pro-IL-1β 
maturation but failed to identify a role in cell lysis [352]. DogMo cells showed rapid cell lytic 
responses following S. Typhimurium infection, while Nlrc4-/- and caspase-1-/-caspase-11-/- murine 
macrophages remained intact up until 6 hour post infection (Figure 4.2.2). This observation raises 
fundamental questions about how inflammasomes function in dogs. Ideally, NLRC4 
inflammasome activation should be repeated in DogMo cells also deficient in their NLRC4 and/or 
NAIP receptors. To this end, I am in the process of generating the equivalent of the DogMo 
primary cells in immortalised murine BMDMs in both, wild-type and Nlrc4-/- background.  
 
There are marked differences in the functionality of the hybrid caspase-1/4/11 protein in DH82 
and mouse macrophages, it is interesting to highlight that DH82 cell lytic responses were similar 
to that of Nlrc4-/- and caspase-1-/-caspase-11-/- murine immortalised macrophages. My results 
however suggested the existence of two separate pathways; one controlling cytokine maturation 
while the other driving cell lysis. There is a possibility that the same cell death pathway is 
responsible for driving cell death responses in murine Nlrc4-/- and caspase-1-/-caspase-11-/- cells 




More importantly, results obtained using DogMo cells could point towards inflammasome 
downregulation in DH82 cells. It is convenient to speculate the presence of an inhibitory protein 
driving dampening of inflammasome responses in the dog. For that, it would be interesting to 
investigate differential transcription patterns in non-stimulated and stimulated primary canine, 
murine, DogMo and human macrophages. There is a possibility that the(se) inhibitory protein(s) 
are constitutively upregulated or perhaps they require transcriptional priming following ligand 
recognition. Firstly, it would be interesting to examine whether one splice variant of the canine 
hybrid is preferentially expressed over the other depending on the activating ligand. It would also 
allow me to investigate whether both transcripts are expressed but with different abundancy. RNA-
seq could potentially provide the identification of potential known regulatory proteins or novel 
transcripts that are differentially expressed in the dog compared to human, mouse and DogMo 
macrophages.  
 
It also raises questions about the importance and true functions of inflammasomes. Could it be that 
the inflammasome deficit is actually an evolutionary adaptation mechanism to tolerate 
microorganisms associated with their mode of life? Research shows that dogs can shed live S. 
Typhimurium in their stool without displaying any clinical symptoms [412]. Some dogs however 
do develop salmonellosis which mainly coincides with other pathogens or clinical conditions 
[311]. It would be interesting to conduct a study investigating inflammasome activation in canine 
gut epithelial cells alongside with enumerating their intracellular burden and bacterial replication 
using GFP-tagged wild-type S. Typhimurium strain. Dogs are carnivores and an alternative 
explanation is that the high protein diet may alter how bacteria behave in the gut and thus host 
immune genes may have been lost because they are no longer required. Based on our current 
knowledge and my thesis work, it is convenient to speculate that the presence of dysfunctional 
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Appendix 1 Sequencing analysis of bulk-edited DH82 cell populations for indels induced by 
CAACCTCAAGGACAAACCGA crRNA for the canine caspase-1/4/11 hybrid gene. DH82 
cells were electroporated with RNP complexes at three different concentrations (100, 200 and 400 
nmol). CrRNA was designed to be near the catalytic site of the canine hybrid gene. Genotyping 
using Illumina MiSeq sequencing showed electroporated only wild-type cells did not carry any 
mutations, while Cas9-edited cells showed a mixture of in-frame and out-of-frame mutations. The 
size of each pie chart corresponds to the number of reads that were analysed for each sample (see 
legend in top right corner). Pie areas in the shade of red represents out-of-frame, areas in the shade 
of blue represents in-frame insertions and deletions, grey areas represent no indel calls (see legend 





Appendix 2 Sequencing analysis of bulk-edited DH82 cell populations for indels induced by 
GCATCCTGAATGGAATCTGT crRNA for the canine caspase-1/4/11 hybrid gene. DH82 
cells were electroporated with RNP complexes at three different concentrations (100, 200 and 400 
nmol). CrRNA was designed to be near the catalytic site of the canine hybrid gene. Genotyping 
using Illumina MiSeq sequencing showed electroporated only wild-type cells did not carry any 
mutations, while Cas9-edited cells showed a mixture of in-frame and out-of-frame mutations. The 
size of each pie chart corresponds to the number of reads that were analysed for each sample (see 
legend in top right corner). Pie areas in the shade of red represents out-of-frame, areas in the shade 
of blue represents in-frame insertions and deletions, grey areas represent no indel calls (see legend 






Appendix 3 OutKnocker analysis of 96 DH82 single cell colonies electroporated with 
CRISPR crRNA targeting the canine caspase-1/4/11 hybrid gene. DH82 cells were 
electroporated with CRISPR crRNA GCATCCTGAATGGAATCTGT to target the canine hybrid 
caspase-1/4/11 gene. Following limiting dilution, up to 96 single cell colonies were selected and 
genotyped using Illumina MiSeq sequencing. Sequencing results were analysed using OutKnocker 
online analysis tool. Each pie chart represents a single colony, whereas the size of each pie chart 
corresponds to the number of reads that were analysed for each colony (see legend in top right 
corner). Pie areas in the shade of red represents out-of-frame, areas in the shade of blue represents 
in-frame insertions and deletions, while grey areas represent no indel calls (see legend in bottom 
right corner). Colony positions in red letters highlight knock-out colonies, while blue letters 






Appendix 4 Illumina MiSeq sequencing confirmed genotypes of caspase-1/4/11 knock-out 
clones A1 and C6. DH82 cells were electroporated with CRISPR crRNA 
GCATCCTGAATGGAATCTGT to target the canine hybrid caspase-1/4/11 gene near the 
catalytic site. Following limiting dilution, up to 96 single cell colonies were selected and 
genotyped using Illumina MiSeq sequencing. Two colonies, A1 and C6 were chosen for 
subsequent phenotypic characterisation. DNA extraction and genotyping using Illumina MiSeq 
sequencing were repeated on a subset of cells for each clone. Information displayed by the analysis 
software includes the file name, number of amplicon reads and indel frequency. The underscored 
nucleotide sequence represents the wild-type reference sequence, while nucleotides highlighted in 
yellow show CRISPR crRNA target sites. Information including total percentage and total number 
of reads corresponding to each identified indel are shown underneath the reference sequence. 
Nucleotides shown in smaller font sizes are less confident calls based on the sequencing data, 
while deleted nucleotides have been replaced by hyphens. The software also provides information 
on the percentage and total number of reads that could not be aligned to the reference sequence 






Appendix 5 Sequencing analysis of indels induced by TTTTATTCAGGCTTGTCAAG 
crRNA for the canine caspase-8 gene. DH82 cells were electroporated with RNP complexes at 
three different concentrations (100, 200 and 400 nmol). CrRNA was designed to be near the 
catalytic site of the canine caspase-8 gene. Genotyping using Illumina MiSeq sequencing showed 
electroporated only wild-type cells did not carry any mutations, while Cas9-edited cells showed a 
mixture of in-frame and out-of-frame mutations. The size of each pie chart corresponds to the 
number of reads that were analysed for each sample (see legend in top right corner). Pie areas in 
the shade of red represents out-of-frame, areas in the shade of blue represents in-frame insertions 
and deletions, grey areas represent no indel calls (see legend in bottom right corner) while empty 






Appendix 6 Sequencing analysis of indels induced by CCTACCGAAACCCCAATGGAG 
crRNA for the canine caspase-8 gene.  DH82 cells were electroporated with RNP complexes at 
three different concentrations (100, 200 and 400 nmol). CrRNA was designed to be near the 
catalytic site of the canine caspase-8 gene. Genotyping using Illumina MiSeq sequencing showed 
electroporated only wild-type cells did not carry any mutations, while Cas9-edited cells showed a 
mixture of in-frame and out-of-frame mutations. The size of each pie chart corresponds to the 
number of reads that were analysed for each sample (see legend in top right corner). Pie areas in 
the shade of red represents out-of-frame, areas in the shade of blue represents in-frame insertions 
and deletions, grey areas represent no indel calls (see legend in bottom right corner) while empty 






Appendix 7 List of indels identified by sequence analysis in CRISPR-Cas9 edited DH82 cells 
for caspase-8 gene using crRNA TTTTATTCAGGCTTGTCAAG. DH82 cells were 
electroporated with RNP complexes at three different concentrations (100-, 200- and 400nmol). 
CrRNA was designed to be near the identified catalytic residue of the canine caspase-8 gene. The 
analysis detected amplicon reads corresponding to wild-type sequences only in the non-
electroporated wild-type control. Cas9 edited cells exhibited a mixture of in-frame and out-of-
frame mutations. These results gave an indication on the type, position, percentage and the number 





Appendix 8 List of indels identified by sequence analysis in CRISPR-Cas9 edited DH82 cells 
for caspase-8 gene using crRNA TTTTATTCAGGCTTGTCAAG. DH82 cells were 
electroporated with RNP complexes at three different concentrations (100-, 200- and 400nmol). 
CrRNA was designed to be near the identified catalytic residue of the canine caspase-8 gene. The 
analysis detected amplicon reads corresponding to wild-type sequences only in the non-
electroporated wild-type control. Cas9 edited cells exhibited a mixture of in-frame and out-of-
frame mutations. These results gave an indication on the type, position, percentage and the number 





Appendix 9 Sequencing analysis of indels induced by TAATTATGGAGACCATTGAA 
crRNA for the canine RIPK1 gene. DH82 cells were electroporated with RNP complexes at three 
different concentrations (100, 200 and 400 nmol). CrRNA was designed to be near the catalytic 
site of the canine RIPK1 gene. Genotyping using Illumina MiSeq sequencing showed 
electroporated only wild-type cells did not carry any mutations, while Cas9-edited cells showed a 
mixture of in-frame and out-of-frame mutations. The size of each pie chart corresponds to the 
number of reads that were analysed for each sample (see legend in top right corner). Pie areas in 
the shade of red represents out-of-frame, areas in the shade of blue represents in-frame insertions 
and deletions, grey areas represent no indel calls (see legend in bottom right corner) while empty 






Appendix 10 List of indels identified by sequence analysis in CRISPR-Cas9 edited DH82 cells 
for RIPK1 gene using crRNA TAATTATGGAGACCATTGAA. DH82 cells were 
electroporated with RNP complexes at three different concentrations (100, 200 and 400 nmol). 
CrRNA was designed to be near the catalytic site of the canine RIPK1 gene. Electroporated only 
wild-type DH82 cells yielded amplicon reads that matched exclusively the wild-type sequence, 
while Cas9 edited cells yielded amplicon reads that contained a mixture of in-frame and out-of-
frame mutations. These results are indicative of the type, position, percentage and number of reads 
associated with each mutation present in the bulk edited population. The underscored nucleotide 
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sequence represents the wild-type reference sequence, while nucleotides highlighted in yellow 
show CRISPR crRNA target site. Information including total percentage and total number of reads 
corresponding to each identified indel are shown underneath the reference sequence. Nucleotides 
shown in smaller font sizes are less confident calls based on the sequencing data, while nucleotides 
replaced with hyphens represents the position of nucleotides deleted by CRISPR Cas9. The 
software also provides information on the percentage and total number of reads that could not be 














Appendix 11 Sequencing analysis of indels induced by TGGAGAAGGCGTAATACACA 
crRNA for the canine RIPK1 gene. DH82 cells were electroporated with RNP complexes at three 
different concentrations (100, 200 and 400 nmol). CrRNA was designed to be near the catalytic 
site of the canine RIPK1 gene. Genotyping using Illumina MiSeq sequencing showed 
electroporated only wild-type cells did not carry any mutations, while Cas9-edited cells showed a 
mixture of in-frame and out-of-frame mutations. The size of each pie chart corresponds to the 
number of reads that were analysed for each sample (see legend in top right corner). Pie areas in 
the shade of red represents out-of-frame, areas in the shade of blue represents in-frame insertions 
and deletions, grey areas represent no indel calls (see legend in bottom right corner) while empty 






Appendix 12 List of indels identified by sequence analysis in CRISPR-Cas9 edited DH82 cells 
for RIPK1 gene using crRNA TGGAGAAGGCGTAATACACA. DH82 cells were 
electroporated with RNP complexes at three different concentrations (100, 200 and 400 nmol). 
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CrRNA was designed to be near the catalytic site of the canine RIPK1 gene. Electroporated only 
wild-type DH82 cells yielded amplicon reads that matched exclusively the wild-type sequence, 
while Cas9 edited cells yielded amplicon reads that contained a mixture of in-frame and out-of-
frame mutations. These results are indicative of the type, position, percentage and number of reads 
associated with each mutation present in the bulk edited population. The underscored nucleotide 
sequence represents the wild-type reference sequence, while nucleotides highlighted in yellow 
show CRISPR crRNA target site. Information including total percentage and total number of reads 
corresponding to each identified indel are shown underneath the reference sequence. Nucleotides 
shown in smaller font sizes are less confident calls based on the sequencing data, while nucleotides 
replaced with hyphens represents the position of nucleotides deleted by CRISPR Cas9. The 
software also provides information on the percentage and total number of reads that could not be 












Appendix 13 Illumina MiSeq sequencing identified knock-out cell clones for the canine 
RIPK1 gene. Limiting dilution of bulk-edited cells generated using crRNA 
GCATCCTGAATGGAATCTGT were carried out. Following limiting dilution, up to 96 colonies 
each originating from a single cell were selected and genotyped using Illumina MiSeq sequencing. 
Sequencing results were analysed using OutKnocker online analysis tool. Each pie chart represents 
a single colony, whereas the size of each pie chart corresponds to the number of reads that were 
analysed for each colony (see legend in top right corner). Pie areas in the shade of red represents 
out-of-frame, areas in the shade of blue represents in-frame insertions and deletions, while grey 
areas represent no indel calls (see legend in bottom right corner). Colony positions in red letters 
















































































































































































































































































































Appendix 14 Large deletion (20,524bp deletion in length) was introduced in the CASP 

















Appendix 15 Uncropped immunoblots presented in Figure 3.3.2. Western blotting analysis of 
full protein extracts of immortalised murine wild-type, Asc-/- and DH82 cell lysates using primary 





Appendix 16 Uncropped immunoblots presented in Figure 3.3.4, GSDMD 
immunoprecipitation. Immunoblotting of GSDMD protein from DH82 cell lysates infected with 





Appendix 17 Uncropped immunoblots presented in Figure 3.5.3, IL-1β 
immunoprecipitation. Western blot analysis of the supernatant reveals small degree of IL-1β 




Appendix 18 Uncropped immunoblots presented in Figure 3.6.3, IL-1β 






Appendix 19 Uncropped immunoblots presented in Figure 4.2.4, IL-1β 





Appendix 20 Uncropped immunoblots presented in Figure 5.9.4, IL-1β 
immunoprecipitation. RIPK1 is essential for inflammatory cytokine pro-IL-1β expression in 





Appendix 21 Uncropped agarose gel presented in Figure 7.2.2. Genotypes of differentiated 







Appendix 22 Uncropped immunoblot presented in Figures 7.3.2 and 7.3.3, GSDMD 
immunoprecipitations. Activated NLPR3 inflammasome cleaves GSDMD protein which induces 
pyroptotic cell death in response to nigericin treatment while murine hybrid caspase-1/4/11 protein 




Appendix 23 Uncropped immunoblot presented in Figure 7.3.4, caspase-1 
immunoprecipitation. Western blotting analysis of caspase-1 protein shows constitutive 





Appendix 24 Uncropped immunoblot presented in Figure 7.3.5, caspase-11 
immunoprecipitation. Western blotting analysis of DogMo hybrid caspase-1/4/11 protein shows 




Appendix 25 Uncropped immunoblot presented in. Figure 7.4.2, GSDMD 





Appendix 26 Uncropped immunoblot presented in Figure 7.4.3, caspase-11 
immunoprecipitation. Western blotting analysis showed the presence of full length wild-type 




Appendix 27 Uncropped immunoblot presented in Figures 7.5.3 and 7.5.4, GSDMD 
immunoprecipitation. GSDMD is cleaved in wild-type murine macrophages in response to S. 
Typhimurium infection while mouse macrophages containing the hybrid caspase-1/4/11 protein 





Appendix 28 OutKnocker sequence analysis identified the FLAG-tag sequence inserted in 
CRISPR edited DH82 cells using CTGAGCGAGGACCCCTGTTA crRNA for the canine 
GSDMD gene. DH82 cells were electroporated with RNP complexes at 400nmol final 
concentrations. CrRNAs and HDR templates were designed to be near the STOP codon of the 
canine GSDMD gene. The underscored nucleotide sequence represents the wild-type reference 
sequence, while nucleotides highlighted in yellow show CRISPR crRNA target site. Information 
including total percentage and total number of reads corresponding to each identified indel are 
shown underneath the reference sequence. Nucleotides shown in smaller font sizes are less 
confident calls based on the sequencing data, while nucleotides replaced with hyphens represents 
the position of nucleotides deleted by CRISPR Cas9. The software also provides information on 
the percentage and total number of reads that could not be aligned to the reference sequence and 





Appendix 29 Phylogenetic analysis of putative and confirmed caspases identified differences 
in the caspase-1-like and caspase-14-like evolutionary branches. The phylogenetic tree was 
generated using neighbour-joining clustering method. Bootstrapping was used to estimate the 
confidence of the branches within the phylogenetic tree. The resulting value provided a level of 
confidence of the branches in the phylogenetic tree, where the higher value represented more 







Appendix 30 Caspase-14 like evolutionary branch contains caspase-14, -15 and 16 genes. The 
phylogenetic tree was generated using neighbour-joining clustering method. Bootstrapping was 
applied to estimate the confidence of the branches within the phylogenetic tree. The resulting value 
provided a level of confidence of the branches in the phylogenetic tree, where the higher value 
represented more confident relationships. Close up image of the caspase-14-like cluster showed 






Appendix 31 List of indels identified by sequence analysis in CRISPR-Cas9 edited DH82 cells 
for caspase-15. DH82 cells were electroporated with RNP complexes at 400 nmol final 
concentration. CrRNAs were designed to be near the catalytic site of caspase-15. Cas9 edited cells 
yielded amplicon reads that contained a mixture of in-frame and out-of-frame mutations. The 
underscored nucleotide sequence represents the wild-type reference sequence, while nucleotides 
highlighted in yellow show CRISPR crRNA target site. Information including total percentage and 
total number of reads corresponding to each identified indel are shown underneath the reference 
sequence. Nucleotides shown in smaller font sizes are less confident calls based on the sequencing 
data, while nucleotides replaced with hyphens represents the position of nucleotides deleted by 
CRISPR Cas9. The software also provides information on the percentage and total number of reads 
that could not be aligned to the reference sequence and the number of reads that were excluded 
from analysis (Phred score dropouts).  
